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STUDIES OF THE EXCRETION OP CHOLESTEROL
AND ITS METABOLITES
S U M M A R Y  Ph. D. THESIS
W . D .  Mitchell.   1968.
This thesis describes work on the development of new techniques 
of faecal neutral steroid and bi le acid analysis and the app lication of 
these techniques to a variety of clinical circumstances in which the 
metabolism of cholesterol, and the output of faecal steroids might be 
altered.
The thesis is in four main parts.
1. A  consideration from an historical standpoint of cholesterol metabolism 
and its regulation; in particular, the reduction of serum cholesterol 
levels by three groups of compounds ;
a) Inhibitors of cholesterol biosynthesis either at an early stage in 
the biosynthetic pathway or at a stage after the cyclisation of 
squalene.
b) Compounds which cause increased excretion of faecal bile acids 
and/or faecal neutral steroids .
c) Compounds which act by impairing cholesterol absorption.
2. A  review of the application of thin layer chromatography (TLC) to 
lipid analysis. In this section the use of silver nitrate impregnated T L C  ^
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reversed phase T L C  and derivatives in the separation of structurally 
similar compounds are discussed together with the application of 
T L C  to quantitative analysis of faecal neutral steroids and bile acids.
3. A  detailed consideration of the way in which T L C  and other methods 
have been modified for use in the present study. The extraction
of neutral steroids and bile acids from faeces is described together 
with methods for their qualitative and quantitative analysis . A  
technique for estimating biliary bile acids is also described.
4. The final section is concerned with the application of quantitative 
techniques of neutral steroid and bile acid analysis to four problems.
a). The effect of oral taurine on serum cholesterol and biliary bile acid 
conjugation was studied in three subjects. The results suggest that 
although the proportion of bile acids conjugated with taurine in human 
bile can be readily increased by feeding taurine this has no effect
on serum cholesterol concentrations .
b). The mechanism by which clofibrate reduces serum cholesterol in 
patients with hypercholesterolaemia was investigated by three approaches.
1). The effect of clofibrate on the pattern of biliary bi le a cids
in five subjects with hyper cholesterolaemia .
2). The effect of clofibrate on faecal neutral steroids and 
bile acids in twenty one subjects.
_3-
3). A  comparison of the effect of clofibrate and L-thyroxine on
serum and faecal lipids in four hypothyroid patients ,
Clofibrate did not cppear to alter the conjugation ratio or the 
pattern of biliary bile acîÆs in the five subjects studied. The results 
of the comparative study with L-thyroxine suggest that the mechanism 
of action of clofibrate is quite different to that of L-thyroxine in lowering 
serum lipids . Studi es of faecal bile acids and neutral steroids in the 
21 subjects strongly suggest that the reduction of serum cholesterol • 
by clofibrate is not produced by an increased excretion of cholesterol 
or its metabolites in faeces. Inhibition of hepatic synthesis of 
cholesterol seems a more likely explanation.
c). The effect of increased oral calcium on faecal neutral steroids and 
bile acids was studied in six subjects. Although calcium markedly 
increased faecal bile acid excretion there was no reduction in serum 
cholesterol concentration.
d). The final problem studied was the effect of dietary cholesterol on 
serum and faecal lipids in a single subject. The results of this experime 
suggest that there is a negative feedback mechanism in which the level of 
dietary cholesterol controls the hepatic synthesis of cholesterol •
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SUMMARY
This thesis describes work on the develop­
ment of new techniques of faecal neutral steroid 
and bile acid analysis and the application of 
these techniques to a variety of clinical cir­
cumstances in which the metabolism of cholesterol, 
and the output of faecal steroids, might be 
altered.
The thesis is in four main parts.
I. A consideration from an historical stand­
point, of cholesterol metabolism and its 
regulation.
II. A review of the application of thin-layer 
chromâtography (TLC) to lipid analysis.
III. A detailed consideration of the way in 
which TLC and other methods have been 
modified for use in the present study.
IV. The final section is concerned with the 
application of quantitative techniques of 
neutral steroid and bile acid analysis to 
states of altered cholesterol metabolism.
VI
NOMENCLATURE
The following trivial
Cholesterol
Coprostanol
Coprostanone
p-sitosterol
Campesterol
Choiestanol
Lathosterol
or ZV —cholestenol
A^-cholesten-3“
one 
Lanosterol
Epichoiestanol 
Epicoprostanol 
Cholic acid
Chenodeoxycholic 
acid
Deoxycholic acid
Lithocholic acid
names have be e n  used.
: choies t-5-eri“3P“Ol • 
Î 5 p-choiestan-3P-ol.
; 3 p - c h o l e s t a n - 3 “ 0n e •
: 24 a-ethyl i—  c h o i e s t- 
5-en-3 P.-ol •
: 24 a-methyl --- cholest-
5-en-3P~ol*
; 3 a - c h o l e s t a n - 3 p - o l .
: 5 a-cholest-7-en-3P“Ol.
; c h o i e s t - 4 - e n - 3 - o n e .
; kf 4, l 4 - t r i m e t h y l -
c h o l e s t a - 8 ; 2 4 — dien- 
3P-01.
: 5 a-cholestan-3<i-ol.
: 5 p-choies tan-3 CL— o l .
: 3 CL, 7 CL, 1 2 a - t r i h y d r o x y -  
3 P-cholanoic acid.
: 3 CL, 7 CL-dihydroxy-3P- 
c hola n o i c  acid,
: 3 CL, 1 2 a - d i h y d r o x y - 5 P -  
c h o l a n o i c  acid.
: 3 a - h y d r o x y - 5 p - c h o l a n o i c  
acid.
PAÎÎT I: A.
CHOLESTEROL METABOLISM
Dr,'' CONTENTS
Discovery of choie sterol and its
distribution in animal tissues.' 1
Biosynthesis 3
Sites of synthesis. 7
Structure of cholesterol, S
Metabolism of cholesterol, 10
Absorption of cholesterol. 13
Mechanism of absorption. l6
Excretion of cholesterol. l8
Excretion as neutral steroids. 19
Excretion as bile acids, 23
A, Formation of bile acids in
the liver, 23
B. Extrahepatic metabolism of
bile acids* 29
■ INTRODUCTION
DISCOVERY:
Cholesterol is the major sterol present in 
the tissues of mammals. It was first described 
in the latter half of the l8th century by De 
Fourcroy, (17^9) but it was not until 1315 that 
Chevreul showed that the substance, obtained by 
ether extraction of gall stones, could bo 
differentiated from other waxes as it was un— 
saponifiable. He named the material choiesterine 
from the Greek "chole", (bile) and "stereos" 
(solid). Between 1824 and I838 cholesterol was 
found in human and animal bile (Chevreul, 1824), 
in human blood (Lecanu, I838) and in brain 
(Couerbe, 1834),
DISTRIBUTION OF CHOLESTEROL:
The amount of cholesterol present varies 
from tissue to tissue and from species to species. 
Table I shows the estimated distribution of 
cholesterol in a 70 Kg, man ( Cook, 1956(a),
2 .
Table 1, The estimated distribution of
cholesterol in man.
Tissue sterol 
System as approximate
^ of total body 
sterol
Brain and nervous system 23
Connective tissue (including
adipose) and body fluids, 22
Muscle 21
Skin 9
Blood 8
Bone marrow 5
Liver 4
Heart, lungs, kidneys, spleen,
blood vessels 4
Alimentary tract 3
Adrenal glands 1
Other glands -
Skeleton -
3Cholesterol is also present in considerable 
concentration in bile (Polonovski and Bourrillon, 
1952) and faeces (Eneroth ad, 1964) but only 
in very smad.l_c on cent rat ions in urine (Kayser 
and Balat, 1952),
The presence of cholesterol is not confined 
to mammalian tissues: it occurs abundantly in
egg yolk (Cobley, 1846) but is present only to 
a minor extent in plants (Heftmann, 19^5)» 
BIOSYNTHESIS:
Bloch and ibittenberg ( 1942a, 1942b) using
deutero acetate, CD^COONa, first showed that an 
intact animal could convert oral acetate to 
cholesterol. More exact data on the incorpora­
tion of the two carbon atoms of acetate into 
cholesterol were obtained by Little and Bloch 
(195c) who found from experiements with double 
labelled acetate that fiteen carbon atoms of 
the cholesterol molecule were derived from the 
methyl carbon of acetic acid and the remaining 
twelve from the carboxyl group.
4The biosynthetic pathway of cholesterol 
from acetate is outlined in the following 
scheme. The pathway may be divided into two 
parts 3
1) The biosynthesis of squalene from acetate 
is derived from an interprétât!on by 
Cornforth (1959)*
2) The biosynthesis of cholesterol from 
squalene. The pathway outlined by 
Cornforth (1959) for this part of the 
biosynthetic sequence no longer holds 
true and scheme 2 is therefore an inter­
pretation derived from works of Clayton 
( 1 9 6 5  ) 5, Pop jak and Cornforth ( 1 9 6 6 ),
Corey et al, (I966) and van Tamelen et al
(1966).
THE FORMATION OF CHOLESTEROL - Part I. Biosynthesis 
of squs.lene fx'oni acetate, .
3CH3CO2H SCHsCOSCoA Co^ xSH +  CHaCOSCoA +  CH3GOCH2COSC0A
(ATP) S-acctyl 
coenzymo A
S-acctoacotyl 
coenzymo A
GH, CE,A3
HoO'
O
' " i,
OH,
■ 0 . ATP
HaC 0  OH3 
I H I
H 2O3POH2O CO2H . HOHiCr—  CO2H
fi-Phosptiomevalomo . ' • Mevalomo acid
acid ;
ATP ■’  ^ •
CHa / •
T P N H
I ■
CHa
(J
H2O 0 OH2 
OoASod) ^  (3O2H
S'3-Hydroxy-3-mettiylglutaryl 
coenzymo A
/1V Intermediate
H2C 0 CHa /
(!) ^  (!)o.
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HsOePaOHa
5-Diphosphomevalonic
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H
CHa
\
0-CH2— GH2OP2O0H3
/ /  ïsopentenyl
Caa3 pyrophosphate
E ' ' ■' CHg
^ 0 = C H —CHaOPaOoHa
/
CHa
g  3,3-Dimethylftllyl pyrophosphate
CHa /  • ■ CHa"
\  ' %
2 C=GH—CHaOPaOoHa +  4 C-CHa—CHaOPaOoHg
/  y
CHa CHa
CHa
2 0= G H —GH2—GHa-
GHa . . ■
GH,
I
GH,
-d)=GH—
+  GoASH
GH2—CHa—G=GH—GHaOPaOfiHa +  HliPaO?
Farnesyl pyrophosphate 
T P N H
'CHa CHa ■ '  * CH3
C=GH—GHa—GHa—( L gH—GHa—GHa—(!)=GH—CHa—
GHa. .
- Squalene ■
6 «
Part IX, Biosynthesis of cholesterol from squalene, 
A scheme based on work of Corey et al,, van
Tamelen and Clayton,
S Q U A L E N E 2,3“ OXI DO SQU A LE NE L A N Ô S T E R O L
°2 W
O 2 (=.)
j CHO
1
CH^OH
HOH
CH
HO
HO' HO' HO-
' C H O L E S T E R O LDE S M O S T E R O L
Sites of S3/nth.QSls.
The synthesis of cholesterol has been 
demonstrated in virtually every tissue of the 
mammalian body with the exception of the mature 
nervous system (Srere cT. 1950)• As the 
cells of the adult brain are incapable of re­
generation it is possible that there might be 
a relationship between the ability of cells to 
regenerate and their ability to synthesise 
cholesterol. The liver was originally reported 
to be the sole endogenous source of circulating 
cholesterol (liotta and Chaikoffy 1955) * This 
is no longer true as cholesterol is now known 
to be synthesised by the rat intestinal wall 
and to enter the circulating cholesterol pool 
(Lindsey and Wilson, 1965, Dietschy and 
Siperstein, 19^5)# Table II summarises various 
sites and the efficiency which these sites 
convert acetate - to cholesterol (Kritchevsky,
1958(a) in the rat.
8,
Tab1e XX, The 'efficiency with which various
sites couvert acetate — to
cholesterol in the rat.
Ti ssue Liver ~ 1
Liver 1.00
Intestine 0.60
Testes 0,31
Kidney 0. ok
Adult skin 0.90
Newborn skin 1.93
Adult brain 0.00
Newborn brain 1.85
Aorta 0.02 (chicken
0,002 (rabbit
STRUCTURES
The elucidation of the structure of 
cholesterol was achieved mainly by Windaus 
and his associates between 1919 und 1992, who 
however failed to arrive at a satisfactory 
formulation,  ^The structure (x )  (figure 2 ) 
was finally established by Rosenheim and 
King in 1932.
■pigure 2.
H O J.. cho lcstcro i.
Cholesterol, a steroid, has a double bond
at the A/3 ring junction as shown, and a 
hydroxyl group in the 3p position. The 
systerriatic name for cholesterol is A'^-cholesten- 
3^“Ol, or cholest-5-^]^-3 G-ol,
Steroids are numbered as in X, The nucleus 
being a relatively flat structure is conveniently 
represented as planar. Groups attached to the 
nucleus which are above the plane of the ring 
system (i.e. on the same side as the angular­
me thy 1 groups at C-10 and C-13) are called (3 and 
bonds joining them to the nucleus are drawn as 
heavy lines. Groups below the plane of the ring
10.
system are called c, and the bonds are drawn as 
dotted linos.
Ring's A and B may be fused either trans- 
(e.g. 5 a-cholestane Xl) or els (e.g. 5 P-
cholestane JXX) but rings B and C are trans in 
all naturally occurring steroids. The rings 
C and D are fused trans in nearly all types of 
steroids. (Figure 3).
Figure 3 *
I I
D - choicotcnd
Metabolism of cholaoterol.
Cholesterol may be derived from the diet 
or be synthesised within the body. The principal
11
site of synthesi'3 is the liver where cholesterol 
is also converted to bile acids (Byers and 
Biggs, 1952).
Most of the cholesterol lost from the body 
is excreted in the bile. Approximately 80^ of 
the cholesterol so excreted is in the form of 
bile acids, Xn man, these are conjugated with 
glycine or taurine (Wootton and Wiggins, 1953)*
Most of the bile acids reaching the intestinal 
lumen are reabsorbed and carried to the liver 
via the portal vein (Siperstein and Chaikoff,
1952), a process known as the enterohepatic 
circulation of the bile acids. The remainder 
is excreted as faecal bile acids.
The remaining 20^ of biliary cholesterol is 
in the form of free cholesterol. Xn the small 
bowel this mixes with ingested cholesterol and 
as the enterohepatic circulation of cholesterol 
is not as active as that of the bile acids a 
larger proportion reaches the colon. The cholesterol 
which is absorbed is transported via the lymphatic
oJu /i *
system and not by the jportal venous system to 
the systemic circulation (Chaikoff ot a1, 195^)•
Bile salts and cholesterol which are not 
reabsorbed are finally excreted in the faeces, 
after further transforrnation by the intestinal 
micro-organisms•
These pathways are illustrated in Figure 4, 
and the processes of absorption, catabolism and 
excretion are explained in more detail in the 
follov/ing sections.
13.
h*
PRECURSORS.^ , . C
ON
LACTÊALSINTESTIN
CHOLESTEROï
i n t e s t ;:;/.e
CHOLESTEROL
FAECES
DE0XYCN0;_;E ACiD 
L IT r lû C H O U C  ACID
c;., _cT_ROL
Csw'i ..O's TANOL 
C O P R O j TANONE
ABSORPTION OF CHOLESTEROL FROM THE XXTESTIN.F ;
The earliest démonstration that cholesterol 
was absorbed From the intestinal tract was made 
by Jankau in I892 using dogs. Twenty-three 
years later Mueller (1915) showed that dietary
14.
cliolesterol is absorbed via the lymphatic system
and that the ratio of free to esterified cholesterol
in the lymph was not altered by feeding free or
esterified cholesterol or fatty acids* It was
not until 195^ however> that Siperstein et al
, 14using choiestero1-4-C » demonstrated the obliga­
tory function of bile salts in cholesterol ab­
sorption* Investigations by Swell et al (l953) 
and Pihl ( 1955(a))showed that cholic or taurocholic 
acids were the most active in promoting cholesterol 
absorption* The conveyance of intestinally 
absorbed cholesterol to the systemic circulation 
via the thoracic duct in preference to the portal 
venous system has been confirmed by Biggs et al 
(1951) in the rat and by Heilman et al (19^0) in
meno This was achieved using tritium labelled 
l4and C labelled cholesterol*
In man the site of cholesterol absorption 
from the int’esfine has been shown by Borgstrom 
(i960) to be in the proximal part of the jejunum.
Balance experiments on the apparent absorption
■5.
of cholesterol in man have shown that cholesterol 
is poorly absorbed: the degree of absorption is
however greatly influenced by the form in which 
it is fed. When fed as crystalline cholesterol 
only 16^ 0 is absorbed, whereas fed as cholesterol 
in the form of eggs 6o^ is absorbed (Cook et al, 
1956). Cook (1958(b )) suggested that on a body- 
weight basis the smaller experimental animals 
have a more marked absorption than do the larger 
species. Table III.
Table III. Absorption of cholesterol in different
animals,
Specimen Typical Amount Absorption
V/eight fed/ day gm^/kg^ body-
weight/day
Hat 300 g. 0.3 40 0.4
Guinea pig 400 g. 0.25 50 0.3
Rabbit 1.5 kg. 0.5 75 0.3
Dog 10-12 kg. 1.6 50-80 0.1
Man 70 kg. Crystalline 15 0,01
10.0
Egg 6.9 60 0.02
However if the amount of cholesterol fed
l6.
to the animal is calculated per unit weight of 
animal then it is evident that the smaller 
animals were presented with a much greater load 
of cholesterol than the larger species Table IV, 
Table IV.
Specimen Typr^.cal Amount of Amount of
VJéiy:ht c" ole sterol choies t ero 1
fed/day g . fed/kg. of
animal g.
Hat 300 g* 0.3 g. 1.0 g,
Guinea 400 g. 0.25 g. 0.7 g.
pig
Rabbit 1.5 kg. 0.5 g. 0.33 g.
Dog 10-12 kg. 1.6 g. 0.l6 g*
Man 70 kg* Crystalline 0.l4 g.
10.0 g.
Egg 6.9 go 0.10 g.
It is therefore unjustified to conclude 
from the evidence presented in Table III that 
there is a species difference in cholesterol 
absorption.
MECHANISM OR ABSORPTION OF CHOLESTEROL;
Several studies on the mechanism of
17.
absorption of cholesterol in rats have establish­
ed that the sterol can enter the mucosal cells 
only as unesterified cholesterol (Treadwell ot 
alÿ 1959? Treadwell et al, I962). The fact 
that cholesterol esters are not absorbed to any 
greater extent than free cholesterol and that 
conditions in the intestinal lumen favour hydro­
lysis (Vahouny and Treadwell, 1958) lend support 
to this theory. Swell ah. (1958) suggested 
that the cholesterol esters formed in the mucosa 
do not pass into the lymph alone, but are trans­
ferred along with triglycerides, phospholipids, 
free cholesterol and proteins, in the form of 
chylomicrons. The exact site of formation of 
such a complex is unknown. Swell and his 
colleagues further suggest that cholesterol 
absorption is closely interrelated with the 
absorption and transport of other lipids and is 
not an independent mechanism. Recently, David 
et al. (1966) have suggested that cholesterol
esters in the diet are hydrolysed by cholesterol
8.
ester hydrolase of either pancreas or mucosal 
brush border and that the free cholesterol is 
transferred to the mucosal cell. Here, they 
believe, it^is_re-esterified for transport in 
the lymphatic system. The finding that the 
rate of re-esterification in the mucosal cell 
is parallel to the rate of removal of the 
ester from the cell and that the brush border 
rapidly takes up dietary cholesterol without 
effecting any quantitative change in its own 
cholesterol content, suggests absorption by a 
displacement mechanism. This had been postulated 
earlier by Glover and Green (1953) and by Murthy 
et al. (1963).
EXCRETION OF CHOLESTEROL;
Cholesterol is eliminated from the body 
in two main ways; 1) direct excretion as 
cholesterol into the gastrointestinal tract from 
the liver in bile and from the intestinal mucosa; 
and 2 ) hepatic oxidation to cholanoic acids which 
are then excreted into the bile as their taurine
19
or glycine conjugates,
1) Excretion of cholesterol as neutral steroids;
Although cholesterol is catabolised mainly 
to bile acids it is also excreted in the faeces 
as neutral steroids. Faecal neutral steroids 
consist of cholesterol and its metabolites 
(mainly coprostanol (XV) and coprostanone (V)) 
together with phytosterols of dietary origin, 
such as p-sitosterol (VX) and campesterol (VXX) 
which are also accompanied by their metabolites 
(Eneroth et al, 19o4), Small amounts of
choiestanol (VXXX) and lathosterol (XX) (%ritchevsky 
19580 )^»Cook, 1958(c), have also been detected.
(figure 3 )*
PlRure 5. '
20.
y. coprostanone 
C K
H O
JY coprostanol
HOH O
VI 0-s itostero l
IX lothosterolHO HO
VIII cholestanol
COPROSTANOL EXCRETION:
The most abundant faecal steroid is normally 
coprostanol• It is formed by microbiological 
reduction of cholesterol in the lower intestinal 
tract, especially in the colon (Rosenfeld e_t al.
21.
19^4 ; Wilson ; 1961). In addition the con­
version of cholesterol to coprostanol by bacterial 
cultures isolated from faeces has also been 
demonstrated^ conclusively (Rosenfeld et al. 1954).
No coprostanol is excreted by germ free animals 
(Danielsson and Gustafsson^ 1959) and coprostanol 
formation can also be abolished by the administra­
tion of a number of antibacterial agents (Rosenheim 
and Webster, 19^3(b), Wainfan et al. 1952, Coleman
and Baumann, 1957 ) • In addition to antibacterial 
agents various dietary constituents have been 
found to influence coprostanol formation (Wilson,
1961) .
Two explanations have been advanced to 
explain the conversion of cholesterol (l) to 
coprostanol (IV).
a) a direct stereospecific reduction of the 
double bond at C5-6 ( Schoenheinier e t al.
1930),
and
b) a three stage conversion from cholesterol (l)
22.
4involving the intermediates -choiesten-
3-one (x) and coprostan-3-one (V) 
Rosenheim and Webster, 19^3 )#
These routes are illustrated in figure 6*
FiCT-re 6.
HOHO
^  A-cholzsten-3-on« V
However, Rosenfeld et al. (195^) showed
23
using radio-active cholesterol that coprostanol 
is produced principally by the direct saturation 
of the C5-Ô double bond of cholesterol,
2, Excrétion as bile acidsï
A, Formation of bile acids in the liver.
Bloch et a1, (19^3) using deuterium labelled
cholesterol demonstrated the direct transformation 
of cholesterol into bile acids in the liver.
This was confirmed in 193^ by Byers and Biggs 
using tritinted cholesterol.
Investigations into the exact nature of 
tlie biliary end products of cholesterol have shown 
that in the rat the major biliary products are 
cholic (Xl) and chenodeoxycholic acids (XIl), 
both present as the taurine conjugates (Siperstein 
et al « 1934 ) ; and in mcin, cholic acid and chenodooxV'
cholic acid plus a small proportion of deoxycholic 
acid (XIIX) conjugated with glycine or taurine 
(v/ootton and Wiggins, 1933) *
Although most of these conjugated bile acids 
are re-absorbed from the intestinal lumen a small
24.
proportion of them pass on to the colon where 
they are converted by bacterial action to free 
bile acids .as a result of removal of the glycine 
or taurine fragment. The 7CL-hydroxyl groups 
is also largely removed by bacterial reduction. 
In this way, cholic acid is broken down to de- 
oxycholic acid, whereas chenodeoxycholic acid 
is converted to lithocholic acid (XIV) (Carey 
and Williams, 1^62, Danielsson et alo I963) 
figure 7.
I  cholesterol
H O
COOH COOH
cholic acid 
“OH
j<IL chenodeoxy- 
Qf..j cholic acid
\  ^ C O O H
H OHO
COOHHO
XIV lithocholic 
acid
XIII deoxycholic 
acidHO" HO
25
The "primary" bile acids are cholic acid 
and chenodeoxycholic acid. A comparison of 
the formulae of these acids with that of 
cholesterol would suggest that the following 
reactions take places—
1) hydroxylation at C-7 and C-12
2 ) inversion of the C-3 hydroxyl group
3 ) saturation of the double bond 
and
4) degradation of the side chain
Bergstrom a1 ♦ (195^0 and Fredrickson and
Ono (193^) suggested that in the conversion of 
cholesterol to bile acids, alteration of the 
cholesterol nucleus occurs before degradation of 
the side chain. However, the observation that 
26”0H cholesterol is metabolised to clienodeoxy— 
cholic acid (Danielsson, 1961(a), and Berseus and 
Danielsson, I9 63) suggests that this is not in­
variably true and that Bergstrom's conclusions 
require modification i.e. the nucleus may be 
elaborated after terminal oxidation of the side-
26
chain.
The first reaction taking place in the 
nucleus seems to be the hydrox3^ 1ation at C-7 
(Lindstedt, 1957(a) Danielsson, 1961(b)). However, 
it may be considered that both hydroxylations at 
C-7 and C-12 occur simultaneously. Once the 
nucleus has been hydroxylated at C-7 and C-1 2, 
the hydroxyl group at C™3 is inverted from the ^- 
to the c- orientation (Danielsson, 1961(b),
Hutton and Boyd, I963)- Hutton and Boyd (1963) 
also showed that the inversion appeared to pre­
cede the saturation of the double bond.
The side-chain is then oxidised very rapidly 
to give a C-24 acid (Briggs and Staple, I960) 
but the initial step is the oxidation of one of 
the terminal methyl groups to a hydroxymethy1 
group (Danielsson, 1960).
If the view that the nucleus may be elaborated 
after terminal oxidation of the side-chain is 
accepted, then it may be concluded that that part 
of the cholesterol which is oxidised to 26-OH
ry27
cholesterol (Danielsson, 19--1, Derscus and 
Daniels son, I963) woall give rise to the cheno­
deoxycholic acid present in the organism while 
the cholic acid pool is derived from the 
cholesterol which undergoes modification of the 
nucleus before any oxidation in the side-chain.
In summary, 'Che degradation of cholesterol 
may be as follows :-
1 ) hydroxylation at C-7 and C-1 2 ,
2 ) inversion of the C-3 hydroxyl group,
3 ) saturation of the Cp-Co double bond,
4) oxidation of a terminal CH^ group to OH,
»5 ) oxidation of this OH group to a C-27 acid
6 ) oxidation at C-24, 
and
7 ) cleavage of the terminal 3-carbon unit 
leaving a C-24 acid.
This is illustrated in figure S. (Van Belle
1965).
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B . Extrahepatic motobollsm of the bile acids.
The bile acids in human bile are conjugated 
witli glycine or taurine, the normal ratio of 
glycoconjugates to tauroconjugates being 3*2:1 
(Sjbvall, i960). This ratio has been found to 
be the same for cholic, chenodeoxycholic and 
deoxycholic acids in human bile. In the large 
intestine most of the bile acids are present as 
free bile acids (Norman and Sjovall, I9 3 8 ).
Norman and Sjovall (l95S) concluded from their 
experiments that the action of micro-oi'ganisms 
does not start until the bile acids have entered 
the caecum and that the first reaction appears 
to be the splitting of the peptide bond. This 
splitting was positively demonstrated to occur 
in the caecum by Portman (1938), The administra­
tion of chemotherapeutic agents to rats resulted 
in only 1-13 '^ of faecal bile acids as free acids 
(Norman, 1955)* This suggested that the peptide 
bonds are split by the intestinal micro-organisms 
and, not by digestive enzymes.
30
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chenodeoxychollc acid wore extensively metabolised 
(Danielsson et r  ^ 19oj) and that only traces' —tiiainw Ml,I" ft,* '
of these "primary" acids have been detected in 
human faeces (Carey and Williams, I9 6 2) suggested 
marked changes in the bile acid molecules during 
their passage through the intestine. The non- 
tx’ans format ion of lithocholic acid in the human 
liver (Carey and Williams, I963) also indicates 
intestinal transformation of the bile acids.
These changes, according to Portman (1958) occur 
in the caecum and colon.
The transfox'mation of the bile acids by the 
micro-organisms results in the excretion of a 
complex mixture of free bile acids in faeces 
(hneroth rA. 1966a, 19660)0 The principal 
bile acids in human faeces are deoxycholic acid 
and lithocholic acid (Rosenfeld and Keliman,
1962, Sneroth et al, 1966a), These two acids 
are formed by the dehydroxylation at C-7 of cholic 
acid and chenodeoxycholic acid (Carey and Williams 5
q 1
1962, Danielsson 17-3) rospectxvely.
A consider able amount of bile o.cids is 
reabsorbed from tlio intestino and reaches 
the liver via'^-the portal blood, in contrast 
to cholesterol which is absorbed via the 
lymph (Siperstein and Cnaikoff, 1932)• In 
the rat and other species e.g. dog, rabbit 
and chicken, the absorptive activity of the 
terminal ileum for conjugated cholate v/as found 
to be four times as groat as that of the 
duodenum (Baker and Searle, I96O, Lack and Weiner, 
1961, 1963)* This restriction of absorption of
bile salts to the distal small intestine allows 
those substances to exert their digestive function 
in the proximal region ^/here fat absorption is 
maximal. Norman and Sjovall (l93S) showed 
by administering cholic acid orally or by an 
intracaecal catheter that over 80^ was reabsorbed 
from the small intestine. They suggested that 
the incomplete absorption from the caecum is
probabZ.y due to ' tue :roûou of* cholic acid
into non-aboorbuhio metabolites. This would 
account for the large variety of metabolites 
present in the small intestine and the few free 
bile acids found in bilo.
Lindstedt (1936, 1937^);using isotope 
labelled bile acids, calculated the bile acid 
pool in man to be approximately 3*56 gu of which 
cholic acid accounted for 1.35 chenodeoxy­
cholic acid 1.4p g. and deoxycholic acid 0.78 g.
The half-life of cholic acid varied from 1.2 to 
4.2 days with a mean value of 2.8 days. Ivy 
et a 1 . 19p7 calculated that che coverage daily 
synthesis of cholesterol in man on sterol-free 
diet was 2.1 g. ; of this, 168O mg, v/as catabolised 
l460 mg. of which were converted to bile acids.
This is much higher than the value proposed by 
Bergstrom (1959) who suggested that only 0.7 g. 
of choiesterol•is degraded to bile acids per day 
and based his value on half-life times and pool 
sizes of cholic and chenodeoxycholic acids.
J J
Tc.o values reported for the daity excr,xon 
of bile CvCids in man enow a marked differenoe 
from laboratory to laboratory, This is reviewed 
by Grundy ph. (1963).
Xn summary cholestérol is derived from i;wo 
sources, dietary cholesterol which is absorbed 
as such, from the intestine, and synthesised 
cholesterol. Cholesterol is lost from the body 
by two main pathwaysj a) direct excretion into 
the gastrointestinal tract. Xn the colon 
bacterial action then produces a mixture of 
neutral steroids which are excreted in the faeces, 
and b) hepatic oxidation of cholesterol to bile 
acids. These are excreted in bile into the 
gastrointestinal tract where they also undergo 
bacterial transformation to produce a complex 
mixture of bile acids which ai"e excreted in the 
faeces. However a proportion of bile acids and 
choiesterol■in*the gastrointestinal tract undergo 
enterohepatlc circulation to reappear in bile.
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city of factors are associated 
with the development of ischaemic heart disease. 
One of these factors which correlates well with 
the incidence of coronary heart ^rsease is the 
level of serum cholesterol (Dawher et al. I962,
Keys et al, I963)* It would therefore seem
important to study factors which affect serum 
cholesterol values in the hope that the results 
obtained might lead to a better underslanding 
of the aetiology and control of atheroma.
Thus dietary and other methods of altering 
serum cholesterol levels may affect the in­
cidence of atherosclerosis,
As part of the work reported in this thesis 
is concerned with therapeutic and dietary altera­
tion of serum cholesterol and the associated 
effect on the excretion of cholesterol and its 
metabolites a brief review on dietary conditions 
and therapeutic agents is given here.
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The early balance experiments of Schoen™ 
heirner and. Br.Qjasch ( 1933 ) with mice suggecced 
that the coneentration of cholesterol in animals 
was regulated by a homeostatic mechanism; 
evidence for which was first provided by Gould 
(1951) who found that hepatic cholesterol 
synthesis in dogs cind rabbits was reduced by 
feeding cholesterol. Other investigators have 
since demonstrated a similar effect in rats 
(Tomkins _e_t ad. 1953 (a)^Laiigdon and Bloch; 1953 ; 
Frantz et al, 1954) and chicken (Sakakida et al. 
1963)* This depression of cholesterol synthesis 
may well be an example of "negative feedback" 
control in that the rate at whi ch material is 
formed is inversely related to the amount pro­
vided from an exogenous source.
The mechanism by which dietary cholesterol 
inhibits endogenous cholesterol synthesis has been 
the subject of extensive studies; Gould and
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Popjak (1957) showed, in rats, that inhibition 
occurred before formation of mevalonic acid in 
the biosynthetic pathway. Siperstein and 
Guest (i960) obtained evidence that the in­
hibition was localised more specifically at 
the conversion of j3-hydroxy-jB-rnethylglutaric 
acid (HMG) to mevalonate. These conclusions
were based on the fact that cholesterol feeding
had no effect on the conversion of mevalonate- 
l4C to cholesterol. However a more direct 
effect of cholesterol on mevalonate synthesis 
was not demonstrated.
Recently, Siperstein aJL. (1966) were 
able to separate mevalonate and p-hydroxy-j3- 
methylglutarate by gas-liquid chromatography, 
l/ith this technique Siperstein and Fagan ( i960 ) 
showed that feedback inhibition by dietary 
cholesterol occurs through inhibition of 
mevalonate synthesis. This is in agreement 
with the conclusion that the major site of the 
cholesterol feedback system is located at the 
reaction responsible for the conversion of
p - h y d r o x y - " t h y l e  to meva-Lona'i;e , 
namely p-hydroxy-p-r;3 un^ l^t^ lutccry 1 reductase ,
The nature of tho inhibitor^ possibly cholesterol 
Itself or one_of its metabolitos is yet to be 
detormined «
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Earlier Karvinen cjt _alo ( 1957 ) suggested 
that the lium^ in intestine has a limited ca%)acity 
for the absorption of dietary cholesterol and 
this limiting effect is considered by Taylor 
et £J_« (1965) to be man's principal protection
from hypcrcholestorolctoraia of dietary origin, 
rathor than a negative feedback mechanism 
rogulciting cholesterol synthesis « This is in 
agreement with the viev/s of Kaplan ct a 1 « (1963)*
It has been shown that decreasing the 
cholesterol content of the diet alone has little 
effect on serum concentx‘*ations (Keys et a 1 *' rt>BwvTw«»
19^5 ) although the ingestion of a high cholestex'ol 
diet especially in tho form of egg yolk and in 
the presence of fat produces a marked élévation
of serum cholesterol (Steiner and Domanskij 
1941; lia os inner et a ^ . 19 f C ; Connorr WH^vn>#»wi * #w-
1961 ; Wells and nronte-Stev/art ^ 19^3)*
Crystalline cholesterol even in the presence 
of fat has usually failed to increase serum 
cholesterol levels (Mes singer et a1o 193G ;
Connor et al « I961 ) . Wells and liront e-Stewart 
(1963) however fou..d no difference between the 
serum cholesterol responses with egg yolk and 
crystalline cholesterol as long as the f^ dc fed 
with the crystalline cholesterol had the same 
iodine value as the egg saponifiable fraction. 
This would suggest that the absorption of 
cholesterol in man is dependent in part on the 
dietary cholesterol and also on dietary fat. 
IhFLUnxCh OF DIfTARY FAT OX SERUh Cl:Chi . IaOL.
Although dietary fat is known to stimulate 
cholesterol absorption in rats (Bellman and 
iTlock, I95I; Kim and Ivy, 1932; Pihl, 1955(b)) 
it is not an essential factor. Dietary fat 
can be broadly classified as saturated fat
(typically of animal origin or derived by 
hydrogenation of an s a t a rat c d f  ^ and un­
saturated fat (typically of vegetable or fish 
origin). The degree of uns a turat i on is given 
by the iodine value. rlany dietary studio^ 
involving these two types of fat have been 
carried out in man and rats and although the 
majority of workers agree that unsaturated fat 
does cause a decrease in serum choiestorol 
levels in man ( ^ dxrons _v£ 19371 Keys rjt,
1937a. ; halmr o s and hi gar d , 1937 ; Keys e_t al, 
1937h 3 Joliffe^ 1961; ninsell^ 1963) and the 
rat (Bloomfield^ 1964ag Bloomfield^ 1964b) 
others claim that it is the cholesterol rather 
than the unsaturated fat content of the diet 
which is more important (Connor ct al« 1964 ; 
Erickson sgl, 1964).
The niecliotnism by which the unsaturated 
acids exert■their influence is not clear. 
Bloomfield (l964'a; 1964b) suggested that the
unsaturated fats cause increased absorption of
_y m e r  case a. cnouosroro^
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assumed to alter t*^ o ecullibrium between serum 
cholesterol and liver orioles ter ol j causing a 
decrease in the concentration of serum cholestez’oi. 
More recently however ^ v/ood ct r 1, (i960) using
synthetic triglycerides ^ have suggested ahaa the 
decrease in serum cholesterol in man» noted 
after ingestion of un^^cburatod fats » is duo 
to increased faecal excretion of bile acids and 
neutral steroids resulting from diminished ab­
sorption.
Earlier workers had also found this increa- v 
in faecal neutral steroids and bile acid excretion 
with unsaturated fat diets but many of 'chem had 
used corn oil as their unsaturated fat (hellrnan 
et al, 1937 > Moore c-t c . I9 6 2 ; Antonis and 
Bersohn» I962) and were thus introducing plant 
sterols such a-s p-sitost erol » and campesterol as 
well as unsaturated, fatty acids. The cholesterol- 
reducing effect of corn oil and other vegetable
î,
o :l AO aoo yco .y oxplainod* Somo 
r:cluced solubility
of cholesterol In the oil » reduced absorption 
of choiestorol from the intestinal tract, in­
creased degradation» incroc^sed wxcretion of bile 
acids and more rapid transport of lipids 
( Nutrition lie views 19 64) . The un s ap o ni fr able
fractron of corn oil has been shown to be an 
effective agent for reducing scrum cholesterol 
in experimental animals (reterson» 1931 ) w.nd 
man (Beveridge » lypS}® The most active com­
pound in this fraction i^ t-sitosterol*
O-'j
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In 1933 rollah showed that although
sx0 03toror causoa comp. Xnhxoxox on oz nyper
choiesterolaemia in rabbits on a cholesterol 
diotj the effect was dependent on the ratio of 
the two sterols. habbits required six times 
as much p-sitosterol as cholosterol and rats 
only a ratio of 3:1 of p™sitosterol to cholesterol. 
Two years later» Glover and Green (1957) carried
4':
out mbsorption cxpcrimc: ts with guinea pigs 
and suggcoted then. 3-ei^cctcrol may comp„.uz 
with choie G t orol at the level of the ''acceptor 
sites’^ of oho Ixpoprooein in particular the 
lipopx'otoxns present in the mucosal cells» 
wliicii control the absorption through the mucosa 
itself. It was originally thought (llernanciez 
c t ah, 1953; Swell c_t 1934 ) that
p-sitosterol might compote with cholesterol for 
estérification whehin tho gut lumen, This is 
no longer accepted as it has been shown thsh 
cholesterol is absoz’bod into the mucosal cell 
in the free state (friedman eh al. I9 5 6 ;
Treadwell » I962 ) ,
While earlier studies have sugg'ested that 
p-si tost orol acts %3redominantly in the gut and 
affects absorption» there is the possibility 
that the small proportion of sitosterol 
absorbed could "function in some other manner 
perhaps as a competitive inhibitor and so 
bring about a decrease in scrum cholesterol
level, £■. . 11 r-' in 1959 sho'vad that
phyt ost erele cl tainc J. Iron toliacco leaves were 
absorbed rnto the mucosal coll to quite an
appreciable extent wish virtually all of it 
present as free sterol. however » after 24 
hours there was only 2,1/i of the f^d dose in 
the lymph » 30)0 of \.til ch was es te'rifled» com­
pared to 20 to 4Gy of cholesterol found in the 
lymph wlien a cos:parable auouzx'j of cholesterol-
144-G been aa.n_nr stored, They suggested
that oho principal block in phytostez-’oi ab­
sorption occurs within the :::ucosa» at a step 
in the transfer mwchunism from mucosa to the 
lymph ; this may be tho csterification or 
chylomicron formation. Swell r 1 , (1959)
also found that administration of phytosterols 
produced an increased faecal excretion of 
cholesterol and related sterols and a lower 
lymph cholesterol concentration than was found
an a controA group of rata
More recently» Kaust and Beveridge (1963)
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sterol^ .-, even aftv,r co:rrvje‘^u-ng for tho excretion
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effect of p-eit'...^  s,^ roi ro.;^y be due to incrs^asod 
excretion of ondogwHous seerei0 in the faeces. 
.bncroth oj; r_t, ( / also report cd az. increase
in faccal neatra.1- ,vt,:,roid excretion in hue.an 
sabjcete given corn oil bat caggeet,_d ohat this
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of plant sterols. b'nlixc haust and bovcridge 
{1963) and Encrceh p;~: r.l., (1964)» Sprit z ut ch.
(1963) did not find an increase in faccal neutral 
steroids but found that pla.nt sterols caused 
an increase in faecal bile acid excretion.
They suggc^ted- ths.t tnc changes in human plasma 
cholesterol levels wore duo to the redistribu­
tion of cholesterol to other tissues. This
x_\croaoc an faecal elle acid excretion may also
y\. — >- »J«>. ' "-T  ^- y_ ^ -!-V V'- - ' • ,"V -J— ^ -» *î /-Xk-^ ^ «ac "A, A *v» ■•  ^ V.j . *»*4 A* , K., w-" V-' 4. ■.-’ *v J* i —4. y%«/ aa —h d*
acids whica will in turn cause an increased 
hepatic degraclatl^^^ of cholesterol to bile
acids. Gerson jpt  ^(1963; I9 63) found
that although intrc.poritoneal injections of 
p-oitosterol into rats produced a lowcrung of 
cholesterol and lipid concentrations in the 
tissues» there was no chaz.ge in the faecal 
ex
14 ± '-i'CO,, \/ath higher C content i/as coipired in
Together these
e effect of 3-
sit03terol on serum cholosterol may be produced
both in the intestinal mac osa and in the liver.
Although costerol does lower the
cholesterol blood levels in man the effccu is 
achieved only by continuing adinini strati on at 
a dose of at least p-lOg./day (preziosi» I964): 
once the tz-oatment is suspended the ciiolesterol 
blood levels tend to return rapidly to the
advantage that sabjocts cannot tderate
it with the result that they quickly dis- 
contin-^.e treatment and consequently there are
c/
Various other sterols have also been tried 
but they normally produced undesirable side- 
effects. Dihydrocholost orol (pr-cholestan-
3p“Ol (VTl)) was fomtd to prevent hyper- 
cholesterolaomia In cockerels (Siperstein et sh. 
i9 53 (a))and rabbi t s ( Ni cho 1 s cgt oh » 1933) mshn- 
tained on a cholesterol diet» but it was absorbed 
itself to quite an extent and was shown to be 
atherogenic in rabbits when added to the diet 
(Curran and Costello» 1936).
A  '-“Choiesten-3“One (iX) was shown to be an 
inhibitor of cholosterol biosynthesis in the 
rat (Tomkins c'* al. 1953(bL'but is converted
' Wwv# k mutt **rw6.SM6* \ //
in viv^ to dihydrocholosterol as one of its 
major metabolic products (Anker and Bloch»
k$.
1949» Stokes et al » 1955)« This renders 
^ "Cholesten-3-one unsuitable as dih.yd.ro- 
cholesterol is itself atherogenic (Curran and 
Costello, 1956).
AZAST.ERQLS.
Oral'administration of diaza-derivatives 
of either cholestanol or ohole*sterol has been 
reported to lower serum cholesterol levels in 
normal and hypercholesterolaemic rats, in 
normal dogs and in man ( Counsell _et al. 1962a; 
Counsell et al. 1962b), The effects of 2 2 , 
25-diazacholestanol have been studied in great 
detail.
Figure 9 .
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22,25-diaza cholestanol
.-vats treated oraxa.y _ or aays sliov;^ :.v a % a_r
of 2'i-fù and 17y In pfav .a end liver cholesterol 
respectively ( R acre y and Counsell, Ip 62 ) aixd 
Sachs and hoifman (1962 y reported a similar 
finding in human subjects^ Fro::; their results 
Sachs and Wo1fman (1962) suggested thau although 
tho primary action of this compound appeared to 
be tho inhibition of cholesterol synthesis 
the level of hydroxymethylglutaryl CoA reductase^ 
a desmosterol“*l.lhe co..*^ 'iOund was also detected 
in the serum of treated paiticnts sugrestinj 
an additional site of inliibition occurring late 
in the cholesterol biosynthetic cycle* More 
recently; Sachs and hoifman (1965) showed 
that 20 j 2p"dia.zachoies tenol dihydrochloride 
moderately reduced plasma total sterols whilo 
effectively lowering the plasms, cholesterol 
concentration in thiirteen hypercholesterolaemic 
s ub j G c t s ; - but t hi s v/a s a c c o rnpani e d by t h e 
progressive accumulation of a precursor sterol 
which they identified by thiln layer chromâto- 
graphy as desmostero1 0
noomycln to humv.vn rosulced in n
signify cunt docronoo in scrum choie ster-:^ ! 
levels (Scciiuol and Steiner^ 1939) which 'wuv. 
accompaniod by an incrousod fuccal excretion
of neutral sterols (howeil y . 19 61 ) and
bile acids (Oolds*..-th IpoS, Goldsmath,
1962 ; Powell re': r ' . 1962)0 hooseinc- kana-
mycin. and chlortctracyclane resulted in a l^ss 
consistent and l^ .,s5 icarhcd decreaoo (Sov.saol and 
Waithe g 1961; Steiner tyy I9 6l ) « Intra-
musculovr neomycin as v;ell as oral strepiomycin^ 
dihydrostreptomycin3 tetracycline, onytetra­
cycline p chloramphenicol^ polymycin h, bacitracin 
and novobiocin were inoffoctivo (Samuel and 
haithe ^ I96I 5 Steiner r_1_* 1961)0
Since neomycin is poorly absorbed from the
gut 3 the effect of the drug must be dependent 
on its effect on the gastrointestinal tract.
Three possible mechanisms of action have been
32
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duo to Its aiOv^rdiotrc proporti o s (Goldsmith
.''V » % « “T ' »>• *<■ .—' >“» \rpo2; Powejv* oc r .%. ^poi y *
b) intestinal nialeibscrption of lipids duo to 
ditirrhooa conscquv.nt upon alteration of 
the bacterial flora ( Jacobson cf: a l . lOoO)* noKPDWM •
c)
ancibiotic with bile acids (Eyssen y_t cF,
..V X" - \xpoo ] *
The last hypothesis is the most recent 
and the work by Eyssen y^ yf[* (i960) with chicks 
does suggest that, in thv.' case of neomycin ^ it 
is the basic and not the antibiotic property 
whi ch causes th.o decrease in serurn cholesterol. 
Using a neutral K-acet^^latcd neomycin which had 
no antibiotic properties and a condensation 
product of two .molecules of stroptomycin with 
diarninoguandine wliich had seven basic groups 
and had about fy of tho cintibiotic activity of
streptomycin they showoi 1,2.at -acetylL:ted 
reoniycin wa--. inactive 2ixt the c o: : d on s a 1: i on 
compound v;as very effective in lov/eriny serum
'e l s  *
ti ons \vexre made by Van den 
(1967) w2-.o sliowwd that h-methylated neomycin, 
a compound without av.tibacterial activity but 
with several basic groups lowered serum 
cîiolesterol levels in human subjects and in­
creased the faecal excretion of neutral steroids 
and blie acids„
A -'Ab:\TS
The formation of insoluble bile salts as 
a mechanism for lowering serum cholesterol 
levels was also studied by 3ipex'’stein et a 1 . 
in 1933(b), They fouiad that the addition of 
ferx'ic chloride^ wiiich precipitates the bile 
acids^ to a diet rich in bile concentrate and 
cholesterol iinoeded the increase in choies ter ol­
aemia in cockerels, however, Boher et al» 
(1937') did not find any change in the intestinal
Jabsorption of cholic acid or o2:o race of hepatic 
cliolestorol mobili :,ation by rnico foil owing the 
oral cidministration of ferric ciToride * Similar 
differences wore eneoa.:\,ercd with the feedi**g 
of aluminium hydroxide gel « Rodbard ryy r__.
(1930) found that alum ini urn hydroxide gel lo\;ered 
blood cholosterol v_nd inhibited atherogenesis in 
cholesterol fed cocxerels but in rats, aluminium 
phosphate gel was ineffective in increasang bile 
acid excretion and in fact increased absorption 
of cholesterol (Setty and Ivy, 1960)0 b.^etary 
calcium has also been shown to be hypocholooterol- 
aomic (Yacowitz yj: ch* I963)* Its mode of 
action in rats is thought to be due to increased 
excretion of faccal bile acids and faecal fp- 
hydroxysterols (fleischman al, 1967)» In
increased dietary calcium on cholesterol meta­
bolism in six Human subjects is presented*
An important development in the lowering 
of serum cholesterol levels by the removal of
c,
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1 33) capable of binding crie biliary aciâo 
selectively in the inocotinal tract and thus 
favouring their excrceion* The resin i^
'I •■ : -V '"\ w^ /- » 'V •—V ■"» '- r ' •*▼''•••> -* f-" . ■*'■'*' T-^ * ► — A-, ">■>
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and seems to have 2*0 toxic effects. It in­
creases faecal bile av,icl excretion by a face or
of 8 in doses of 10 g.>/d^ .y without causing
steatorrhea» Toiuaent y  g^l* (1960) found that
it lowered the serign cholesterol levels i^ i
cockerels on a cholesterol enriched diet a.^ d
also in no m o  cholost erolaemi c cockerels and 
dogs. The clinical use of choiestyraohno has 
been extended to the treatment of pruritic in 
primo.ry biliarf cirrhosis and obstructive 
jaundice (Carey, I96O; Carey and Williams 3
1 9 6 1 ).
is by now w c 1 ecjaolashcc. oha'c serum 
cholestérol levels are markedly influenced by 
thyroid iioivnoncs ( hi idea t .. 1 * 1939 s Strisov/er
et ch, 1959), In i960,; ^sya and Cliver studied 
the effect of thyroxin.^ and some of its analogues 
on serum cao^esceroj. ^ q \^ o ± s » j.ney concj-uaea 
tjiat of the analogues studied, the compounds 
iodinated as the 3 *1-3 ” positions were cho most 
active in all respects and that she ; aeve- 
isomers were more active than the d itz^ o-isomers 
in those compounds whi ch were optical active.
riowever, cue c. c : : r "o - a s ome r s wore x ouna us oe
less in-CGiv ro cause a m n a  m a n  one .m
isomers and were still able to lower serum 
cholesterol levels, hritchevsky (196c) suggested 
that the thyroid hormone, despite the fact chat 
it causes increased synthesis of cholesterol, 
lowers serum cholesterol levels by increasing 
the deyradation and excretiowc of cholesterol.
Tygsm:n ' ■-' , _n Ivpf covered t2xat
patients with p^ ...,.-.oriary tuberculosis had a 
marked decrease in serum cholesterol levels 
after treatment with p-a.ninosaiiicylic acid 
(f * A .S *)» hat or Tygstrm and co-workers (1960) 
observed that ?*A*S* aduanistereu oro^lly ( 12 g*/ 
day) could reduce seru.n cholesterol levels by 
as much as jOy bus that r...trc^venous aduhnistra™ 
tion of the drug w^ as considerably less effective, 
from their re sults they sugge st ed that P ,A ,S, 
acts by impairing cholesterol absorption. Un­
fortunate ly-; approxi:::Cctely of the subjects
treated with P,A,S, complained of nausea, vomit­
ing and/or diarrhoea*
Q . r “S-^ . •y’"-' n ' n -do i —/ ■ h 1 -L—/ . s.O' . if #
This compound was found by Reid (1960) to 
lower serum cholesterol levels but due to ^ide 
effects such a5 tinnitus^ deafness and gastro­
intestinal irritation; caused by the high dosage 
required, it is unsuitable for practice,
fCi ^ - - .-s. , - -h  ^ y> y' ' ' " X y\ ' ' * “ ^'"~
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to depress cholesterol synthesis ; a-phenyl- 
butyric ueid- -(-SeL,r^ :berg and Avigun, 1960(a) 
trrparanol /iGR-29 ) ^^ hlc2iu and hachenzie, 19591
Avigan <rt 1960x 1 Avij^n us _yl, I96O0)
and nicotinic acid ( 2/c.rsons, 1961),
I'c is thought 'Uho.s a-’phenyl2xutyric acid 
inhibits the fire u sSs^ p in choies c-erol bio­
synthesis i*e* formation of acetyl Cocnzyme A, 
whereas triparanol. was shown to iiniibit 
cholesterol biosynthesis mainly at tho desmo- 
oJv.x'-ol stage ( Steinberg-and Avigan^ 1960 (b ) ^ 
Steinberg og^  gh_. I96O and Frantz c_g _r 9.* 1960),
Tripax^anoi has also been found to inhibit other 
st£iges of cholesterol biosynthesis (holmes and 
hi fullio ; 1962) , A^iis drug however has serious
side effects; givang rise to cataracts ; ich vhyosi s 
and alopecia (Goodman and Gil man.; 19 6 3 ) together 
with accumulation of desmosteroi in serum; and 
it is no longer u^ed* Xn 1933 Altscnul e
_ . T- _ T , -y " —'-n - ' .' . ^   ^- /-\ - ' '"h <-■ -■' T/" /-t ■—■ — f*
,. A I ^  *•' - i - V 11 '■“ ■'* -V— ''- f  ^ -*•-» k-* ‘-y Â 'C-t —«_■ b*v
lowered plasita c h o l e 1 lev:h..^ , Parsons
(1961) showed that nicolxnic acid caused an 
inhibition of the incorpcrution of acetate 
into serum c-toIosterol * Similar results have 
been obtained by hunn “s ul* (1961) and Gold- 
smith (1961), hUw experiments of Killer g:. 1.
(1962) suggest that nicotJ^nic acid inhibits the 
synthesis of cholesterol prior to t2*e squalene 
cyclisation stc^ p* lfj.i^  is baoed on their 
finding only c2xo^^^terol an the serum of a 
patient treated with 2>.2»c^tinic acid « ho2/ever, 
the side effects of nicotinic ccCid; flushing and 
pruritus, make it unsuitable for long term 
administration as a cholesterol lowering agent
( hi t s chul jgt , 19555 Go odman and Gi Iman,
1965).
l' V L
In 3.9 62, Thorp and haring found that a 
series of aryloxyisobutyric acids and related 
compounds reduced ootul lipid and cholesterol
cone entrât a or: t.io _ r cn:o o - o e or racs*
The most efftctive cf Tie se t^-ts ot2iyl 2- ( n— 
chlorophen.oxy ) -2-m h y i p rc oi onate ( G21h ) o:e i t s 
free acid, In the same year Cliver (1962) re­
ported. that a mixture of CPX3 plus androsterone
omid'h, lowered seru:a cholosterol and se:^..Itromxu" .j.      ^ .a  t   x  t a  x'urn
triglyceride levels in patients wiLth ischaemic 
heart oise:-.se. It was sho\.n: in Ifof that 
CPXh alone (known as Clefihrate or .^tro;nid-S; 
\fas as effective as ^h^cromid’^ in reducing scrum 
cholesterol and serum tr:Lrlycerice levels :ln 
man* The meCimism of action of this compound 
is still unknown althv^_^h it has been suggested 
that it inhibits either the hepatic synthesis 
o :f chole s t erol ( zar 11 off and Tuckcx", 19 64 , enxd 
Nestel et r1 * I963) and triglycerides (Tuorp,
1962) or the lo2'/ density lipoproteins wh:lch 
transport txuLglycerides in the serum (Strisower 
et e 1 . 1965)1 * ethers have found no change in
trigTyoerido production and have sugy<3stGd that 
Clofibrate acts by increasing the removal of
o A. Vy» U A y*-. K* A -r  ^ p j ,  ^   ^\ < ^  J. S -L . . A * ' ‘ V «H . C ‘ A J  ,* O Y* O v  -*v X VA
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and dyspepsia (Gooaisan aixü Gxl;.:an, I963) have been 
observed in about id/ of %)c,.iicnta treated with this 
drug* Stndi^^s of faeco.i neutral steroid and bile 
acid excretion in pationto tx^cated with this drug 
are repo;."'tod in thic thoaic*
In 3uiiuriary , the con 1 pounds revi eivcd v:hich. reduce 
serum cholesterol l^vcJ^s in h^p or choice ter olaemic 
human subjects and e:cpL.rimentL..1 y ii*euced liypor^ 
chol^wotcrol.y^emia in animals may be crvided into 
three groups acccecding to their supposed mechanism 
of action;
a) Inhibitors of cholesterol biosynthesis either 
at an early step in the biosynthetic pathway
or at a ,utugc after the cyclisation of squalene, 
Txiese agents include anas terols, <c-phonylbutyric 
acid, tripax’anolj nicotinic acid and clofibrate*
b) Compounds'which cause increased excretion 
of faecal bi lo acids and/or faecaj. neutral
c c
union uni tliyroid
hormones * Ferrie chloride and aluminium 
hydroxide gel nave eecn shown to increase 
faecal bile acid excretion in ^::cerimental
0.A A 1 mjOrn À* A "Am ^
c) The final group contains p”-amino5alJ.cylic 
acid; x;hic2x as Thought to act by impairing 
•cholosterol absorptions p-si bo^terol may 
al^c act in t.iis wuy, and salicylac acid * 
The chanio... of she action of salicylic 
acid on lipids is not coL.plctely undex'™ 
stood*
T'wo practical issues are raised by this
consideration of cholcstex'ol metabolism;
1) That a widc variety of approaches h^Lve been 
tried in order to control serum cho^^escerol 
levels,
2 ) That relatively little x^ rork had bo^n carrier 
out on the c;ccretion of cholesterol and its
s ■ i l./ *•. A-irt« m K»,* t V -•' / k_ J' .t »»'• —' ^ U  »/ l ^  m  O'*- -V A- i»-
situation* oiie teclui^cp.cs used xve.
modifications of classic,
grapuy (TEC), t.i^' foi2LC.vd._g sections wiii O' 
t e a  to a co: 
in lipid analysis (fart Xl) and to specific 
modifications and uo ccclmiques (Part IXX) used 
in as.:3Cssv..ont of ' quantitc^cion of excretion of 
cholesterol and its metabolites *
64.
PART II.
A REVIEW OF TLC AND ITS APPLICATIONS 
TO LIPID ANALYSIS
65.
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SEPARATION OF L IP ID S  BY CHROMATOGRAPHY 
TH IN -LA Y E R  CHROMATOGRAPHY (T L C )
During the last 15 years, the more 
traditional techniques of lipid analysis, such 
as fractional crystallization, have been almost 
completely replaced by chromatographic methods. 
Initially column chromatography was used ex­
clusively but later the introduction of cellulose 
and glass-fibre papers impregnated with silicic 
acid enabled small quantities of lipid to be 
separated with greater resolution and speed.
More recently paper-chromatographic methods 
have been largely replaced by thin-layer 
chromatography (TLC) which has the advantages 
of giving more discrete spots with consequently 
better resolution and, in adsorption systems, 
of allowing more corrosive and sensitive 
detection agents to be employed than are possible 
with impregnated cellulose papers.
Thin-layer chromatography was first intro­
duced in a convenient form as a procedure for
67.
analytical adsorption chromatography by Stahl 
in 1956 who used glass plates coated with a 
layer of adsorbent material.
By ascending one-dimensional thin-layer 
chromatography, the developing solvent rises 
and transports the individual substances at rates 
which depend on their physical characteristics. 
Separation also depends on the solvent and on 
the chromatographic matrix. The processes in­
volved in separation may be adsorption, partition 
or ion-exchange or a combination of those.
Various adsorbents for TLC are manufactured 
commercially and are almost exclusively oxides, 
hydrated oxides or salts e.g. alumina, silicic 
acid and magnesium carbonate. The most generally 
useful adsorbent is silica gel, available with 
or without calcium sulphate as a binder to 
afford a firmer layer. It may also be impreg­
nated with phosphors which cause fluorescence 
under ultraviolet light. Various ionic materials 
may be incorporated which form complexes with
68.
the compounds to be separated and hence increase 
their separation from each other. Impregnation 
of the adsorbent on the plate with hydrocarbons 
such as undecane or tetradecane allows reversed- 
phase partition-TLC to be carried out. Coating 
the plate with cellulose ion-exchange resins or 
with dextran gel ("Sephadex") widens the scope 
of the method considerably although these 
modifications have not yet been fully exploited.
Thin layer plates may be "poured", "sprayed" 
or "dipped" but to obtain a uniform layer it is 
much better to use "spread" plates.
LOCATION OF COMPOUNDS ON TLC PLATES
Detection of compounds on TLC plates may 
be achieved destructively or non-destructively.
A convenient destructive procedure entails 
spraying the plate with a charring reagent such 
as 50^ sulphuric acid and heating in an oven at 
a high temperature (approx. 180^0 .). This 
produces dark spots on a relatively white back­
ground. Milder treatments with acidic reagents
69.
or with other reagents such as phosphomolybdic 
acid in ethanol, frequently afford characteristic 
coloured spots on heating. For non-destructive 
detection, the plate may be sprayed with water 
(when hydrophobic compounds may appear as 
glistening spots) or with a fluorescent material 
allowing detection by quenching of fluorescence 
under ultraviolet light. Scanning equipment can 
be used to detect radioactive material. Non­
destructive techniques must be used if the com­
pounds are to be recovered from the thin-layer 
plate for further analysis.
MEASUREMENT OF VALUES
As in paper chromatography, the rate of 
advance of each compound in a given solvent 
on a given adsorbent is expressed as an Rp 
value :
distance of the substance from the 
origin
Rp value =
distance of the solvent front from 
the origin
However to overcome the effect of variations
70.
in conditions send in layer thickness it is 
advisable to run a known comparison compound, 
for instance a dye or a known standard compound, 
together with the unknown mixture on the same 
chromatogram so that effective comparison can 
be made between plates. In this way a relative 
value is obtained.
Relative _ distance of substance from origin 
Rp value ~ distance of known substance from
origin
APPLICATIONS OF TLC
Adsorption TLC has been used extensively 
in the analysis of naturally occurring fats, 
oils (Malins and Wekell, I963; McKillican and 
Sims, 1963) and waxes (Haahti e_k aT. 1963).
Human skin fat and sebum have also been analysed 
by adsorption-TLC (Haahti and Nikkari, 1963) and 
total lipid extracts of human and animal blood 
serum, as well as various organs have been 
fractionated by a similar technique (Chalvardjian 
et al * 1962, 1964 ; Hofmann and Bergstrom, I962;
71.
Kaunitz ejt aA. I962; Krell and Hashim, 1963; 
Stein and Stein, I962). Fractionation of 
steroids (Avigan ejb al. 19^3 ) and free and con­
jugated bile'acids (Eneroth, I963; Hofmann,
1962) has also been carried out using adsorption 
TLC. Convenient separations of phospholipids 
(Hofmann, I963), sulpholipids (Martensson, I963), 
glycolipids (Sweeley and Klinosky, 1963) and 
carotenoids (Davies ejt ad. I963) have also been 
made possible.
Until fairly recently, adsorption TLC was. 
used almost exclusively but reversed-phase 
partition TLC, and TLC on layers containing 
complexing agents have permitted separations 
that previously could not be accomplished by 
any simple method. By impregnating TLC plates 
with silver nitrate, various classes of compounds 
can be resolved even further according to their 
degree of saturation. This has been applied 
to vegetable oils and animal fats (Barrett 
et al. 1962; Barrett et al. I963), human skin
72.
lipids (Haahti ejt aJ.. I963) to sterol esters 
isolated from human blood serum (Haahti e_k al. 
1963 ; Morris, I963) and to the separation of 
higher fatty acid isomers and vinylogues 
(Morris, I962)•
Reversed-phase partition chromatography, 
although it has not been used as widely as 
adsorbent or silver nitrate impregnated TLC, 
has been found to be useful in the resolution 
of triglycerides and cholesterol esters (Michalec 
et al. 1962)•
THE SEPARATION OF STRUCTURALLY S IM IL A R  STEROLS 
BY T L C .
The analysis of certain groups of sterols 
in biological material into their constituent 
compounds has proved extremely difficult. For 
example choies tan-3 p-ol (dihydrocholesterol) and 
A^-cholestenol (lathosterol) which accompany 
cholesterol in serum, faeces and several tissues 
(Kritchevsky, 1958(b); Cook, 1958(c); Mosbach e_t al.
1963) cannot be separated from cholesterol by 
ordinary TLC (Cargill, I962; Avigan al. I963)
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or glass paper chromatography (Swartwout et al♦ 
i960 ; Hamilton and Muldrey, I961). With gas- 
liquid chromatography, resolution of mixtures 
of cholesterol and cholestanol is also difficult. 
Partial separation of these sterols has been 
achieved using a selective stationary phase 
(Horning at aJL. I963) but it is only when 
derivatives are used that complete separation 
occurs (Horning at aJL. 1963)*
Cargill (1962) and Michalec (1963) separated 
cholestanol from cholesterol on thin-layer plates 
after bromination, which converted cholesterol 
to the faster-moving dibromide but left the 
saturated cholestanol unaltered. Unfortunately, 
more polar oxidation products of cholesterol 
were formed at the same time (Cargill, I962) 
which made it difficult to estimate the cholesterol 
after developing the chromatogram. Avigan et al»
(1963) were able to separate A -cholestanol from 
cholesterol with benzene-ethyl acetate (2 0 :l) on 
Silica Gel G, but the plates had to be 4o cm.
74.
long and the development took 24-36 hours.
De Vries (1962) introduced the use of silica 
gel impregnated with silver nitrate for the 
separation of cis and trans isomers of fatty 
acids by column chromatography. This principle 
has been extended to the TLC of lipids of 
several classes differing only by one double 
bond (Avigan aA. I963; Morris, I962; I963; 
Barrett et al. I963; Gr^en and Samuelsson,
1964).
The efficiency of this technique is ampli­
fied if sterol derivatives rather than free 
sterols are used. Copius-Peereboom and Beekes
(1965) obtained better separation of cholestanol 
7
and A -cholestanol acetates than of the free 
sterols. Claude (1965) also found that the 
acetates of cholesterol and cholestanol could 
be separated from each other and also from 
desmosterol acetate, but better separations 
were obtained of their propionates. Svoboda 
and Thompson (I967) reported the separation of
75.
the isomers 24- and 25- dehydrochoiesterol ace­
tates on silver nitrate impregnated TLC.
Although silver nitrate impregnated TLC 
has been successful in resolving mixtures of 
closely related sterol derivatives it fails to 
separate cholesterol from the closely related 
phytosterols such as p-sitosterol and campesterol 
either in acetate or free form.
However Copius-Peereboom and Beekes (I965)
used reversed-phase TLC to successfully separate
the acetates of cholesterol and phytosterols.
The incorporation of bromine into the solvent
system for the reversed-phase TLC improved the
separation of cholesterol, p-sitosterol, campesterol
and stigmasterol acetates from each other. These
authors also found that cholesterol was not
7separated from A  -cholestenol by reversed-phase 
TLC. It is also important to note that the 
use of bromine* results in the decomposition of 
sterols with a system of conjugated double bonds 
and sterols devoid of the normal ^^^ double
76.
ybond (e.g. A -sterols and lanosterol).
QUANTITATIVE ANALYSIS OF FAECAL NEUTRIL STEROIDS 
AND BILE ACIDS
ESTIMATION OF NEUTRAL STEROIDS
The quantitative determination of individual 
faecal neutral steroids has proved to be very- 
difficult because of the similarities in their 
molecular structures and physical properties.
Over the past few years there have been several 
methods published, many of which rely on pre­
cipitation of the sterol with digitonin followed 
by regeneration of the sterol and photometric 
analysis frequently by the Liebermann Burchard 
reaction. (Antonis and Bersohn, I962; Haust and 
Beveridge, I963). However these techniques 
do not measure all the steroids present in 
faeces. For example, coprostanol, normally the 
predominant faecal neutral steroid, is incom­
pletely precipitated by digitonin (Wells and 
Moore, I961) and coprostanone, which may account 
for one third of the total faecal neutral steroid 
(Miettinen et al. I965), is not measured by the
77*
Liebermann Burchard reaction. Isotopic balance 
techniques (Heilman e^ aA. 1957) have the dis­
advantage that radioactive sterols must be 
administered to the patients.
Of the earlier methods the most accurate 
would appear to be that of Goldsmith et al. 
(i960). This te Clinique separated the neutral 
steroids by glass paper chromatography into 
three main groups, the principal compound of 
each group being cholesterol, coprostanol and 
coprostanone respectively. The optical density 
(OD) of each spot was measured after charring 
with sulphuric acid, the relationship between 
the OD and the amount of steroid charred being 
linear over a range of 0.6 pg. to 1.2 pg.
It had several disadvantages; one being that 
it could not differentiate between the plant 
sterols of dietary origin and the endogenous 
sterols; another that the charred spots had 
to be cut from the glass paper chromatogram 
before the OD could be measured. . The more
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recent methods of Eneroth e_t al. (1964) and
Miettinen ejb aA. (1965) incorporate column 
chromatography, TLC and GLC and are able to 
measure all faecal neutral steroids, whether of 
plant or animal origin. The method of Miettinen 
et al. (1965) is especially well controlled,
using an internal standard to compensate for 
any losses through the procedure. The sensiti­
vity of this method is such that 1 g. of faecal 
homogenate containing as little as 25 pg, of 
mixed neutral sterols can be analysed accurately. 
It has a disadvantage that there are several 
steps between the extraction of the faeces and 
the measurement of the steroid concentration. 
ESTIMATION OF FAECAL BILE ACIDS
The complexity of the mixture of faecal 
bile acids has rendered separation and quantifica­
tion extremely difficult. Most methods current­
ly available have relied upon the titration of 
total bile acids with alkali which results in 
spuriously high values due to incomplete removal
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of acidic contaminants. These methods have
recently been reviewed by Grundy et al.(I965)«
In the method devised by Grundy al. (1965)
the bile acids are isolated by column chromato­
graphy, thin-layer chromatography and then 
estimated as the trimethylsilyl ethers of 
their methyl ester’s by gas—liquid chromatography. 
This technique has the advantage that not only 
total bile acid measurements can be made but 
changes in individual bile acids can also be 
observed. The method appears to be very 
reproducible with recoveries of the order 
of 90^ and extremely sensitive. Faecal samples 
containing 50 pg. of mixed bile acids can be 
analysed accurately (Grundy et al. 1965). More 
recently Eneroth et al. (1966(a),(b)) have identi­
fied the bile acids in faeces with gas—liquid 
chromatography combined with mass spectrometry 
following a similar purification procedure to 
that of Grundy et al. (1965) and concluded that
deoxycholic acid and lithocholic acid were the
80
main faecal bile acids. Semenuk and Beher 
(1966) have devised a method of direct densito­
metry of bile acids on thin-layer chromatograms 
using phosphomolybdic acid to locate and measure 
the compounds. The colour density response 
was linear over a range of 0.25 to 4.0 pg.
The remarkable resolving power of thin- 
layer chromatography and the fact that compounds 
can be estimated in situ on the thin layer plate 
indicated that it would be an ideal technique 
for the qualitative and quantitative analysis 
of faecal neutral steroids and bile acids.
The next section contains a description of the 
methods devised and the results of these in­
vestigations .
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MATERIALS
1 . Silica gel. MN-Kieselgel G-HR (Camlab 
Ltd., England).
Dowex 50U-X8 cation exchange resin (H^ 
form) (V.A, Howe Ltd., London).
Dowex 1-X2 anion exchange resin (Cl form) 
(V.A. Howe Ltd., London). (This resin
was converted to the hydroxyl form by 
suspension in 1 M. sodium hydroxide).
2 « Solvents
2 2^,4“Trimethyl pentane Analar (BDH)
Sulphuric Acid Analar (BDH)
All other solvents were redistilled before
use o 
3 . Reagents
Silver nitrate 
Phosphomolybdic acid 
Potassium iodate 
Sodium hydroxide (pellets) 
Ammonium carbonate 
Sodium chloride
Analar BDH)
85.
Hexamethyldisilazane. Koch-Light Labora­
tories Ltd.
Trimethylchlorosilane.
Diazomethane•
Standards ' ' —
Coprostanol Southeastern Biochemicals
Coprostanone " "
Cholestanol " "
cholestenol " "
cholesterol recrystallised
Epicholestanol Steraloids Ltd.
Epicoprostanol " "
Cholic acid B.D.H.
deoxycholic acid 
lithocholic acid 
glycocholic acid 
taurocholic acid
Sigma
Calbiochem
Calbiochem.
Southeastern Bio 
chemicals
(B.D.H.)
U.S.A.
B.D.H.
Croydon)
)
12-Hydroxystearic acid Calbiochem.
London) 
U.S.A.) 
U.S.A.) 
U.S.A.)
)
Figure lQ(a).
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Procedure for the separation of faecal neutral 
steroids from bile acids.
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PREPARATION OF 'FAECAL NEUTRAL STEROID AND BILE 
ACID EXTRACTS.
(1 ) Collecting and Drying of Faeces
Faeces were collected in weighed plastic 
containers' 'during a period of 3“7 days and 
stored in a deep freeze until required. The 
specimens were then weighed and homogenised 
with distilled water in a weighed homogeniser.
An aliquot of the homogenate representing a 
known weight of faeces was transferred to a 
tared 2^0 ml. round bottom flask, freeze-dried 
for approximately 2k hours, and the flasks re­
weighed. The dried faeces were removed and 
transferred t o  s m a l l  s c r e w - c a p p e d  jars which 
were then stored in a desiccator until required.
(2 ) Extraction of Faeces
A known weight (between 1 .-2.0 g.) of dried 
faeces was extracted with 95^ ethanol in a 
Soxhlet extraction apparatus under nitrogen 
atmosphere for 6 hours. The extract was then 
separated into acidic and neutral fractions by 
passing it through Dowex ion-exchange resins, as
88.
described below.
(3) Ion-Exchange Column Chromatography.
Column I .
A glass column of* inside diameter I.3 cm. 
and length 39 cm. was fitted with a stopcock, 
a coarse sintered disc and a reservoir to hold 
approximately 50 ml. Dowex 5OW-X8 cation ex­
change resin (hydrogen form) (approx. 15*0 g.), 
suspended in 80^ ethanol, was poured into the 
column and allowed to settle to a depth of 
16 cm. above the sintered disc. The resin was 
then washed with a further 100 ml. of BOJo ethanol. 
Column II.
Dowex 1-X2 anion exchange resin (approx. 
l4 .0 g.) was converted from the chloride form to 
the hydroxyl form by suspension in aq. 1 M. 
sodium hydroxide. The suspension was poured 
into a glass column similar to column X and 
allowed to settle to a depth of 13 cm. above 
the sintered disc before washing with 100 ml. 
aq. 1 M. sodium hydroxide. The column was
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then brought to neutrality with distilled water 
before being washed with 100 ml, of 80^ ethanol.
The columns were then arranged so that the 
eluate from column I drained directly into the 
reservoir of column II,
Neutral Steroid Fraction
The faecal extract was poured into column 
I and allowed to percolate at a flow rate of 
4-5 ml./min. into column II. When approximately 
5*0 ml, of the extract was left in column I, 50 ml, 
of 80^ ethanol was added in I5 ml. aliquots and 
the eluate was allowed to run through into column
II. Column I was allowed to run dry and the 
eluate from column II containing neutral steroids 
was collected. This fraction contains cholesterol, 
coprostanol and coprostanone together with their 
phytosterol analogues.
Bile Acid Fraction
The faecal bile acids retained on column II 
were then eluted with 25O ml, 0,1 M, ammonium 
carbonate in 50^ ethanol after washing the column
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in the following manner according to ICuron and 
Tennent (1^61);-
a) 25 ml. 50^ ethanol
b) 50 ml. distilled water
c) 25 ml. 00^ free water
d) 100 ml. aq. IM sodium chloride
e) 100 ml. aq. 0.5 M ammonium carbonate
f ) water to neutrality
g) 25 ml. CO free water
h) 25 ml. 50^ ethanol
The bile acid fraction consists of a mix­
ture of trihydroxy bile acids, when present, 
and the dihydroxy and monohydroxy bile acids 
which are predominant. The main constituents 
of these three groups of bile acids are cholic 
acid, deoxycholic acid and lithocholic acid 
respectively.
The faecal neutral steroid fraction and 
the bile acid fraction were then separately 
evaporated to dryness on a rotary evaporator 
and the residues dissolved in acetone, trans­
ferred with washings to 15 ml. vials and then 
evaporated to dryness with a stream of nitrogen 
The residues were dissolved in 3 ml. of
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re-distilled acetone and stored in tightly- 
capped vials in a deep-freeze until analysed 
by TLC.
THIN-LAYER CHRQMATQGKAPÎiY 
PREPARATION OF TLC PLATES
The following procedure was used, A 
smooth suspension of silica gel in distilled 
water (30 g. in 60 ml, water) was obtained by 
shaking the mixture in a stoppered 250 ml, 
conical flask for 90 secs. The plates were 
then spread with a Camag Spreader, left over­
night at room temperature to dry and then 
stored in a desiccator until required. This 
method produced TLC plates with a uniformly 
thick (0.25 mm.) layer, (The Desaga and Shandon 
spreaders were both tried but the layers obtained 
were not uniformly thick.) Solutions of the 
compounds to be separated were applied with a 
10 pi. Hamilton syringe about 1.5 cm. from the 
lower edge of the plate and the plate placed 
in a chromatography tanl-c filled to a depth of
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approximately 0«5 cm, with a suitable develop­
ing solvent. The tank was lined with filter 
paper to ensure saturation of the atmosphere 
in the tank with solvent vapour.
PREPARATION OF SILVER-NITRATE IMPREGNATED TLC 
PLATES
\\Then required, a silica gel plate was 
sprayed with 25/^  aqueous silver nitrate until 
evenly moistened and dried in an oven at 110^ 
for 30 min. It was allowed to cool to room 
temperature before applying the sample. The 
silver nitrate layer started to darken after 
standing 12-24 hrs., even in the dark, so that 
impregnated plates were used on the day of 
preparation.
PREPARATION OF REVERSED-PHASE TLC PLATES
A silica gel plate, 20 cm. long, was im­
pregnated with stationary phase by allowing 15^ 
n-undecane in petroleum ether (B.pt. 40-6o^) 
to rise nearly to the top of the plate in a 
TLC tank. The samples were then applied and 
the plate left in a fume cupboard for 1 hr.
93.
to allow the petroleum ether to evaporate.
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THIN-LAYER CHROMATOGRAPHY OF NEUTIbVL STEROID 
FRACTION
First separation; Silver nitrate - imprégnâted 
thin-layer Chromatography
An aliquot from the faecal neutral steroid 
extract was subjected to silver nitrate im­
pregnated TLC in the solvent system chloroform- 
acetone (98 : 2). The solvent front was allowed 
to rise I5 cm. above the origin. To make the 
sterols suitable for light photography the 
plate was sprayed with lO^ S ethanolic phospho- 
molybdic acid and then heated at l40^ for I5- 
20 min. to produce brown spots on a yellow back­
ground (see Results section, Figure lO).
The effect of impregnating silica gel with
silver nitrate on the R^ values'of cholesterol,
A  -cholestenol and the C^^ stands is shown in
Tables V and VI (Results section, p. 109-110),
Extraction of sterols from silver nitrate im­
pregnated plate
The sterols were detected by lightly 
spraying the dried plate with distilled water* 
The plate was viewed against a dark background
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when the sterol's appeared as white spots as 
the thin layer started to dry* The smallest 
amounts that could be detected with certainty 
in this way were 15 pg. of cholesterol and 5 pg. 
of A -cholestenol. The spots were ringed with 
a fine point, allowed to dry, scraped off the 
plate into conical centrifuge tubes and ex­
tracted. Extraction with methanol, chloroform 
and ethanolic ammonia were compared, the latter 
being found most suitable (Results section,
Table VII, p. 113).
Extraction with ethanolic ammonia
The silica gel in the conical centrifuge 
tube was extracted with 50^ ethanolic ammonia 
(3 x 4 ml.). The combined extracts were diluted 
with an equal volume of distilled water and re­
extracted with 3 X 10 ml. redistilled benzene.
The benzene extracts were washed with 20 ml. of 
distilled water, dried over anhydrous sodium
sulphate, filtered and evaporated to dryness 
o
at 40-50 under reduced pressure. The residue
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was either subjected to further chromatography
(see below) or a Liebermann-Burcliard reaction
was carried out at this stage (p, 100 )•
Second separation; Keversed-phase chromatography 
at 1 ow t fetnperatur e
The residue from the.single spot containing 
7cholestanol and A -cholestenol was taken up in
a small volume of chloroform. The mixture of 
7A  “Cholestenol and cholestanol was resolved 
conveniently by reversed-phase TLC, The tank 
containing mobile phase (acetic acid ;acetonitrile 
( 1:1 ) , 70^ saturated with undecane (iCaufmann and 
Makus, i960))was placed in a deep-freeze (-15 to
-20^) for 15 mins, (for temperature equilibration) 
before development of the plate. The prepared 
plate was developed until the solvent reached a 
height of 15 cm, (time 3“3y hours). Undecane 
was removed from the plate by heating for 1 hour 
at 150^ and the sterols were located with 
ethanolic phosphomolybdic acid (Results section, 
Figure 11), If the plate was sprayed immediately
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after being taken out of the oven, it was not 
necessary to heat further to induce colour 
development.
Adsorption Thin-Layer Chromatography;
Quant if ica tiro n of Faecal Neutral Steroid
Fraction
The TLC plate was prepared as previously 
described (p • 91 ), cleaned by initial develop­
ment in benzene-ethyl acetate (8;l) and allowed 
to dry in a fume-cupboard at room temperature. 
The faecal neutral steroid extracts for quantita­
tive analysis and standards were then applied 
and the plate was developed at room temperature 
in benzene-ethyl acetate (8:1) to a height of 
15 cm. Subsequently the plate was dried in a 
fume cupboard at room temperature. The com­
pounds were subjected to densitometry in situ 
(p. 98 ).
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ADSORPTION THIN-LAYER CHROMATOGlblPHY ;
QUANTIFICATION OF FAECAT, BILE ACID FRACTION.
The bile acid fraction and standards were 
applied as previously described and the plate 
developed in-*hexane-diethyl ether-methanol- 
acetic acid (90 ; 20 ; 3 :2 , Brown and Johnston, 
1962). This solvent system caused the fatty 
acids to move approximately 10 cm* in a I5 cm. 
development and left the bile acids at the 
origin. The plate was then air dried in a 
fume cupboard and placed in an oven at 100^ for 
20 min, to remove traces of solvent. After 
cooling, the plate was developed in 2 , 2 , 4-
trimethyl pentane-ethyl acetate-acetic acid (5: 
25:0,2 ; Eneroth, I963) to a height of 10 cm. 
This gave a very good separation of the bile 
acids and was also effective in separating 
hydroxy-fatty acids from the bile acids. The 
bile acids were then subjected to densitometry 
in situ (see below).
Measurement of Steroid Concentration by 
Densitometry
The plate was sprayed with 1^ potassium
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iodate in lOJo sulphuric acid and heated at 100^ 
for 20 min. to produce dark brown spots on a 
white background which proved extremely suit­
able for scanning (see Results section, Figures 
12 and 13).
The optical density (O.D.) of the charred 
spots was measured with the Joyce Loebl Chromo­
scan with Thin Layer Attachment. The attach­
ment is suitable for both reflectance and trans­
mittance operation and uses the recording and 
integrating facilities of the Chromoscan.
Best results were obtained using the narrow 
slit width and transmission on the Thin Layer 
Attachment combined with the largest cam in the 
Chromoscan. He TLC plate was placed on the sample 
table and was scanned in the direction in which 
the plate was spread and chromâtographically 
developed which helped to eliminate the effect 
of any irregularities in the layer arising 
during spreading. The O.D. of each spot was 
shown graphically in the shape of a peak on a
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piece of paper attached to the recording drum 
and the area under the curve was recorded on 
an integrator. At the end of each run, the 
sample table carrying the TLC plate was stopped 
automatically. The table and plate were then 
moved back manually so that the slit of light 
was again at the origin and the plate was 
moved horizontally to the next lane to be 
scanned. A linear relationship between the 
amount of steroid or bile acid applied and the 
optical density (O .D.) of the charred spot 
as recorded by the integrator on the Chromoscan 
was obtained (see Results section, Figures l4 
and 15). The standards used were cholesterol 
and coprostanone (10 to 25 pg*)? coprostanol 
(20 to 50 pg*) and deoxycholic acid and litho­
cholic acid (10 to 25 pg. in each case).
Measurement of sterol concentration by Liebermann— 
Burchard Reagent
Sterol concentrations were also estimated 
according to the procedure of Abell e_t al (1952).
3 ml. of Liebermann—Burchard reagent (acetic
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anhydride, cooled to less than 10° in a glass 
stoppered bottle ; cone,sulphuric acid:glacial 
acetic acid — 20sl:10) was added to the sterol 
samples which had been placed in a 25° water 
bath. The optical density (0.D .) was measured
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at 620 mp. after 2 min. (optimum time for A. - 
cholestenol) and after 35 min. (optimum time 
for cholesterol). Sterol concentration of the 
samples was obtained from a standard graph of 
O.D. plotted against concentration.
Measurement of sterol concentration by the method 
of Zak et al. (-1954).
Tubes containing varying concentrations of 
cholesterol were evaporated to dryness under 
nitrogen and the residue dissolved in 0.5 ml, 
of isopropyl alcohol. The contents were well 
mixed and 2.5 ml. of Colour Reagent added.
This reagent contained 0.075 g. Fe(N0^)^.9 H^O 
dissolved in 95 ml. glacial acetic acid + 5 ml. 
distilled water and 43 ml. concentrated sulphuric 
acid. The cholesterol extract and colour re­
agent were remixed and the tubes placed in a 
95  ^ water bath for 8 mins. The tubes were
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then removed, cooled and the optical density 
(0 ,D«) of the colour read at 520 mp. in a spectro­
photometer. Sterol concentrations of the test 
samples were obtained from a standard graph of 
O.D, plotted against concentration.
Measurement of sterol concentrations by gas- 
liquid chromatography (OLC)
Gas—liquid chromatography was carried out 
to compare the results obtained by the quantita­
tive TLC densitometry technique with an established 
technique. The GLC quantitative procedure was 
based on that devised by Brooks (1964) for the 
measurement of serum cholesterol.
A Pye Argon gas chromatograph was used. 
Operating conditions were ; 1^ SE-30 Gas Chrom.
Q (80-100 mesh) packed in a glass column (5 ft. 
long, internal diameter = 5 .Omn) , temperature
o / I220 , argon flow 35 ml./min., chart speed I50 mm./ 
hour, detector voltage 1,250 volts and sensiti­
vity X 10. Trimethylsilyl ethers were pre­
pared by evaporating the extract to dryness and 
redissolving the steroids in a mixture of
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dimethylforinamide (for'neutral steroids) or dry 
pyridine (for bile acids), hexamethyldisilazane 
and trimethylchlorosilane in the proportions 
4 :4 :1 . The tubes were stoppered, well shaken 
and left at room temperature for at least 1 hour. 
The samples were then evaporated to dryness in 
a stream of nitrogen, extracted with chloroform, 
centrifuged and the supernatant re-evaporated 
before being taken up in a known volume of 
chloroform. An aliquot (l.O pi.) was injected 
with 0.5 pi. choiestane (O.5 pg.) and the ratios 
of the emergent peak heights of the sample to 
that ofchoiestane were determined. By inject­
ing mixtures of standards, linear relationships 
were obtained between the ratio of peak heights 
and the amount of neutral steroid or bile acid 
injected.
The bile acids were methylated with diazo- 
methane prior to the formation of their trimethyl 
silylethers•
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TSCKNXQUB yOR ANALYSIS OF BT.LE 
Collection of Bile
Under X-ray control a nasal tube was passed 
into the duodenum and the gall bladder stimulated 
to emptying by an intravenous injection of pan­
creozymin (Boots). Bile was then collected 
and frozen until required for analysis. Before 
analysis the bile was diluted with ethanol and 
the precipitated protein removed by centrifuga­
tion. The supernatant was subjected to further 
analysis (see below).
The separa.tion of conjugated biliary bile acids
and the determination of their conjugation 
ratio by TLC.
Glycine and taurine conjugates of the bile 
acids were separated by thin-layer chromato­
graphy of the supernatant on silica gel pro­
washed with water. Triplicate samples of bile 
and duplicate standards of glycocholic acid and 
taurocholic acid were run on each plate in the 
solvent system butanolsacetic acid:water (10:1:
1 , Ganshirt et al. I960). Compounds were located
• 05.
by spraying lightly with water. The plate was 
allowed to dry. Glycocholic and taurocholic 
acid spots and appropriate blank areas were 
scraped off into conical centrifuge tubes.
They were reacted with 4 ml. of 65^ 0 sulphuric 
acid at 6o° in a water bath. After 30 min. 
the tubes were removed, the contents remixed 
and the tubes replaced in the water bath for 
a further 30 min. The tubes were cooled to 
room temperature under a stream of cold water, 
centrifuged and the optical densities were 
read at 387 mp. (Ganshirt aT. I960). The 
linear relationship between the O.D. at 387 mp. 
of the supernatant of the extracted spot and 
the amount of bile acid applied to the plate as 
described by (Ganshirt et al. I960) was confirmed
(see Results section, Figure 17)* The ratio 
of the values obtained from the extracts corres­
ponding to the‘glycocholic and taurocholic acid 
spots gave the conjugation ratio (g /T) of bile 
acids•
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The extraction and separation of biliary bile
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acids
To determine the pattern of the bile acids 
conjugated with glycine and taurine it was 
necessary To'^Kydrolyse the conjugates. One 
ml. samples of bile were autoclaved with 2 ml, 
of 2 N. sodium hydroxide in sealed glass ampoules 
at 120° for 4 hours. After cooling, the con­
tents were neutralised with concentrated hydro­
chloric acid using Congo Red as indicator. The 
free bile acids were extracted ( 3 x 4  ml.) with 
ether. The ether extracts were washed free 
of hydrochloric acid, evaporated to dryness and 
dissolved in acetone. Thin-layer chromato­
graphy on silica gel was performed in the solvent 
system iso-octane ; isopropyl ether : acetic acid 
(2:1:1, Hamilton, I963). Control and treatment 
samples from one patient were run on the same 
plate. After drying, the plate was sprayed 
with ethanolic phosphomolybdic acid and the bile 
acid spots which developed after gentle heating 
were then photographed, (See Part XV, Figure 18)
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STATISTICAL METHODS.
Student
The significance of changes in serum and 
faecal lipids—from their mean pretreatment 
levels was determined by the Student "t" test 
for paired values*
-  C £ ( x ) )
n
n
\
X = mean change.
(n-l)
X = change from mean pretreatment level
of each subject *
n - number of values.
Correlation Coefficient.
The association between serum and faecal
lipids or the changes from their mean pretreatment
levels was determined by the correlation coefficient (r).
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THE APPLICATION' OF SILVER IMPREGNATED TLC AND 
REVERSED-PHASE TLC TO THE SEPARATION OF 
FAECAL NEUTRAL STEROIDS
7Separation of cholesterol from A -cholestenol and 
cholestanol by silver nitrate impregnated 
TLC
During a study of human faecal neutral 
steroids it was found that cholestanol and
7A  -cholestenol could be completely separated 
from cholesterol on 20 cm, plates coated with 
silica gel impregnated with silver nitrate.
Evidently cholesterol forms the expected silver 
complex at its double bond and is retarded while 
A  —cholestenol moves ahead with cholestanol.
The faster spot containing cholestanol and A"^- 
oholeatenol could be resolved by a second reversed»^ 
phase TLC at low temperature.
The best separation of cholestanol plus
7A  —cholestenol from other sterols was obtained with 
the solvent system chloroform:acetone (98:2),
The R_ values for these two sterols and cholesterol 
in other solvent systems are given in Table V,
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Table V .
y A comparison of the Rp values of cholesterol 
A  —cholestenol and cholestanol on silver nitrate 
impregnated TLC plates developed in several 
solvent systems.
Rp Values
j
Solvent cholesterol A  -cholestenol cholestanol
system
Benzene; 0,11 0,15 0,15
hexane(9 :1)
Benzene: 0,19 0,19 0,19
ethyl ace­
tate (20s1)
Benzenes 0,^5 0,46 0,46
ethyl ace- 
tat e (5 :1)
Chloroform; 0.70 0.73 0,73
acetone 
(92:8)
Chloroform: 0,62 0,68 0.68
a cetone
(9 6 :4 )
Chloroform; 0.39 0.50 O.5O
acetone 
(98:2)
It is apparent from the results in Table VX that 
not only did silver nitrate impregnated TLC separate
1 1 0 ,
7A  -cholestenol' and cholestanol from cholesterol 
but also that the value of each sterol was 
increased. Cholesterol migrated 1.2 times 
further while -cholestenol and the C^y stanols 
all moved 1,4 to 1,5 times further. Consequent­
ly cholesterol was separated from its companions 
Table VI,
Table VI,
Effect of silver nitrate impregnation on 
R values* of choiestenols and C^» stanols on 
TLC plates.
On Ratio
On Silica R^ on
Silica Plus Silica -i- AgNO^
Alone Silver Rp on Silica
Nitrate alone
Cholesterol 0,40 0.48 1,22
A  -Cholestenol 0.39 O.57 1.46
Cholestan-3P* 0,39 0 .59 1,51
ol
Coprostan-3P” 0,51 0,72 1,40
ol
Coprostan-3GL- 0,51 0.74 1,46
ol
Cholestan—3ci- 0,58 0,80 1,40
ol
Solvent :chloroform-acetone 98 : 2, run I5 cm,
*Means of four replicates on each of two pairs 
of plates run in the same tank simultaneously.
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Although cholestanol and A  -cholestenol 
moved further than cholesterol they ran well 
behind coprostanol, both in a mixture of pure 
sterols and in a naturally occurring mixture 
(Figure lO).
Figure 10.
{
coprostanol
cho.'estanol
/J-cholestcnol
cholesterol
origin
Photograph of thin-layer chromatogram on Silica 
Gel G impregnated with silver nitrate. Sprayed 
with phosphomolybdic acid. 1, 10 pg cholesterol;
2, 10 pg cholestanol; 3* 10 pg -cholestenol;
4 , 10 pg coprostan-3p-ol; 5» mixture; and 6, 
neutral lipid extract of human faeces. S, solvent 
front. Origins at base of the photograph were 
enlarged after chromatography for easier 
visualization. The fast spots in the faecal extract 
are steroid 3-lGetones and esters.
1 1 2 .
Xn experiments in which this separation
method was api>lied for neutral lipid extracts
from human faeces, spots of up to 70 pg. of
cholesterol and 200 pg. of coprostanol have
been very well separated from cholestanol and 
7A -cholestenol.
Comparison of the three extraction methods 
used to elute the sterols from the silver 
nitrate impregnated plate
7To separate cholestanol from A  -cholestenol 
the spot containing these two sterols was ex­
tracted from the silver nitrate plate and then 
subjected to reversed—phase thin-layer chromato­
graphy. Three methods of extraction were 
examined; methanol, chloroform and 50^ ethan­
olic ammonia. The extracted sterols were 
measured by the Liebermann-Burchard reaction 
(see Method section, p. 100 )• The results
are shown in Table VII.
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Table VII.
A comparison of the three extraction procedures
Jo Recovery
Extraction
method
Methanol
Chloroform
50jS Ethan- 
olic Ammonia
Sterol Choies- 
Added terol 
(MS' )
5 0  (jg.
50  f i g .
5 0  fig. 8 9 ^
Choles-
tenol
10^
kofo
81^
Number of 
Estimations
3
5 
5
It was thought that the Ag might have in­
hibited the Liebermann-Burchard reaction and 
this was investigated.
The effect of Ag"*" on the Liebermann-Burchard 
reaction.
The results are shown in Table VIII.
Il4
Table VIII.
The effect of on the Liebermann-Burchard
reaction*
Sample
50 fig*
cholesterol
Ag concentration 
0
1*38 pg. 
7*90 pg.
138.0 pg.
790.0 pg.
O.D. after 35 
mins.
,0.070
0.070
0.063
0.072
0.042
0.034
0.010
0.000
0.000
0.000
The optical density of the colour result­
ing from the Liebermann-Burchard reaction of 
30 pg. of cholesterol was reduced by in
the presence of 7*9 pg* Ag^.
The effect of Ag*^  on the method of 2ak ejt al.
The method of Zak et al* 1934 (see Method 
section, p. 101 ) was tried as an alternative 
to the Liebermann-Burchard reaction. The Zak
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procedure, when'modified slightly by replacing 
ferric chloride with ferric nitrate to avoid 
cloudiness produced by silver chloride, was 
not inhibited by Ag^# Table IX.
Table IX.
The effect of Ag^ on the method of Zak 
et al. (1934).
Sample Ag^ O.D. at cholesterol
concentration 320 mp. concentration
30 pg* 0 0.280 50 pg.
cholesterol
* 7*9 pg* 0.261 48 pg.
0.279
" 13.8 pg. 0.239 47 pg.
0.288
" 31 *6 pg. 0.268 46 pg.
0.248
•' 138.0 pg. 0.232 46 pg.
0.268
» 790.0 pg. 0.290 46 pg.
0.232
However this method gave less consistent 
7recoveries for A -cholestenol than the Liebermann-
Burchard reaction. The mean percentage recovery
7from 3 samples of 30 pg. of A  -cholestenol was
li6.
46^ with a range of 24-78^.
The separation of A  -cholestenol from cholestanol 
by reversed-phase TLC.
After extraction from the silver nitrate
imprégnâte*d plate the mixture of cholestanol
Y
and A  -cholestenol was separated by reversed- 
phase TLC. (Figure 11).
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Fi gure 11.
f
A^-choîestenol
cholestenol
origin
Photograph of low temperature r^versed-phase 
thin-layer chromatogram of 1, A-cholestenol 
(1 pg.); 2, mixture; 3» cholestanol (1 pg.);
S, solvent front. Origin at base of the 
photograph.
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With this technique the unsaturated A*^- 
cholestenol migrated faster than cholestanol, 
even at room temperature. By lowering the 
temperature to between -13 and -20^ the separa­
tion factor"was increased from 1.173 to 1.39# 
This improved separation was necessary because 
the edges of the spots were not as sharp as on 
layers of silica gel alone. The loads of
sterols which could be completely separated 
in this system were rather small since with 
more than 5 pg# of each sterol some blurring 
of the spots occurred. Cholesterol migrated 
with cholestanol in this, second system, hence 
the need for a preliminary step to resolve a 
mixture of cholesterol, A^-cholestenol, and 
cholestanol by TLC.
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QUANTITATIVE TLC DENSITOMETRY
CoTnparison of colour development reagents.
For precise densitometry it is necessary 
to produce the maximum possible contrast 
between the "spot and background. Several 
spray reagents were tried e.g.:-
a) , lOfo phosphomolybdic acid in methanol;
this gave blue spots on a yellow back­
ground which was not uniform in optical 
density.
b) ifo eerie ammonium sulphate in lOjS sulphuric 
acid: this gave coloured spots on a faintly 
yellow background.,
c) Potassium dichromâte in 80^ sulphuric acid; 
this gave an uneven greyish background with 
black specks.
d) 35?^  phosphoric acid; this gave a back­
ground similar to c).
e) 5OJ0 sulphuric acids this also gave a back­
ground similar to c).
The only suitable spray reagent was found
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to be 1^ potassium iodat© in lOjG sulphuric acid 
(see Method section, p . 98 )• This gave dark
well defined spots under the conditions employ­
ed. (Figures 12, 13). Using this spray re­
agent linear relationships were obtained be­
tween the optical density (O.D.) of the neutral 
steroids and the amount of steroid applied to 
the TLC plate. Similarly for the faecal bile 
acids. (Figures l4, 15)#
The separation of the free fatty acids, 
especially the 12- hydroxy stearic acid from the 
faecal bile acids is shown in Figure I6 .
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Figure 12.
F A E C A L  N E U T R A L  STEROIDS  
2 3 4 5 6  A B B  C D
solvent
front
coprostanone
A  0  0  $  0  #  #  #  #  #  e  coprostano
f #  #  #  #  cholesterol
origin
A photograph of a typical thin-layer chromatogram 
of faecal neutral steroids and standards. Origin
at bottom. Lanes 1-6 are six faecal neutral
steroid extracts and lanes A B C  and D contain 
cholesterol standards (spots nearest origin) 10, 
13, 20 and 23 pg., coprostanol standards (2nd
spot from origin) 20, 30, 4o and 30 pg. and
coprostanone standards (3rd spot from origin) 10, 
13, 20 and 23 pg.*. The spot nearest the sol­
vent front in the extracts is a mixture of sterol
esters, triglycerides and hydrocarbons.
Standard B is duplicated.
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Figure 13.
1 2  3 4 5 6 A B C D E
y tTfrir 
 ^ • • • • •
solvent
fro n t
lithocholic
acid
• • • • • •  % deoxychollc
acid
# # # # & # prigin
Thin-layer chromatogram of faecal bile acids and 
standards. Origin at bottom. From left to 
right lanes 1-6 are six faecal bile acid extracts 
and lanes A - E contain deoxycholic acid standards 
(spot nearest origin) 13, 20, 23 and 30 pg. and ^
lithocholic acid standards 10, 13, 20 and 23 pg. . 
The spot nearest the solvent front in the faecal 
extracts is a mixture of fatty acids and pigments. 
The spot just ahead of lithocholic acid is a 
hydroxy fatty acid thought to be 12 hydroxystearic 
acid.
Deoxycholic acid 20 pg. standard is duplicated in 
B and C.
Lithocholic acid 20 pg. standard is duplicated in 
C and D.
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Figure l4.
O D
160
C H O L E S T E R O L140
120
100
80
40 C O P R O S T A N  -3 -O N E
20
10 155 20 25
OD
200
180
16 0
C O P R O S TA N -3P  -O L140
120
100
80
60
40
10 20 30 40 50
Hg- H-g*
Standard graphs for cholestérol, coprostanol 
and coprostanone showing the straight line 
relationship between O.D. of the charred spot 
and quantity of steroid present*
124.
Figure 15»
O . D .
9ü
70
L i t h o c h o l i c
A c i d
60
50
40 D e o x y c h o l i c
A c i d
30
20
1510 205 25
1*8-
Standard graphs for deoxycholic acid and litho­
cholic acid showing the straight line relation­
ship between 0.D# of the charred spot and quantity 
of bile acid present*
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Figure l6.
STQ 1 2  3 4 STQ 5 6 7 6 STQ
T r* t f f • T '.
* # # e # # # %
$ e • •  • # %
0 • • • % ij t f I
1 * 1  # % 4
l2~OH-stearic
acid
lithocholic 
oc id
deoxycholic
acid
origin
Thin-layer chromatogram of faecal bile acid 
extracts 1 to 8 and mixtures of deoxycholic 
acid, lithocholic acid and 12-hydroxystearic 
acid standards.
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RECOVERIES AND REPLICATS VARIATION 
RECOVERY FROM ETHANOLIC EXTRACTION PROCEDURE
The procedure for extracting sterols and 
bile acids from faeces was checked by recovery 
experiments* Cholesterol and deoxycholic acid 
standards were added to extraction thimbles and 
the extraction procedure was carried out. After 
6 hours extraction with 95/« ethanol under nitro­
gen, the extracts were evaporated to dryness 
with a rotary evaporator and the residue dissolved 
in 3 ml. of re-distilled acetone. Aliquots were 
then applied to a thin layer plate for quantifica­
tion. The results are shown in Table X.
Table X.
Recovery of cholesterol and deoxycholic acid 
by the extraction procedure *
Cholesterol Deoxycholic Acid
Sample Added Recovered Added Recovered
üilî. D.Sjl
1 22.7 ‘ 22.3 11.3 10.9
2 18.3 18.7 10.4 9.8
Mean 20.50 20.50 10.95 10.35
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Recovery from Xon-Exchange Columns
The presence of neutral steroids and bile 
acids in their respective eluates was checked 
by passing cholesterol and deoxycholic acid 
standards through the ion-exchange columns and 
running samples from the various eluted fractions 
on TLC. Cholesterol was detected only in the 
80^ ethanolic fraction and deoxycholic acid in 
the fraction eluted by O.IM ammonium carbonate 
in 50^ 0 ethanol.
Recovery of Neutral Steroids and Bile Acids 
Added to TLC Plate
Recovery of Neutral Steroids
Duplicate TLC plates each containing five
standard mixtures of cholesterol, coprostanol
and coprostanone and six equal aliquots of a
faecal extract, three of which had known amounts
of a mixture of cholesterol, coprostanol and
coprostanone added to them were developed.
The spots were charred and the amount of
cholesterol, coprostanol and coprostanone in
the faecal extracts calculated (see Methods
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section, p. 98 )• The results are shown in
Table XI.
Table XX.
Recovery of neutral steroids from faecal 
extracts by TEC.
Cholesterol Copros tanol Coprostanone
Added Re — 
covered
Added
PIS'*
Re-
covered
Added Re­
covered
15 14.8 20 21.3 10 9.9
Plate
1
Tt 16.3 It 20.3 tt 9.9
It 16.3 tt 18.1 It 8.4
It 15.8 tt 19.6 tt 10.5
Plate
2
It 15.8 ft 20.5 It 9.0
tt 15.5 tt 22.6 It 8.0
Mean 15.75 20.40 9.28
S.D. _+o.56o +1.226 ±0.975
105^ 102^ 93fo
Bile Acids.
A similar recovery experiment was carried 
out using deoxycholic acid and lithocholic acid
129.
The results are ’ shown in Table XXX*
Table XII.
Recovery of bile acids from faecal extracts 
by TLC.
Deoxycholic Acid Litliocholic Acid
Added Recovered 'Add e d Recovered
Rg-i. PfA- liCL*. MfhL
15 14.0 15 15.8
Plate " 14.0 " 13.0
1
" 13.6 " 16.3
" 13.6 " 16.5
Plate " 13.8 " 16.3
2
" 13.8 " 16.3
Mean I3.8 I5.7
S.D. +0.179 +1.341
105^ 1
RECOVERY OF NEUTRIL STEROID AND BILE ACIDS 
AFTER COMPLETE ANALYTICAL PROCEDURE
Faecal specimens, with and without added 
neutral steroid and bile acid standards were subjected 
to the complete analytical procedure i.e. solvent
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extraction under nitrogen, ion exchange
chromatography and thin layer chromatography
as described in Method section (p.87-92;
97-100). Tha^results are shown in Table XIII.
Table XIII.
Recovery of neutral steroids and bile 
acids after complete analytical procedure.
Sample 1. Sample 2.
Com­ Added Recovered Added Recovered
pound
cholesterol 10.3 10.0 10.3 10.4
coprostanol 10.5 10.3 10.5 10.7
coprostanone 13.5 13.0 13.5 13.8
deoxycholic
acid
9.5 8.8 9.5 8.9
lithocholic
acid
13.4 13.3 13.4 12.3
Variation of Replicate Estimations
To check the reproducibility of the 
technique, aliquots from a single faecal specimen 
were analysed by the complete procedure. The
results are analysed in Table XIV.
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Control Data; Faecal Neutral Steroid and Bile
Acid Excretion in Normal Human
The faecal excretion of neutral steroids 
and bile acids in three young (26, 27 and 29 
yrs.) healthy subjects was studied for three 
weeks. Faeces were collected for five days 
each week. The subjects were staff members 
and were not on a restricted diet. The results 
and standard deviations are shown in Tables XV. 
and XVI.
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Comparison of* the dally excretion of faecal 
neutral steroids and bile acids measured 
by TLC densitometry and GLC.
The daily faecal excretion of neutral 
steroids and bile acids in six faecal specimens 
was measured by TLC densitometry (Method section, 
p. 98 ) and by GLC (Method section, p. 102 )*
The results are shown in Table XVII.
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The total 'sterol content of the diet was 
also analysed and the values ranged from l84 
to 375 mg./day (mean = 1^4 mg./day) (five 
daily diets were analysed).
To determine whether there was much 
variation in the excretion of plant sterols 
in subjects during an ordinary ward diet, the 
faecal neutral steroid extracts of eight sub­
jects were examined by GLC (Method section, 
p. 102). The mean percentage of steroids 
excreted as plant sterol metabolites three to 
six days after admission was 9«7/o (±4. 6^) and 
ten to fifteen days later was 9.1/° (±2.7/o).
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BILIARY BILE ACIDS
The method of Ganshirt ±1, (i960)
(see Method section, p.l04 ) was used in the 
measurement of glycocholic acid and taurocholic 
acid as it was a relatively simple and accurate 
method. The adsorbent used, Macherry Nagel 
Kieselgel MN-GHR, was found to be the most 
suitable as the others gave high and variable 
blank values.
To check the reproducibility of the method 
two bile samples were analysed three times.
In one sample the glycinestaurine ratios (g/T) 
were 4.0, 4.4 and 4.6 and in the other the 
ratios were 3*5> 4.2 and 4.2. The linear re­
lationship between the optical density (O.D,) 
at 387 nip. of the supernatant of the extracted 
spot and the amount of bile acid applied to the 
plate is shown in figure 17 *
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Figure 17 «
0 2
O.D.
t aurochol ic
acid
403010
Standard graphs for taurocholic acid and 
glycocholic acid showing the straight line re­
lationship between 0.D. of the extracted spot 
and quantity of bile acid present*
139
DISCUSSION
l4o
SEPARATION OF CHOLSSTBtOL. CHOLESTANOL AND
I^7''-'c h 6l'e s t e n o l b y  s i l v e r n i t r a t e  i m p r e g ­
n a t e d  TLC AMD REVBRSEP-PHASB TLC.
a) Silver nitrate impregnated TLC
The separation of these compounds from
each other has proved extremely difficult
(part II), It has not been possible to
accomplish separation of cholesterol from A -
cholestenol by ordinary TLC as reported by
Bennett and Heftman (1962) but the separation
of these sterols was achieved on plates 4o cm.
long (Avigan e^ 1963)* The introduction
of silver nitrate impregnated TLC to lipid
analysis (see Part II) suggested a means of
'7separating cholesterol, choiestanol and A -
cholestenol,
Surprisingly enough, silver nitrate TLC
*7systems accomplished the separation of A - 
cholestenol from cholesterol even although they 
both possess a‘ single double bond. This
difference in may be explained by suggesting 
that the double bond at position 7 Is less
iki.
accessible than’ that at position 5 and that 
this reduces the tenacity with which it is 
adsorbed by the silica gel surface. The
ease of separation of cholesterol and cholestanol 
by these TLC systems is more easy to explain 
since they differ in structure by a single double 
bond. The general increase in sterol values 
on silver nitrate impregnated thin-layer 
chromatograms compared with those in the more 
standard adsorption TLC systems is probably 
due to a reduction in surface area available 
for adsorption or alternatively, to increased 
hydration brought about by less thorough drying 
of the layer.
The increased resolving power of the
technique was somewhat offset by a number of
associated disadvantages. Standard extracting
solvents, such as methanol and chloroform gave
7low recoveries' of A  -cholestenol from the im­
pregnated plates as measured by the Lieberraann- 
Burchard reaction (see sections, Method ,
142.
OResults Table VXX), an effect later shown t 
be due to inhibition of the reaction by the 
large concentration of silver ions present 
(results section, Table VIII). This difficulty
was overcome by eluting with etha.nolie
ammonia which cleaves the silver-stei'o 1 com­
plex and. facilitates assay of the free compound. 
An attempt to further enhance the reliability 
of the quantitative assay-of sterols from 
silver nitrate impregnated TLC plates was made 
using the reagent of Zak et al, (1954) (Method
section, p, lOl), the ferric chloride in the 
reagent being replaced by ferric nitrate to 
avoid cloudiness due to silver chloride pre­
cipitation, However, little success was ob­
tained by this method, the recoveries being more 
variable and generally lower than those given by 
the Liebermann-Burchard reaction (results section, 
p, 113)? possibly due to high blanlc values 
relative to the colour-response of A  -cholestenol, 
b ) Reversed —phase TI,C ,
143.
LXiile it proved, impossible to separate
7cholestanol from A  -cholestenol using silver- 
nitrate impregnated TLC, even although many 
solvent systems were tried, this separation 
was achieved with relative simplicity using 
reversed-phase TLC at low temperature (results 
section, Figure 11). With this procedure 
however, only small amounts of these sterols 
(l pg.) could be well separated. This to­
gether with the fact that charring resulted 
in a dark grey background limited the detecting 
spray reagent to phosphomolybdic acid. The 
improved separation at low temperature compared 
with that at room temperature is probably due 
to the stationary phase and the mobile phase 
becoming less miscible at the low temperature, 
resulting in an increase in the development time 
which together enhance the partitioning of the 
compounds. ■
From these results (Part 11; Results 
section, p. 108-118) it appears that thin layer
l44.
chromatographic’ separation of cholesterol,
7A  -cholestenol and cholestanol from each other, 
either as free sterols or as derivatives is best 
achieved by the combination of silver nitrate 
impregnated TLC and reversed-phase TLC.
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QUANTITATIVE ESTIMATION OF PASCAL NSUTIUL 
STEROIDS AND BILE ACIDS 3Y TLC DENSITO­
METRY
Quantification of steroids and bile acids 
by densitometry of the spot produced by charring 
on a TLC plate is dependent on seversil factors, 
a few of which are listed below,
a) A uniformly thick layer of silica gel.
b) A good separation between well defined 
spots and
c) A suitable spray reagent.
a) The procedure and api^aratus for producing 
a uniformly thick layer has been described 
(Methods section, p, 9I ). This is especially 
important when using an automatic integrator as 
any irregularities in thickness of the layer 
might result in inaccuracies in the recorded 
peak areas for the compounds scanned.
b) Effective separation is necessary to allow 
the discrete scanning of each spot ensuring that 
the area recorded under each peak is due entirely 
to a single spot. The procedures described
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for neutral steroids and bile acids (see 
Method section, p. 97 ) resulted in the com­
pounds being well separated from each other 
(see Results section, Figs. 12, 13 and I6 ).
c) To obtain spots suitable for precise 
densitometry in situ it is necessary to pro­
duce the maximum possible contrast between 
spot and background. The most suitable re­
agent for this purpose was 1^ 5 potassium iodate 
in 10^ sulphuric acid as it produced dark 
brown spots on a white background (see Results 
section, Figs, 12 and 13)* The other spray 
reagents tried all produced non uniform back­
grounds (see Results section, p. II9 ).
Although these three criteria were ad­
hered to it was necessary to include a series 
of standards with each plate as the degree of 
charring varied from plate to plate even when 
the temperature of the oven and the period of 
heating were kept constant. This was probably 
due to the amount of spray reagent varying from
.47
plate to plate. The number of extracts which 
could be run on each plate was six (Results 
section. Figs, 12 and 13)*
Comparison with other techniques
The recoveries through the method were 
adequate and its reproducibility compared 
favourably with that of the GLC technique 
(Results section, Table XVTl) while having the 
considerable advantage of increased simplicity 
and speed. For example, there are only two 
stages between the extraction and the quantifica­
tion by densitometry which not only reduces the 
time required for assay but also tends to im­
prove recoveries, in addition the mass measure­
ment in situ on the thin layer plate is quicker 
and losses are less likely to occui’ than if 
extraction from the plate is carried out before 
for example measurement by colorimetry (liaust 
and Beveridge,' 1964) or by GLC (Miettinen _et al,
1965)* The method of Goldsmith et al (1960) 
although one of densitometry is not carried out
l48.
in situ (see Part II, p. 77 )•
A disadvantage in the densitornetry method 
described in this thesis is that plant sterols 
are not measured separately from endogenous 
sterols. Complete faecal sterol analysis 
has been achieved by a combination of TLC and 
GLC (Eneroth et al. 1964; Miettinen et al.
1963)* However from patients on an ordinary 
mixed diet, the contribution of plant sterols 
to total faecal steroids is small and relatively 
constant (see Results section, p. 136) and so 
the densitometry technique is not seriously 
affected. The plant sterols are in fact measured 
with their corresponding homologue of animal 
origin viz, cholesterol, coprostanol and 
coprostanone and so an accurate measurement of 
the faecal excretion of total neutral steroids 
is obtained by the densitometry technique.
Faecal bile acids
In the measurement of faecal bile acids 
by densitometry, the initial development in the
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solvent system of Brown and Johnston (1962) 
is essential as this ensures removal of fatty 
acids and hydroxy fatty acids (see Results 
section, Figure- I6 ) and acidic pigments from 
the bile acids. The presence of these com­
pounds causes over estimation of bile acid 
excretion when titration techniques are used 
(see Grundy sT. I965}. The TLC technique 
of Semenuk and Beher (1966) is similar to the 
method described in this thesis but the spray 
reagent used by these authors was found to be 
unsuitable (see Results section, p. II9 ).
However, their method in their hands had con­
siderable sensitivity.
The densitometry method reported here 
measures the bile acids as three groups i.e. 
the raonohydroxycholanoic acids, the dihydroxy- 
cholanoic acids and the trihydroxycholanoic acids. 
The principal components of these three groups 
are lithocholic acid, deoxycholic acid and 
cholic acid respectively. Although it measures
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the total bile acids present, it does not 
assay individually the isomers present in each 
group. This is relatively unimportant as the 
principal bile acids in faeces are deoxycholic 
acid and lithocholic acid. The important 
point is that the excretion of tote.l faecal 
neutral steroids and total bile acids can be 
measured accurately by the densitometry technique 
This concludes Part 111 on Methods. The 
following and final section Part IV describes 
the application of these techniques and discusses 
the results obtained.
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INTRODUCTION
The relationship between ischaemic heart 
disease and elevated serum cholesterol levels 
has resulted in a wide variety of compounds 
being tested in an attempt to control serum 
cholesterol concentrations, A brief review of 
the effects of some of these compounds has been 
presented in Part IB of this thesis.
There are two main routes by which 
cholesterol is lost from the body.
a) direct excretion into the gastrointestinal 
tract from the liver and from the intestinal 
mucosa and
b) the conversion in the liver to bile acids 
which are then excreted as their taurine 
or glycine conjugates (see Part IA). 
ComiDounds which affect either of these two
pathways 'would therefore be expected to exert 
some influence‘on serum cholesterol levels.
In the following sections a more detailed 
review of a small number of these compounds
154.
has been given followed by a description of 
experiments designed to determine their effects 
on the excretion of cholesterol and its cata— 
bolitas «
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THE EFFECT OF TAURINE
It has been suggested that the proportion 
of taurine to glycine conjugated biliary bile 
acids may influence the serum cholesterol con­
centration (Kritchevsky, 1958(c), 196I ; Howe
et al. i960; Hellstrom and Sjovall, I96I;
Failey ejt sR. 1962). In general, conjugation 
with taurine is associated with low serum 
cholesterol; glycine conjugation with high 
serum cholesterol. On the one hand the dog 
and the rat are resistant to experimental hyper­
che les ter olaemia induced by adding cholestei'ol 
to the diet (Steiner and Kendall, 1946; Gould, 
1951) and their bile acids are conjugated en­
tirely with taurine (Bremer, 1956), On the
other hand, the rabbit is susceptible to 
cholesterol feeding (Wang ^t al, 195^0 and has 
its bile acids conjugated with glycine (Hellstrom 
and Sjovall, 1962),
If Cebus monkeys, rats or mice are fed 
diets deficient in sulphur containing amino acids,
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but rich in cholesterol they develop hyper- 
choies ter olaemia (Mann aT. 1953). Addition 
of taurine to these diets decreases the levels 
of serum cholesterol (portman and Mann, 1955; 
Portman and Stare, 1959 ; Seidel et al. i960). 
Similarly the raised serum cholesterol of rats 
given cholic acid and a high-choiesterol diet 
can be reduced by taurine (Herrmann, 1959 ) # In 
mice 0.1^ of taurocholic acid in the diet induces 
less hypercholesterolaemia than either glyco- 
cholic acid or free cholic acid (Howe et al.
i960).
In man the ratio of glycine-to taurine- 
conjugated bile acids (G/T ratio) averages 3:1 
(Wiggins and Wootton, 1958; Sjovall, i960).
The hypercholesterolaemia of myxoedema is 
associated with an increased G/T ratio of approxi­
mately 7 (Hellstrom and Sjovall, I96I), an 
abnormality which is corrected by thyroid hormones 
In thyrotoxicosis on the other hand the G/T ratio 
is about 2 (Hellstrom and Lindstedt, I964).
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Doses of nicotinic acid sufficient to reduce 
serum cholesterol also reduce the proportion 
of bile acids conjugated with glycine (Failey 
et al. 1959). Nicotinic acid is excreted in 
the urine as its glycine conjugate nicotinuric 
acid (Miller e_t aT. I960) and this might deplete 
the body of glycine (Kritchevsky, 1961). Diets 
rich in unsaturated fat appear to produce more 
cholic acid in bile than those rich in saturated 
fats (Lindstedt et al. I965; Hellstrom and 
Lindstedt, I966). The type of dietary fat 
does not however have a consistent effect on 
the G/T ratio (Hellstrom and Lindstedt, 1966), 
Sjovall (1959) was able to increase the 
proportion of taurine conjugated bile acids in 
human bile by feeding as little as 1,5 g./day 
of taurine whereas large amounts of glycine 
(21.Og./day) did not affect the G/T ratio.
Unfortunatèly‘ Sjovall did not record the serum 
cholesterol level of the normal men in this study 
Since taurine is derived from cysteine
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it is likely tliat diet can influence the con­
jugation of bile acids and if serum choiesterol 
levels can be changed by altering the taurine 
conjugation of biliary bile acids a relatively 
simple way of controlling serum cholesterol 
levels in man might be developed.
These considerations prompted this study 
of the effect of feeding taurine on the serum 
cholesterol concentration and bile acid con­
jugation pattern of men with normal lipid meta­
bolism,
THE EFFECT OF CLOFIBRATE
Although clofibrate has been widely used 
in clinical trials, not only in patients with 
disorders of lipid metabolism, but also in 
apparently healthy adults, the mechanism by 
which it reduces the serum lipids has not yet 
been established. Xn I965, Thorp suggested 
that it displaces thyroxine from the plasma 
albumin into the liver, thereby inhibiting 
hepatic synthesis of lipids. If this were so
159.
then the effects of clofibrate on lipid meta­
bolism would probably be similar to those 
produced by the administration of thyroxine.
It is well established that serum cholesterol 
levels are markedly influenced by thyroid 
hormones ( Gildea e_t ad. 1932; Strisower e_t al. 
1954) and that hypothyroidism leads to elevated 
serum cholesterol levels in a number of animal 
species including man (Pitt-Rivers and Tata,
1959). The question of whether or not the 
plasma concentration of cholesterol is abnormally 
low in thyrotoxicosis has been much debated 
(Peters and Man, 1950) but is not generally 
agreed.
From the work of Karp and Stetten (1949)? 
Byers ^t (1952), Friedman ad . (1952)
and Eriksson (1957) it appears that thyroxine 
stimulates both the synthesis and excretion of 
cholesterol and that the changes observed in 
the plasma cholesterol level when thyroid 
activity is altered are the net results of these
l6o
two opposing effects• As has been described 
(page 156) the ratio of glycine to taurine 
conjugated bile acids (G/T) is also affected 
by thyroid hormones. The hypercholestorol­
aemia which accompanies myxoedema is associated 
with an increased G/T ratio whereas in thyro­
toxicosis the G/T ratio is low.
A s a result of their cholesterol lowering 
ability thyroxine and its analogues, have been 
used in the treatment of hypercholesterolaemia 
in euthyroid subjects (Oliver and Boyd, I956; 
Goolden, 1956; Beierwaltes and Ruff, 1938»
Boyd and Oliver, I960) and in hypothyroid sub­
jects (Gross e_t ad. 1952 ; Malmros and Swahn,
1953; Boyd and Oliver, I960), In the euthyroid 
patients serum cholesterol was usually depressed 
without measurably altering the basal metabolic 
rate (BMR). However, continuation of the dose 
at a constant level often led to the return 
of plasma cholesterol to the pretreatment level
l6l
(Boyd and Oliver, 1$60). Increasing the dose 
to maintain the serum cholesterol lowering 
effect may then increase the BMR. Treatment 
of hypothyroid subjects with thyroxine or its 
analogues decreases serum cholesterol levels 
within a day or two and with some of the 
analogues reduction occurs within a few hours 
of administration (Boyd and Oliver, I960),
In contrast to the effect on cholesterol, 
serum triglycerides are only slightly reduced 
by thyroxine (Best and Duncan, 1964; 1966).
To study the mechanism of action of clo­
fibrate and to compare its effect wdth that of 
thyroxine, three investigations were carried 
out into :-
a) The effect of clofibrate on the conjugation
of biliary bile acids in patients with 
hypercholesterolaemia (p. I68).
b) The effect of clofibrate on serum and
faecal lipids in humans (p, 174), and
c ) a  comparison of the effects of clofibrate
1Ô2.
and L-thyroxine on the serum and faecal 
lipids in hypothyroid subjects (p, 19?)•
THE EFFECT OF ORAL CALCItki
Epidemiological investigations in different 
countries have shown an inverse relationship 
between the hardness of drinking water and the 
mortality from cardiovascular disease (Kobayashi, 
1957; Schroeder, I96O; Morris et al. I96I;
Bibrck ejt ad. 1965). Atheroma has been sho^vn 
to be more extensive in young subjects (aged 30- 
44 years) living in Glasgow, a soft water area, 
compared to subjects of the same age group living 
in London, a hard water area (Crawford and Crawford, 
1967). As elevated serum cholesterol and tri­
glyceride levels are well established as high 
risk factors in the development of ischaemic 
heart disease (Dawber et ad, 1962; Morris et ad,
1966) depression of these lipids by increased 
calcium intake (Yacowitz e^^t ad, I965 ) might 
explain the relationship between the hardness of 
drinking water and atherosclerosis. The
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mechanism by which calcium produces a reduction 
in the serum cholesterol is not clear, but it 
has been suggested that calcium may interfere 
with cholesterol absorption (Wells and Cooper, 
I95Ô; lacono i960).
The role of magnesium « the other principle 
cation of hard water - in the pathogenesis of 
ischaemic heart disease is less certain (see 
Schroeder, i960 ; Morris aJL. 1962),
An investigation was made into the effect 
of oral calcium on the excretion of cholesterol 
and its metabolites (p, 207)*
THE EFFECT OF DTETCARY CHOLESTEROL
In 1963 » Keys et al, showed that decreasing 
the cholesterol content of the diet had little 
effect on serum cholesterol concentrations. 
Earlier experiments (Mayer e_t aT, 195^) had 
similarly suggested that dietary cholesterol 
intake and plasma cholesterol levels were un­
related. This was supported by Bhattathiry 
and Siperstein (1963) who found that although
l64
the addition of cholesterol, in the form of 
eggs, to the diet depressed cholesterol syn­
thesis in the human liver, the level of plasma 
cholesterol remained unchanged.
However, Connor e_t a_l. (i960, 1964 ) found
that by increasing the dietary intake of 
cholesterol by the addition of egg-yolk, the 
serum cholesterol levels were markedly increased 
and when the subjects were fed a cholesterol- 
free diet, the serum cholesterol levels decreased.
At present, there are two alternative 
mechanisms which are thought to protect man 
from hypercholesterolaemia of dietary origin.
The first, is the negative feedback mechanism 
in which the level of dietary cholesterol controls 
the hepatic synthesis of cholesterol. This has 
been found to operate in many experimental animals 
such as rat (Frantz _et aT. 195"^) 3 dog, rabbit 
(Gould, 1951) chicken (Sakakida at aH. 1963) 
and is discussed in more detail in Part IB p, 37 
of this thesis.
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The second protective mechanism is the 
limited capacity of the human intestine to 
absorb cholesterol (Karvinen et al. 19571 
Kaplan ejfc aT, 1963» Taylor ejfc I965;
Taylor and Ho, I967).
The effect of dietary cholesterol on serum 
and faecal lipids was investigated in one sub­
ject (p. 224),
EXPERIMENTAL
1 ) The effect of feeding taurine on bile acid 
conjugation and serum cholesterol levels 
in man
Four experiments were carried out in three 
men. Each experiment consisted of a 2 week 
control period, a period of IO-I5 days in which 
taurine was added to the diet and a further 2 
week control period. J.M., 26 years old, was
receiving physiotherapy after a mild right hemi- 
paresis due to cerebral arterial thrombosis.
J.C. was a clinically normal volunteer aged 
62 years* C. McL., aged 3 k years, was con­
valescing after medical treatment for a duodenal 
ulcer.
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The subjects were admitted to a metabolic 
ward where each received a constant diet through­
out the experiment. J.M. was studied during 
two dietary regimens in which the fat content 
was 30 g. of butter in the first experiment and 
3*0 g. of sunflower seed oil in the second.
Two weeks were allowed for adjustment between 
the two regimens. The other subjects were 
given mixed diets based on estimated consumption 
at home. Dietary fat in these subjects was 
given in saturated form. Taurine, 1.3 g* per 
day, was given in divided doses with meals during 
the 10-13 days treatment period. Body weight 
changed by less than 3 kg. during the three 
experimental periods.
Fasting serum cholesterol levels were 
measured daily during the experiments by the 
method of Abell et al. (1932). On two occasions
in each subject (before and towards the end of 
the taurine period) the duodenum was intubated 
and bile collected and the conjugated biliary
167
bile acids analysed as described in Part III 
(p. 104).
a) Serum cholesterol
Results of the four experiments are shown 
in Table XVIII in which mean serum cholesterol 
levels from the 8th day to the end of the taurine 
periods are compared with means of all the deter­
minations in each control period.
Table XVIII
The effect of taurine on serum cholesterol 
concentrations•
Subject Mean serum cholesterol
(mg./lOO ml.)
Control Taurine Control
J.M. (butter die t) 214.7 206.5 210.5
J.M. (sunflower 
oil diet)
seed
168.1 160.3 148.6
J.C. 228.8 231.1 227.2
C. McL. 185.0 185.0 197.1
Mean 199.2 195.7 195.9
Feeding taurine had no consistent effect
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on serum cholesterol despite the considerable 
reduction in the glycine/taurine ratio of con­
jugated biliary bile acids (Table XIV).
Table XIV
The effect of taux’ine on glycine/taurine
ratio of conjugated biliary bile acids.
Subject Glycine/Taurine Conjugation
Ratios
Control Taurine
J.M. (butter diet) 4.8 1.1
J.M, (sunflower
seed oil diet) 3.4 0.8
J.C. 4.9 0.6
2) The effect of clofi.brate
a ) The effect of clofibrate on the conjugation
of biliary bile acids in patients with 
hypercholes terolaemia.
Clofibrate (0.3 g. q.i.d.) was given to
five patients with hypercholesterolaemia or
ischaemic heart disease. Further details are
given in Table XX.
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None of the patients was judged on clinical 
grounds to have thyroid disease and none %\ras re­
ceiving any other choiesterol-lowering treat­
ment. Patients 1 and 4 were each given a constant 
diet of mixed foods {35i° of calories from fat) 
in the metabolic ward. Patients 2, 3 and 3
were asked to continue their usual diet at home 
while clofibrate was given.
Serum cholesterol was measured by the method 
of Abell et al. (1932). Bile was collected
before starting clofibrate and after two weeks 
treatment in three patients and after one month's 
treatment in two of the outpatients (Nos. 2 and
3). The chromâtographic separation of the con­
jugated bile acids and the determination of the 
glycine/taurine ratio was carried out as described 
in Part XII (p. 104). The significance of 
changes in serum cholesterol and G/T ratio from 
their mean pretreatment levels was determined 
by the Student "t" test for paired values.
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A. Changes in serum cholesterol
One month's treatment led to an average 
drop in serum cholesterol of ZZ^ o ( Range h-2 to 
-379^) but the changes were not significant,
B, Changes in bile acid conjugation
During clofibrate treatment the G/T ratio 
of biliary bile acid conjugates showed little 
change in four patients and a decrease in 
patient No, 3 ( a.n out-patient). Table X2iX, 
Table XXI,
The effect of clofibrate on the glycine/ 
taurine ratio of biliary bile acid 
conjugates•
Patient No. G/T ratio
Control Clofibrate
1 1.4 1,1
2 2.9 2.3
3 4.3 4.0
h 2.3 2.9
5 ' 2,3 1.1
Mean - 2.68 2.28
The mean G/T ratio changed from 2.68 to 2.28.
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The ratio on treatment was not significantly 
different from the control ratio*
On inspection of the thin-layer chromato­
plates of hydrolyzed bile there was no obvious 
change in the relative proportions of cholic, 
chenodaoxycholic and deoxycholic acids. 
Chromatograms from the first k patients, before 
and during treatment, are shown in Figure 18 
Bile acids from the fifth patient gave a similar 
result.
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Figure 1 8, Thin-layer chromatoplate of free 
bile acids in hydrolyzed biles of first 4 
patients. Origin at bottom. From left to 
right : patient 1 control, patient 1 treatment,
patient 2 control, patient 2 treatment, standards 
(from below upwards; cholic, chenodeoxycholic, 
deoxycholic and lithocholic acids), patient 3 
control and treatment, patient 4 control £tnd 
treatment. The major spots in the bile samples 
are, from below upwards, cholic, chenodeoxycholic 
and deoxycholic acids, with cholesterol running 
to the front.
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b ) The effect of clofibrate on serum and
faecal lipids in liutnans
Details of the 21 subjects investigated 
are presented in Table XXII, Eighteen were 
ambulant pati'ents admitted to the ward for 
clofibrate therapy. Of these, nine had had 
a myocardial infarction from six months to ten 
years previously, eight had other forms of 
occlusive arterial disease, and one had familial 
hypercholesterolaemia• Two of the normal sub­
jects were members of the scientific staff, and 
the third was convalescing from an attack of 
acute rheumatism.
After a preliminary period of three to six 
days, clofibrate was given for nine to fifteen 
days at the dosage indicated in Table XXII,
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Pasting biood samples were obtained three 
times per week for serum cholesterol and tri­
glyceride estimations, and the values presented 
are therefore the mean of two or three blood 
samples taken during each faecal collection. 
Faeces were collected (three-day collections 
in ten subjects and six-day collections in 
eleven subjects) before clofibrate administra­
tion, and again between the ninth and fifteenth 
days of clofibrate therapy, With one exception, 
the subjects were given an unrestricted ward 
diet throughout their hospital stay. In order 
to assess any effect due to dietary change on 
admission to hospital, 1 subject (M.W,) was 
maintained throughout the experimental period 
on a constant diet, approximating as closely as 
possible to her habitual diet. The composition 
of this diet per 2k hours was as foHows : - 
total calories 951» total fat 51 g.» cholesterol 
900 mg,, carbohydrate 83 g., and protein kO g.
Ten subjects were readmitted several months
177.
later (range 1 ‘to 9 months, mean 4,6 months) 
for a further 6-day collection of faeces, 
Clofibrate had been continued during the inter­
val in a dosage of 0,75 g# twice daily in 7 
subjects and 1,0 g. twice daily in 3 subjects. 
Serum total cholesterol was measured by 
an autoanalyzer method (Technicon N,24p ), and 
serum triglyceride by the method of van Handel 
and Zilversmit (l957)*
Faecal specimens were stored in weighed 
containers in a deep freeze until processed as 
described in Part 111 (p . 87 )« Faecal bile
acids and neutral steroids were measured as 
described in Part III (p, 97 )• In addition, 
since the above technique does not separate the 
parent neutral steroids from their analogues 
of plant origin, gas-liquid chromatography 
(Eneroth et al, I964) was used to separate these
compounds in the neutral steroid extracts of 
11 subjects, and the percentage of total neutral 
steroids formed by plant sterols was determined
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before and during clofibrate treatment.
Faecal fat (neutral fat plus free fatty acid) 
estimations were carried out on freeze dried 
specimens by Soxhlet extraction of ai^proxi- 
mately 1.0 g. of the dry matter with diethyl 
ether for 6 hours (Harrison, 19^9)#
The significance of changes in serum 
lipids and faecal constituents from their mean 
pretreatment levels was determined by the Student 
"t" test for paired values.
Serum Cholesterol
Within nine to fifteen days of commencement 
of clofibrate therapy serum cholesterol levels 
had fallen significantly (Table XXIII, Figure 19) , 
18 of the 21 subjects showing a fall of between 
2 and 13O mg. per 100 ml. serum. In 12 of these, 
cholesterol fell by more than Ip/o of the initial 
level. Two subjects (E.D. and J.M,) showed 
no significant change, and in the remaining sub­
ject (j.H.) the serum cholesterol increased by 
4l mg, per 100 ml, over the mean basal level.
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The greatest reduction in serum cholesterol 
level occurred in those subjects with the high­
est pretreatment levels, and a significant 
correlation was observed between the height of 
the initial cholesterol level and the magnitude 
of the fall (r = -0.48, p < 0,05). Both the 
high and low dosage groups showed a reduction 
in serum cholesterol level. The decrease was, 
in fact, greater in the group on 1 g, clofibrate 
daily (50 mg. per 100 ml, p < 0 ,05) than in the 
group on 2 g, daily (15 mg, per 100 ml,), the 
former group having higher pretreatment levels.
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Figure 19 
and 2 g, 
on serum 
levels.
The effect of clofibrate, 1 g, (x-x) 
(O-O) daily for nine to fifteen days, 
cholesterol and serum triglyceride
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The decrease in cholesterol levels in the 
13 male subjects (18 mg. per 100 ml.) was sig- 
nificantly less than that seen in the 8 females 
(57 mg. per 100 ml., p < 0 ,05) in whom there was 
a greater proportion with high initial cholesterol 
levels.
Ifhen the estimation was repeated in 10 sub­
jects between one and nine months later, a sig­
nificant reduction of serum cholesterol had not 
been maintained, although seven of the subjects 
showed serum cholesterol levels which were be­
tween Xk and 127 mg. per 100 ml. below their 
pretreatment levels. In the remaining three 
subjects (a.K., F.R., and W.B.) increases of 
10 mg., 29 mg., and 71 mg. per 100 ml. were 
observed relative to their pretreatment values.
The mean decrease for the whole group of 3I mg. 
per 100 ml. was not statistically significant 
(Table XXIII).
Serum Triglyceride
Clofibrate led to a significant reduction 
of serum triglyceride levels within nine to
183.
fifteen days (Table XXIII, Figure 19)# Sixteen 
of the subjects showed decreases of 6 to 89 mg, 
per 100 ml. and in fifteen of these patients the 
fall was 15^ or more of the initial level. No 
appreciable change was seen in the remaining 
five subjects. Although the pre treatment values 
were similar in the two groups, the subjects on 
clofibrate 1 g. daily showed a greater decrease 
in serum triglyceride (mean decrease 42 mg. per 
100 ml. p < 0.05) than the group on 2 g. clofibrate 
daily (mean decrease 17 mg. per 100 ml,). The 
Serum triglyceride changes did not differ in 
m a l e  and f e m a l e  subjects. There was no sig­
nificant correlation between the height of the 
pretreatment triglyceride level and the magnitude 
of the decrease occurring during clofibrate 
therapy. Of the subjects who showed no tri­
glyceride change in response to clofibrate, only 
one (E.D.) also failed to show a decrease in 
cholesterol. There was no significant corre­
lation between the pretreatment levels of
/
184
cholesterol and' triglyceride in the 21 sub­
jects, nor between the magnitude of the de­
creases obtained in cholesterol and triglyceride 
on clofibrate therapy.
IVlien serum triglyceride estimations were 
repeated in ten subjects between 1 and 9 months 
later (Table XXIIl), seven had levels between 
6 and 70 mg. per 100 ml, below their pretreat­
ment levels, while two (M.W. and W.B.) had small 
increases of 7 mg. and 17 mg. per 100 ml. The 
remaining subject (j.P.) showed a marked increase 
in triglyceride from her mean pretreatment level 
of 179 mg. per 100 ml. to 385 mg, per 100 ml., 
although her serum cholesterol at this time was 
22 mg. per 100 ml. below its pretreatment value. 
Faecal Excretion
Clofibrate led to a significant increase 
in the wet-weight of faeces excreted per 24 hours. 
The increase occurred in nine of the ten subjects 
on 2 g. clofibrate daily, the tenth subject (A .W.) 
showing no change. In the group on 1 g*
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clofibrate daily only two subjects (j.E. and 
J.G.) showed an appreciable increase.
The changes in faecal wet-weight were 
associated with changes in the weight of 
material obtained after freeze-drying of the 
faeces (expressed as grams per 2k hours of dry 
faeces), a significant increase being observed 
only in the group on 2 g. clofibrate per day 
(Table XXIV),
During the first week of clofibrate 
therapy there was also a significant increase 
in the number of stools passed per week (mean = 
6.6, p < 0.02), as compared with the number re­
corded during the pretreatment period (mean ^
5.4 stools per week). By the second week of 
medication the number of stools passed was no 
longer signifleantly greater than before treat­
ment (6.0 stools per week). Records of the 
number of stools passed were available for only 
eight of the ten subjects on 2 g. clofibrate 
daily. Of the remaining two subjects, who were 
staff members, one (D.M.) complained of mild
187.
diarrhoea while-taking clofibrate. No sig­
nificant difference was observed between the 
two groups in the number of stools passed 
during clofibrate therapy.
Faecal Fat
The mean faecal fat values are shown in 
Table XXIV. During the pretreatment period, 
the fat content of the faeces in all subjects 
was within the range quoted as normal for this 
method of fat analysis (3.6 to 22.3 g. per 
100 g. dry faeces) (Foweather, I926). The 
small mean increase in percentage of faecal 
fat during clofibrate medication was not 
statistically significant.
There was a small but significant increase 
in fat excretion (g. per 24 hours) after nine 
to fifteen days* clofibrate (Table XXIv)• This 
effect was confined to patients taking the larger 
dqsage of the drug, three of whom (A .W ., E.D. 
and D.M.) showed levels at or above the upper 
limit of normal (5*0 g., 5*1 g* and 5.7 g# per
188.
2k hours respectively) (Hendry, i960). The 
small dosage group showed an insignifleant de­
crease In daily fat excretion.
One to nine months later, the values ob­
tained for fat content of the stool and daily 
fat excretion were not significantly different 
from those observed in the pretreatment period 
(Table XXIV).
Faecal Neutral Steroids
Values for the faecal excretion of in­
dividual and total neutral steroids are shown 
in Table XXV. and Figure 3D. These are reported 
as faecal neutral steroid content (mg. per 100 g. 
dry faeces) and as daily neutral steroid excretion 
(mg. per 2k hours). In the group given clofi- 
brate 2 g. daily, the daily neutral steroid out­
put showed a significant increase after nine to 
fifteen days* treatment. This effect was not 
seen in the low dosage group, in which a small 
decrease in faecal neutral steroid output was 
observed. A significant correlation was observed 
between the change in daily neutral steroid output
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TOTAL f a e c a l  
NEUTRAL STEROIDS  
mg./24hri .
MEAN PR ETR EATM ENT LEVEL1300
MEAN VALUE A FTE R  TREATMENT 
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Fip:ure 20. The effect of clofibrate on the 
daily excretion of faecal neutral steroid?. 
Results are plotted as means standard errors. 
The number of subjects in each group is given 
in parentheses.
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during clofibrate therapy, and the change in
serum cholesterol level (r = P  ^ O.O5 ).
Clofibrate had little effect on the total
neutral steroid content of faeces although
values tended to decrease. This trend was
observed also in subject M,¥, whose dietary
intake of cholesterol was constant throughout
the experiment.
The pattern of individual faecal neutral
steroids showed a significant change only in the
case of D,M., in whom there was an increased
proportion of faecal cholesterol during clpfi—
«
brate medication. In the pretreatment period 
the percentage of faecal neutral steroids ex­
creted as cholesterol in this subject was 13^ 
as compared with l6^ for the remaining subjects. 
After nine to fifteen days ^ clofibrate therapy, 
however, an increase to 44^ was seen in D,M., 
while no significant change was observed in the 
other subjects.
After one to nine months' treatment with
19^ .
clofibrate, the only difference in faecal 
neutral steroid excretion from that seen in 
the pretreatment period was a small but 
significant decrease in daily faecal cholesterol 
output (Table XXV,). No significant change 
was observed in the percentage of total neutral 
steroids formed by plant sterols after nine to 
fifteen days' treatment with clofibrate (11,7 ± 
5*0^) as compared with that in the pretreatment 
period (12.7 i 6,4^).
Faecal Bile Acids
The values for the faecal excretion of 
individual and total faecal bile acids are 
shown in Table XXVI and Figure 21, They are 
expressed in two ways: as faecal bile acid
content (mg, per 100 g. dry faeces) and as 
daily bile acid excretion (mg, per 24 hours),
A significant decrease in faecal content of 
both deoxycholic acid and lithocholic acid 
(expressed as mg, per 100 g, dry faeces) was 
seen after nine to fifteen days' treatment with
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Fi.^ure 21< The effect of clofibrate on the
daily excretion of faecal bile acids. Results 
are plotted as means standai’d errors. The 
number of subjects in each group is given in 
pair enthe ses.
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clofibrate (Table XXVI,). The decrease in 
bile acid output was more marked in the group 
taking 1 g. clofibrate daily, and this group 
also showed a significant decrease in daily 
bile acid excretion* When the group taking 
clofibrate 2 g. daily were analysed separately, 
the decrease in faecal bile acid content was 
found to be less marked, and not statistically 
significant, and no decrease in daily bile acid 
excretion was observed*
After one to nine months* clofibrate 
therapy, the faecal bile acid content and daily 
bile acid excretion remained significantly less 
than during the pretreatment period (Table XXVI,).
An alteration in the excretion pattern of 
the individual bile acids was seen in only one 
sample during clofibrate medication. The bile 
acid pattern in subject D,M*s, pretreatment 
faecal specimen (deoxycholic acid 274,8 mg, per 
100 g* dry faeces, lithocholic acid 71.1 rng, per 
100 g. dry faeces) was similar to that seen in
196.
the other subjects: after nine to fifteen days*
treatment with clofibrate no lithocholic acid 
was detectable, and the specimen contained 
cholic acid 130,5 mg. and deoxycholic acid 
259*0 mg, per 100 g. dry faeces.
Summary of Results
The administration of clofibrate in a 
dosage either of 1 g, 0%^ 2 g. daily for nine to 
fifteen days reduced serum cholesterol and tri­
glyceride levels. The changes which were 
observed in faecal output and faecal constituents 
differed somewhat in the two dosage groups.
In the group on 1 g, daily, faecal weight, 
faecal fat, and faecal neutral steroids were un­
changed, but a significant reduction in faecal 
bile acid excretion occurred.
In the group on 2 g, daily, there was an 
increase in weight of faeces excreted during 
the collection period. This was associated 
with small but significant increases in daily 
excretion of faecal fat and faecal neutral steroids.
197.
The daily bile acid excretion showed no 
significant change, and the faecal bile acid 
content, in fact, tended to decrease.
Analysis of faecal lipids after several 
months of clofibrate medication showed con­
tinued reduction of bile acid excretion, and 
a slight fall in neutral steroid excretion 
significant only in the case of cholesterol. 
Values for the individual subjects are 
given in the Appendix in Tables XL-LXXVl.
c) A comparison of the effects of clofibrate 
and L—thyroxine on. the serum and faecal 
lipids in hypothyroid subjects
Four hypothyroid subjects were studied.
Further details are shown in Table XXVII,
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Three (A ,G ., J.3. and M.M.) were treated 
initially with clofibrate 1.5 g. per day for 
twelve to eighteen days. At the end of this 
period six days without treatment were allowed 
to elapse before commencing thyroxine therapy 
for nine to twelve days. Two of the patients 
(A.G. and J.B.) were given L-thyroxine 0.05 mg. 
per day and a third (m .M,) was given 0,10 mg, 
per day. The fourth patient (L.B.) was treated 
only with L-thyroxine 0.05 mg, per day for five 
days and then with 0.10 mg. per day.
The collection of blood and estimations 
of serum cholesterol and triglyceride concentra­
tions were carried out as described in the pre­
ceding section. Faecal specimens were collected 
and neutral steroid and bile acid extracts ob­
tained as described in Part III (p. 87 ).
Neutral steroids and bile acids were measured 
according to the method in Part III (p. 97 ), 
Faecal fat was estimated by the method of 
Harrison (1949).
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Serum lipids
The serum lipid results are shown in 
Table XXVXIÏ• In the three subjects treated 
with clofibrate, the serum cholesterol levels 
decreased. Treatment with thyroxine caused 
an increase in serum cholesterol in two of the 
three subjects previously treated with clofibrate 
The subject given only thyroxine showed a de­
crease in serum cholesterol concentration.
During clofibrate therapy all three showed 
decreases in serum triglyceride levels. Treat­
ment with thyroxine produced a marked increase 
in serum triglyceride levels in all three sub­
jects. The patient treated with thyroxine 
only showed a slight decrease in serum tri­
glyceride levels.
201.
H
B
O
a
H
bn
B
(n
'd
•rl
A
•H
i
k0
en
H
H
g
M
0
r-i
■S
H
0
d co *iH
%
cn O
k
d XQ rd
H
-P
d0
s0 •p
% d0
d
H
0
4-:
G d0 d
PUl•H
îxPd 0
p rHÜ
rH
d
cn
(ü
P
-p
ü
0
•o
p
dco
0
•d
•H
A
•H
00 1 I 1 1 1 1
H I 1 1 rH 1 1 1 ex
C l rH
ex 00 00 O CO C - X "
rH ï> - rH o\ m c - -d* -d- rH
C\i - -  C ^^— r i r \ rH rH H H
CO
H
ex
iH
l A (A CA o o O OO H ex ex A ex ex CAex CA ,^J- rH rH H rH
ex CA 1
1 ex 1 i CA 1ex
CA ex 00 00 XO CA
H lA co co co A
ex ex •
A CA o A \Û VO-d- ex VO O ex Aex -d- A r-î rH H
(•2h
O pq
«3
PQ
J
k
0 O 
-P O 
(A rH ^
S 0 \  .
d rH • H
P O 5J0 Ë
0 h Ë CO Ü -
g
o
I,•ri
i3
pq
0d o
•H O  
fn H
PQ
J
S 0
d  ü  .  rH
h X Ë
0 H Ë 
co bli^
202
Faecal Fat and Weight
There were no significant changes in the 
excretion of faecal weight or faecal fat during 
treatment with clofibrate.
Faecal Neutral Steroids
Faecal neutral steroid excretion rates 
are shown in Table XXXX. During treatment 
with clofibrate daily faecal neutral steroid 
excretion increased in two of the three sub­
jects (M.M, and A.G.) and in all three patients 
after thyroxine administration for 12 days. 
Faecal neutral steroid excretion increased in 
subject L.B, who was treated only with L- 
thyroxine «
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Faecal bile acids
As is illustrated by Table XXX after 12 
days treatment with clofibrate two of the 
subjects (A.G. and J.B.) showed a decrease 
in daily faecal bile acid excretion while 
during treatment with thyroxine the same two 
patients had an increase in daily faecal bile 
acid excretion after 12 days. The daily 
faecal bile acid excretion of subject L.B. 
also increased after 12 days treatment with 
thyroxine but fell to just below the basal 
level after 18 days treatment with thyroxine.
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Xn summary, clofibrate treatment led to 
a decrease in serum lipid levels in all three 
subjects, an increase in daily faecal neutral 
steroids in two of the three subjects and a 
decrease in daily faecal bile acid excretion 
in two of the three subjects.
Thyroxine treatment led to an increase in 
serum cholesterol levels in two of the three 
subjects, an increase in serum triglyceride 
concentrations in all three subjects, an in­
crease in daily faecal neutral steroid in all 
three subjects and an increase in daily faecal 
bile acid excretion in two of the three subjects
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3• The effect of oral calcium on the excretion 
of cholesterol and its metabolites
Five female and one male subject were
investigated. The main clinical findings
in each pa.tijs.nt are given in Table XXXJ.
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Patients were admitted to a metabolic 
unit and studied under three dietary regimens.
Xn the first (period a) the calcium intake 
ranged from 0.233 g./day to 0.733 g./day, the 
fat intake from 32.9 to 65.9 g./day and the 
sterol intake ranged from '82.5 to 407 mg./day 
with each patient having a fixed intake of 
calcium, fat and sterol. Each patient was in­
vestigated on this basal diet for a period of 
four to six weeks. Xn the second regimen 
(period B), the calcium intake was increased 
by l.l4 g. in each patient. Calcium glycero­
phosphate was given to patients 1 to 5 and 
calcium gluconogalactogluconate was given to 
patient 6 . This was continued for four weeks. 
In the third regimen (period C), the calcium 
intake was maintained at this increased level 
in patients 2 , 3 » 4 and 5 by giving ly pints 
of dried skimmed milk. There were no equilibra­
tion periods between dietary regimes. The fat 
content of the diet remained unaltered during
210.
period. B, but when the dried skimmed milk was 
added, the dietary intake of fat was increased 
by 0.3 g./day.
Throughout the period of study, faeces 
were collected for 7 day peiûods and processed 
as described in Part III (p. 87 ). Total fat
(acidic and neutral) was measured by the method 
of Panton and Marrick (1934). Neutral steroids 
and bile acids were determined by the densito­
metry method described in Part III (p, 97 ).
Faecal calcium was estimated after ashing by 
titrating with EDTA using ammonium purpurate 
as an indicator (Nordin and Smith, 1965)*
Dietary calcium was estimated on two 24 hour 
samples of the diet after ashing (Nordin and 
Smith, 1965)•
Serum cholesterol (Technicon Autoanalyser 
N24p) and serum triglyceride (van Handel and 
Zilversmit, 1957 ) levels were measured twice
weekly on fasting blood samples.
The significance of changes from mean
basal levels was determined by the Student "t" 
test for paired values. The results given in 
the tables are the means of the four weekly 
values obtained during the three regimens. 
Faecal neutral steroids
Faecal neutral steroid excretion data are 
shown in Table XXXIX.
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Faecal cholesterol increased in each subject* 
The average increase for the group being 
statistically significant during periods B and 
C* In period B, when calcium supplements were 
added there was a steady increase in faecal 
cholesterol output during each of the four week­
ly periods from a mean .of 80 mg./day to a mean 
of 130 mg*/day* During period C, when dried 
skimmed milk was substituted for calcium glycero­
phosphate, there was no significant change in 
the cholesterol output compared with period B, 
though the output remained significantly higher 
than that during the control period on the basic 
die t.
The output of coprostanol fell significantly 
during period B *
The faecal output of coprostanone was not 
significantly affected by the addition of calcium 
glycerophosphate or skimmed milk to the diet.
The total neutral steroid output showed no 
change during treatment with calcium glycero­
phosphate but increased significantly when dried
214.
skimmed milk was fed.
Faecal bile acids
Following the addition of calcium glycero­
phosphate to the diet, there was a significant 
increase in the output of deoxycholic acid and 
lithocholic acid. Table XXXIXI.
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This increase became apparent after the 
end of the first week and continued throughout 
the period of calcium supplementation.
During period C, when skiinmed milk was 
substituted for calcium glycerophosphate, the 
faecal output of bile acids did not differ 
from that in period B.
Faecal f t , faecal dry weight and faecal ca 1 ciurn 
During the period of supplementation of the 
diet with calcium glycerophosphate, there was a 
significant increase in faecal'acid fat, total 
fat and faecal dry weight (Table XXXXV.).
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With the addition of calcium glycerophosphate 
there was also a marked increase in the faecal 
calcium which reached a maximum in the second 
week and thereafter remained at this level.
The substitution of dried skimmed milk did 
not affect the faecal fat, dry weight or calcium 
when compared with period B. The faecal dry 
weight and calcium remained significantly above 
the level of excretion during the period on the 
basic diet.
The patients did not complain of any gastro­
intestinal symptoms, such as diarrhoea, during 
the experimental period.
Serum lipids
The results are shown in Figure 22, and Table
XXXV.
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Figure 32, 'Change in serum cholesterol and
serum triglyceride levels during calcium 
supplementation*
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The serum.choiesterol and serum trigly­
ceride levels tended to fall during period B 
but the decrease was not significant » The 
fall was not evident until the second week 
and was greatest during the 3rd and 4th weeks. 
This pattern was similar to the changes observed 
in faecal excretion (Figure^)* Following the 
addition of the dried skimmed milk, which in­
creased the daily fat intake by 0.3 g# there 
was a rise in the serum cholesterol level to 
above the basal levels, and an even greater 
rise in the serum triglyceride though again 
these changes were not significant,
Body Weight
A small decrease in weight occurred in all 
cases. The mean weight loss during the whole 
experiment ( 12 weeks) was 1.6 1 . 2  Kg. The
weight changes during periods A and B were 
similar while that in period 0 was of smaller 
magnitude* The weight loss cannot be attributed 
to the introduction of calcium into the diet
222*
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because it was also evident during the basal 
period.
224.
Dietary cholesterol; i t s effect on
serum lipids and faecal excretion
of neutrc.l steroids and bile acids
One subject only was studied, who received 
a diet low in cholesterol content (l29 m g „/day 
of cholesterol) and essentially free of plant 
sterols for fourteen days* Fasting blood 
sami-)l0 S were taken twice weekly for four weeks 
prior to the start of the low cholesterol diet 
and three times a week during the l4 days of 
this experimental period. Faecal specimens 
were obtained in five day collections during 
the four weeks basal period and a six day 
collection was obtained during the last six 
days of the low cholesterol diet.
The high cholesterol diet (2.0^8 g./day 
of cholesterol in the form of eggs, cheese and 
cream) was begun after the low cholesterol diet 
and was again essentially free from plant 
sterols. The dietary period was fourteen days, 
Fasting blood samples for serum lipid estima­
tions were obtained thrice weekly throughout
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the fourteen days and a faecal collection was 
obtained during the final six days of the high 
cholesterol diet.
The basal diet (0.374 rag./day of cholesterol) 
was the subjects normal home diet and the 
cholesterol content was obtained from a diet 
hi story*
The collecting,drying and extracting of 
faeces was carried out as described in Part IXl 
(p. 87 )* Faecal neutral steroids and faecal
bile acids were measured by the densitometry 
method described in Part III (p, 97 ). Serum
cholesterol was measured by the Technicon 
Autoanalyser (N.24?) and serum triglyceride 
by the van Handel and Zilversmit (1957) 
technique.
The serum lipid results are shown in 
Table XXXVI.
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Serum choiesterol levels showed a slight 
decrease from the basal levels during the low 
cholesterol diet* During the high cholesterol 
diet however, there was an increase of 6 3 mg.^ 
over the low cholesterol diet and an increase of 
29 mg.^ over the basal level.
Serum triglyceride levels increased from 
the basal level during the low cholesterol 
diet and increased even more during the high 
cholesterol d i e t .
The daily excretion of faecal neutral 
steroids and bile acids are shown in Table 
XXXVJI and XXXVIII.
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During the low cholesterol diet, a marked 
decrease in total neutral steroid excretion and 
total bile acid excretion was o bserved. No 
coprostanol or coprostanone were detected in 
the neutral steroid fraction. A considerable 
amount of cholic acid was excreted with no 
apparent excretion of lithocholic acid during 
this period.
During the high cholesterol diet, only 
cholesterol was detected in the neutral steroid 
fraction. Cholic acid was the major faecal 
bile acid excreted and again no lithocholic 
acid was detected.
The sterol balance of the patient during 
the three dietary periods is shown in Table 
XXXXX.
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Table XXXIX. The effect of dietary cholesterol
on the sterol balance.
Diet Sterol Steroid Output Outout-
Intake Neutral + Acidic intake
rng./24 hr. mg./24 hr.
Basal 374.0 961.9 +587.9
Low 129*0 344.4 +215.4
High 2058.0 1797.4 -260.6
From these results it appears that the 
subject was excreting more steroid than was 
ingested during the basal and low cholesterol 
diet whereas during the high cholesterol diet 
the converse occurred.
231.
DISCUSSION
In all of the investigations except one 
the number of subjects studied was small and 
only tentative conclusions can therefore be 
drawn from the results. This is especially 
true of the cholesterol-feeding experiment in 
which only one subject was studied. However, 
the experiments illustrate several of the 
steps in the two main pathways of cholesterol 
excretion, i.e. excretion in bile as bile acid 
conjugates and in faeces as neutral steroids and 
bile acids, which if altered may cause changes 
in serum cholesterol concentrations.
1 • The effect of feeding taurine
The results show that the proportion of 
bile acids conjugated with taurine in human bile 
can readily be increased by feeding I.5 g* taurine 
per day. This is in agreement with the finding 
of Sjdvall (1959). Taurine feeding for 10 to 
15 days at this level, however, produced no 
effect on serum cholesterol concentrations, a 
result which is in keeping with incidental
232.
observations by two other groups. Failey _et a 1 . 
(1962) mentioned that in preliminary studies, 
feeding taurine as a dietary supplement to man 
appeared to have no effect on the serum 
cholesterol concentration while He 11strom and 
Sjovall (1961) showed that although the G/T 
ratio fell serum cholesterol continued to rise 
in a similar experiment in which a patient with
mild hypothyroidism was given 3 g. taurine per
day for two months.
Amongst mammals two groups may therefore 
be distinguished. The first, represented by 
man and the rabbit, in which taurine has no 
effect on serum cholesterol levels and the 
second, including rats, mice and monkeys in 
which taurine produces a distinct effect. Xt 
is of some interest that the former conjugate 
their biliary bile acids mainly with glycine 
and the latter with taurine.
2 • The effect of clofibrate
a) On biliary bile acids and serum cholesterol
33
The mean change in the glycine/taurine 
ratio during clofibrate treatment was small 
(-Ü.4 ) and insignificant. The changes in 
individual subjects between control and treat­
ment periods were of the same order as varia­
tions found by Sjovall (1960) between repeat 
bile collections in healthy men. There was 
no change of G/T ratio in the two patients 
under metabolic ward conditions and the small 
changes in the three out-patients could have 
resulted from variations in dietary taurine 
as shown in the preceding section and by 
Sjovall (1959).
The number of patients studied was not 
large enough to permit detection of small 
changes in the G/T ratio, but it seems likely 
that clofibrate does not produce major changes 
in the conjugation pattern of biliary bile acids. 
This is in contrast to hypothyroid patients 
treated with thyroid hormone. The mean de­
creases in the G/T ratios of these subjects
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reported by Hellstrom and Sjovall (1961) and 
Hellstrom and Lindstedt (1964) were 5*4 and 
4.3 respectively.
It is of interest that in the five sub­
jects treated with clofibrate (p. 168 ) there
appears to be a relationship between the serum 
cholesterol concentration and the G/T ratio. 
However when additional data from the section 
on taurine feeding is considered then the 
relationship no longer holds (r = -O.I3).
Tlie serum cholesterol levels and G/T ratios 
of a group of nine hypothyroid subjects 
(Hellstrom and Lindstedt, 1964) before and 
after treatment with thyroid hormone were also 
analysed but again there was no correlation 
between the concentration of the serum cholesterol 
and the G/T ratio. (untreated r - O.ÛI5» 
treated r = 0 . 4o 6 ) .
There did not appear to be any change in 
the proportions of the bile acids during 
clofibrate therapy.
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Thorp (1963) has suggested, among other 
possibilities, that clofibrate might act by 
displacing thyroxine from its binding by plasma 
albumin resulting in increased free thyroxine 
in the liver. If this is the mechanism that 
lowers plasma cholesterol during clofibrate 
treatment one might expect a reduction in the 
glycine/taurine conjugation ratio of biliary 
bile acids because large reductions have 
occurred consistently when hypothyroid patients 
were treated with thyroid hormones (Hellstrom 
and Sjovall, I96I; Hellstrom and Lindstedt, 
1964). The finding that clofibrate produces 
no significant change in the G/T conjugation 
ratio is suggestive evidence against the 
thyroxine mechanism. It cannot, however, be 
considered conclusive because the patients in 
this study were euthyroid and it is not known 
at present what effect thyroxine has on the G/T 
conjugation ratio in euthyroid human subjects. 
Furthermore a true dissociation between the
36.
cholesterol lowering and G/T conjugation 
effects of clofibrate has not been demonstrated 
because the cholesterol clianges were not 
statistically significant,
b ) The effect of clofibrate on serum and 
faeca.l lipids
Changes in plasma lipids with clofibrate
Clofibrate reduced serum cholesterol and 
triglyceride in the majority of the subjects 
(p. 178). The ability of the drug to lower
the serum levels of both cholesterol and tri­
glyceride is now well established (Acheson 
and Hutchinson, I963; Berkowitz, 1963(a);
Green et al. I963; Oliver, I963). As noted 
in the present series, the hypolipidaemic effect 
of clofibrate occurred within one to two weeks 
of treatment (Carlson et al. I9 6 3 ; Denborough,
1963) although in some cases the maximum effect 
may not be attained, for several months (Laubinger,
1964), The observation that the greatest fall 
in cholesterol occurs in those patients with 
the highest pretreatment levels has also been
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made by Counihan and Keelan (I963). Similarly, 
dietary treatment, d-thyroxine, and clofibrate 
were all found to depress the serum cholesterol 
in proportion to its initial level (Hansen, I963).
It has been stated by some workers (Heilman et al. 
1963) that females show a greater reduction in 
serum cholesterol levels than males in response 
to clofibrate medication, while others (Acheson 
and Hutchinson, I963; Green et al. I963;
Knuchel, 1964) have observed no sex differences
in the magnitude of fall in serum cholesterol.
The greater response shown by the females in 
the present series may be due to the fact that 
they had a greater proportion of high pretreat­
ment serum cholesterol levels than the males.
In contrast to the findings of Oliver (1962) 
it was found that a daily dose of 1 g. clofibrate 
was sufficient to produce a hypolipidaemic effect 
over a two-week period. The fall in serum 
cholesterol and triglyceride in the group taking
1 g. clofibrate daily was, in fact, larger than
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that obtained in the group given clofibrate 
in an initial dosage of 2 g$ daily. This 
observation also is probably due to the higher 
pretreatment serum lipid levels in the small 
dosage group.
After several months of clofibrate treat­
ment most of the 10 subjects had maintained 
serum cholesterol and triglycez’ide levels below 
the pretreatment values. The large increase, 
after a transient fall, in the already elevated 
triglyceride in subject J.P. is unexplained, 
although substantial increases in serum tri­
glyceride levels during treatment with clofibrate 
have been reported in a minority of subjects 
by other authors (Oliver, 1963; Fasoli and 
Ce Sana, 1963; Cramer, 1963)* The increase
in serum triglyceride level in this patient was 
not associated with factors previously shown 
to cause elevation in this value such as weight 
gain (Albrink e_t aJL. I962), or changes in 
dietary intake of fat (Antonis and Bersohn,
'39.
1961 ) or carboîiydrate (Ahrens et al. I981).
Changes in faecal excretion
The increase in number of stools passed 
during the first week of clofibrate medication 
was presumably a side-effect of the drug, which 
appeared to be mild and transient when a small 
initial dose of clofibrate was used. %n the 
higher doseige group the effect was of longer 
duration, and was reflected in the increased 
weight of faeces excreted after nine to fifteen 
days of clofibrate therapy. One of the sub­
jects reported mild diarrhoea after commencement 
of clofibrate (2 g. daily), and other workers 
(Oliver, I963; Prior and Campbell, 19^3 ) have 
noted that diarrhoea or intestinal hurry might 
occur when clofibrate was given in an initial 
dosage of 2 g. to 3 daily. There was no 
evidence of steatorrhoea during tx’eatment.
The small increase in daily faecal fat excretion 
is well within the normal range, and is probably 
the result of intestinal hurry in the subjects
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on the larger dose. This is in accord with 
the finding that reduction of serum lipids 
during treatment with a combination of clofibrate 
and androsterone is not associated with 
steatorrhoea when cholesterol is lowered by 
means of a bile-sequestering resin (Berkowitz,
1963(b).
A change in the pattern of excretion of 
faecal neutral steroids and bile acids occurred 
only in subject D.M# This subject, in whom 
clofibrate caused mild diarrhoea, also showed 
increases in weight of faeces excreted and in 
daily fat excretion which were greater than those 
seen in the other subjects. The increased pro­
portion of cholesterol and the presence of 
cholic acid both reflect diminished bacterial 
degradation of these compounds, and are presumably 
the result of intestinal hurry in this subject. 
Mechanism of serum lipid changes
A reduction in serum cholesterol level 
following clofibrate therapy might, in theory,
2kl.
be achieved by several means; firstly, b]/" 
increased excretion of cholesterol into the 
gastro-intestinal tract via the liver and bile 
and secondly, by reduced absorption of 
cholesterol from the gastro-intestinal tract.
Both these effects would be manifested by in­
creased excretion of neutral steroids in the 
faeces, A third possibility is increased 
degradation in the liver of cholesterol to bile 
acids, which would result in incireased faecal 
bile acid excretion. Fourthly, the synthesis 
of cholesterol in the liver and gastro-intestinal 
tract might be diminished by clofibrate. In 
such an event the excretion of cholesterol and 
bile acids into the gastro-intestinal tract 
would tend to fall, resulting in decreased 
faecal excretion of neutral steroids and bile 
acids.
In the low-dosage group, the marked fall 
in serum lipids was accompanied by a significant 
reduction in faecal bile acids, and a similar,
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though smaller, change in faecal neutral 
steroids. These results are compatible with 
the last-mentioned mechanism; namely, a de­
creased rate of cholesterol synthesis reflected 
in diminished faecal excretion of cliolesterol 
and its end-products. After several months 
of clofibrate therapy, the faecal excretion 
of bile acids and, to a lesser degree, neutral 
steroids was still lower than in the pretreatment 
period, suggesting that this mechanism continues 
to operate. In the high-dosage group however, 
these faecal lipid changes were partly obscured 
by increased faecal lipid output resulting from 
intestinal hurry. The fact that the serum 
lipid changes in this group were smaller than 
those in the low-dosage group confirms that the 
increased faecal lipid output in the high-dosage 
group was not causally related to the fall in 
serum lipids which occurred at the same time,.
The suggestion that the fall in serum lipid 
levels and in faecal lipid output both result
243.
from diminished lipid synthesis is further 
supported by the observation that subjects 
with the largest fall in serum cholesterol 
tended to show the greater reduction in faecal 
neutral steroid, output.
Any theory of the mechanism of action of 
clofibrate must account for the fact that it 
reduces the serum levels of both cholesterol 
and triglyceride. One explanation which has 
been advanced is that binding of clofibrate 
to the plasma albumen reduces its affinity for 
other acids, including thyroxine and non- 
esterifled fatty acids (Thorp, I983). This 
is said to result in a preferential localisation 
in the liver of thyroxine and its active meta­
bolites, which in turn leads to decreased 
hepatic synthesis of cholesterol and triglyceride 
while decreased peripheral availability of 
thyroxine reduces lipolysis in adipose tissue, 
Howrever, a study of bile acid conjugates before 
and during clofibrate therapy did not confirm
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an increased thyroid-like activity, in that 
the characteristic change in the glycine ; 
taurine ratio did not occur (Part IV, p. l68). 
Moreover clofibrate administration was found 
by Danowski and Alley (1967) to reduce 
cholesterol and triglyceride levels in a sub­
ject with complete primary myxoedema, indicating 
that availability of thyroid hormone is not 
essential for the hypolipidaemic effect of 
clofibrate.
Although these findings suggest that 
clofibrate does not exert its hypolipidaemic 
action in the manner described above, there is 
some evidence that it reduces lipid synthesis 
in the liver. A diminished hepatic content 
of cholesterol and triglyceride has been found 
in rats given clofibrate (Azarnoff et al. I983)» 
Further animal studies have indicated that 
clofibrate inhibits cholesterol biosynthesis 
at some stage prior to the formation of meva- 
lonate (Azarnoff et al. 1965; Avoy et al.
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1965)» It has been established that there 
is no accumulation in the plasma of humans of 
cholesterol precursors such as desmosterol, 
which would indicate a block in the final 
stage of cholesterol synthesis. Other in­
vestigations have produced, in studies of 
serum lipoproteins, indirect evidence of in­
hibition of synthesis of triglyceride (Walton 
et al. 1983) and of the very-low-density lipo­
proteins which transport triglyceride (Strisower 
et al. 1963). While the experimental observa­
tions in the present study can provide no 
direct evidence for or against these theories, 
the findings of diminished faecal output of 
bile acids and neutral steroids during clofibrate 
medication indicate diminished excretion and 
catabolism of cholesterol, possibly resulting 
from diminished cholesterol synthesis.
c) A comparison of the effect of clofibrate 
and L~thyroxine on serum and faecal 
lipids in hypothyroid subjects.
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A decrease was observed in serum 
cholesterol levels in all three subjects on 
clofibrate within 12 days of treatment. The 
lowering of serum cholesterol by clofibrate 
in euthyroid patients is well known (see 
previous section), but there have been re­
latively few reports of its effect on hypo­
thyroid subjects. Harrison and Harden (1966) 
failed to detect any lowering of serum cholesterol 
after three weeks treatment with clofibrate in 
two subjects with gross myxoederna although 
Danowski and Alley (I967) observed a marked 
decrease in serum cholesterol in one woman with 
primary myxoederna after treatment with clofibrate.
During thyroxine treatment, serum 
cholesterol levels tended to increase above 
pretreatment level in the three subjects 
treated initially with clofibrate.
In contrast to these findings, the subject 
L.B, who was treated only with L-thyroxine 
showed a decrease in serum cholesterol levels,
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a finding also reported by Malmros and Swalin 
(1953) and Boyd and Oliver (i960). However, 
it may be that in the present study the serum 
cholesterol concentrations of the three sub­
jects treated initially with clofibrate had 
been lowered to such an extent that the sub­
sequent effect of thyroxine was less apparent. 
Serum triglyceride
The decrease in serum triglyceride con­
centrations observed in all three subjects 
during treatment with clofibrate is in agree­
ment Danowski and Alley (1967). During 
thyroxine therapy however, serum triglyceride 
levels increased markedly in these three 
subjects.
The serum triglyceride level in subject 
L.B. showed little change during treatment with 
L-thyroxine. A similar situation had been 
observed earlier by Best and Duncan (1964,
1966) in euthyroid subjects given D-thyroxine.
Feldman and Carter (1963) however had observed
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falls of 24 to 48^ in four hypothyroid subjects
during treatment with this compound. Their 
basal values ranged from 366 to 515 mg./lOO ml. 
serum which are much higher than the basal 
values of the subjects in this report.
The finding by Stri sower and Strisower 
(1964) that D-thyroxine lowers principally 
the Sf°0-20 lipoprotein class w^ ^hereas clofibrate 
lowers principally the Sf^20-400 class, the 
triglyceride carrying lipoprotein, together 
with the relatively low basal triglyceride 
level might explain the failure of L-thyroxine 
to lower serum triglyceride levels.
From the serum lipid results, especially 
the serum triglyceride values, it appears that 
clofibrate is a more efficient hypolipidaemic 
agent than L-thyroxine and that the mechanism 
of action of clofibrate does not depend on the 
presence of thyroxine. This is especially 
borne out by the results in subjects A.G. and 
J.B. whose protein bound iodine concentrations
2 49.
were < 1.0 |J.g./o and 1.0 respectively.
Faecal neutral steroids and bile acids
Treatment with, clofibrate showed no con­
sistent effect on the excretion of faecal neutral 
steroids but the tendency for the bile acid 
excretion to decrease similar to that ob­
served in euthyroid subjects (see previous 
sect!on).
The increase in faecal neutral steroid and 
bile acid excretion during thyroxine therapy, 
also reported by Weiss and Marx (l955) and 
ICritchevsky (1960), suggests that tliyroxine 
increases the catabolism and excretion of 
cholesterol.
It therefore appears that the mechanisms 
of action of clofibrate and thyroxine in 
lowering serum cholesterol levels are different. 
Clofibrate decreases the faecal excretion of 
neutral steroids and bile acids (Part IV) 
whereas the results of this study and of other 
workers indicate that thyroxine increases the
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excretion of neutral steroids and bile acids. 
Unlike thyroxine, clofibrate has no effect on 
the glycine to taurine ratio of biliary bile 
acids (part IV). Other workers have suggested 
that clofibrate decreases the hepatic synthesis 
of cholesterol (Azarnoff e_t aA, I965; Avoy 
et al, 1965)* Thyroxine on the other hand
has been shown to increase cholesterol syn­
thesis (Rosenman et al. 195^)*
The effect of oral calcium on cholesterol 
metaboli sm
Three main changes in faecal lipid excretion 
occurred during increased calcium intake.
Faecal cholesterol excretion increased sig­
nificantly during calcium glycerophosphate 
administration and was accompanied by a 
significant decx'ease in coprostand excretion. 
Total neutral steroid output therefore remained 
constant. When the skimmed Tnilk diet was 
substituted for calcium glycerophosphate, faecal 
cholesterol remained elevated while coprostanol 
excretion increased, causing a significant
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increase in the excretion rate of total neutral 
steroids.
Faecal bile acid, excretion increased 
during calcium supplementation attaining 
statistical significance during calcium glycero­
phosphate treatment.
The following mechanisms may be involved in 
these changes :-
a) The incx'ease in cholesterol excretion follow­
ing calcium glycerophosphate may result from an 
inhibition of coprostanol formation rather than 
an increased output of endogenous choiesterol, 
This is based on the finding that total neutral 
steroid excretion remained unchanged,
b) The significant increase in total neutral 
steroid excretion on the skimmed milk diet may 
on the other hand have resulted from an increase 
in endogenous cholesterol output duxTng this 
period,
c) The increase in faecal bile acids during 
both calcium supplementation periods is probably
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due to the formation of insoluble calcium 
salts of bile acids rendering them less readily 
reabsorbed•
d) The formation of these insoluble bile salts 
would then also cause an increase in neutral steroid 
excretion, as soluble bile salts are necessary
for optimal cholesterol absorption, (Siperstein 
et al. 1952),
e) The presence of increased amounts of bile 
acids in the colon might also inhibit coprostanol 
formation as has been demonstrated in rats, (Wells,
1957).
f) Reduction in the efficiency of bile salt 
reabsorption has been shown to increase cholesterol 
turnover and also cholesterol and bile acid out­
put , (Bergstrom and Danielsson, 1958),
The six effects listed above may be 
interrelated in the following way.
Calcium, in the organic forms tested, 
reacts with bile acids to form insoluble salts 
which are less easily absorbed than those bile salts
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normally present in the intestine. Total bile 
acid excretion is therefore increased. There are 
then two secondary effects; firstly, on the 
bacterial conversion of cholesterol resulting 
in a decrease in coprostanol formation, and 
secondly, on the absorption of cholesterol 
resulting in an increased excretion of endogenous 
cholesterol•
The increase in faecal fat observed during 
calcium supplementation can also be explained, 
partly by a reduction in the availability of 
bile acids but mainly by the formation of calcium 
salts of fatty acids. This increase in faecal 
fat excretion together with the increase in 
faecal dry weight has been previously reported 
by Yacowitz e_t ^1, (1965).
The changes in serum cholesterol and tri­
glyceride levels were not significant. While 
the concentration of each compound fell towards 
the end of the calcium glycerophosphate period, 
they rose again following the introduction of
254.
skimmed milk. The form in which the calcium 
is given therefore appears to influence its 
effect on serum cholesterol and triglyceride.
In this case, the small rise in fat and carbo­
hydrate intake due to the skimmed milk may 
have been responsible for the differences.
The interval of two weeks between commencement 
of calcium glycerophosphate and its maximum 
effect on serum lipids was the same as that 
for the excretion of faecal lipids (see Figures 
22, 23), These results are contrary to the
findings of Yacowitz et al. (1965) who gave
approximately two and a half times as much 
calcium and observed a decrease in serum lipid 
levels after four days. More recently Maibach 
(1967) found after four weeks of oral calcium 
(1,5 g. per day) that serum cholesterol levels 
were not significantly decreased. He also 
found no significant change in serum be ta-lipo­
proteins or total lipid levels.
The lack of effect of an increased excretion
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rate on serum cholesterol concentration may 
have been due to the dose of calcium administered, 
which was lower than in other reported studies, 
or it may have been due to an increased 
cholesterol synthesis resulting from the mal­
absorption of the bile acids*
The amount of calcium administered In the 
present study was far greater than that normally 
obtained even in the hardest water, and it 
is difficult to believe that the lower cardio­
vascular mortality in hard water areas could be 
due to the reported serum cholesterol lowering 
effect of calcium.
However, there does appear to be a "water 
factor" influencing cardiovascular mortality *
In Japan (Kobayashi, 1957)> United States 
(Schroeder, I960) , Great Britain (Morris _ejb al. 
1961) and Sweden (Biorck et al* I965 ) associa­
tions have now been shown between local drinking 
water and cardiovascular disease; the softer 
the water the higher the mortality.
2 5 6 .
Studies concerning the constituents of 
water and cardiovascular disease by Morris et al,
(1962) showed that only the calcium content 
correlated with cardiovascular disease. Parsons 
et al, (1961) in Tasmania observed marked clinical
improvement in patients with coronary artery 
disease when treated with magnesium sulphate 
but whether this is due to increased magnesium 
or sulphate (Schroeder (1960) showed a correlation 
between various anions such as sulphate, bi­
carbonate and fluoride in water and deaths from 
cardiovascular disease)) is not known.
More recently, Crawford and Crawford (1967) 
suggested that the higher incidence of deaths 
from cardiovascular disease in the soft water 
areas might be due to increased susceptibility 
of the myocardium in the soft water area. They 
studied cardiac lesions found in a very soft 
water area (Glasgow) and in a very hard water 
area (London) in two comparable series of medico­
legal autopsies; men who had died from an
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accident and men who had died suddenly and un­
expectedly from ischaemic heart disease. In 
the accident series the prevalence of myocardial 
scars (healed infarcts) was greater in the soft 
than in the hard water area. An important 
finding was that there was more atheroma and 
more lumen stenosis in the soft water area at 
ages 30-40 years but there was no difference 
between the two areas at ages 45-69 years, only 
"old occlusion" was commoner in the Glasgow area. 
From their results it appears that there is 
initially a more rapid development of cardio­
vascular disease in the soft water area but as 
time passes the development of the disease in 
the hard water area progresses until in the 
older age group there is no difference between 
the two areas.
The results of this study show that calcium, 
when taken as calcium glycerophosphate, increases 
faecal bile acid excretion, faecal fat and faecal 
cholesterol excretion but total neutral steroid
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excretion remains unchanged. It appears there­
fore that in this form, calcium inhibits the 
formation of coprostanol without affecting 
cholesterol absorption. However, when taken 
as skimmed milk, total neutral steroid excretion 
increased as did faecal bile acid and faecal 
fat excretion suggesting that cholesterol ab­
sorption was inhibited. Although it appears 
that calcium has a similar effect on bile acid 
excretion as cholestyramine, a bile acid binding 
resin (Bergen et al. 1959)» it is not so efficient 
as cholestyramine in lowering serum cholesterol 
levels. From these results it ai^pears doubtful 
that oral calcium supplements can be recommended 
as a means of reducing serum cholesterol con­
centrations •
The effect of oral cholesterol on serum 
cholesterol concentrations
The slight decrease in serum cholesterol 
level during the low cholesterol diet, in the 
single patient studied, is in agreement with 
the findings of Keys et al. (1965) that
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decreasing the cholesterol content of the diet 
has little effect on serum cholesterol con­
centrations . The increase in serum triglyceride 
during this period may have been due to the 
increased carbohydrate and reduced fat intake 
which occurred during this dietary period (Ihrens 
et al. 1961), Serum cholesterol changes ob­
served during the high cholesterol diet are also 
in agreement with those previously reported by 
Connor et al. (I96O, 1964) but are at variance
with the findings of Bhattathiry and Siperstein
(1963). However, these workers obtained their 
serum cholesterol values' after the subject had 
been on the diet for only 3 days and the slight 
increase in serum triglyceride levels reported 
may have been due to the increased dietary 
intake of fat*
The marked decrease in daily excretion of 
faecal neutral steroids was probably due in 
part to the decreased amount of dietary cholesterol 
and in part, to the effect this decreased dietary
Z6o.
cholesterol has on cholesterol metabolism.
The decrease in excretion of faecal bile 
acids suggests that there is either a diminished 
secretion of bile acids into the gastrointestinal 
tract or an increased absorption of bile acids 
from the intestine. As bile acid absorption 
is normally very efficient, the former suggestion 
is more likely.
During the high cholesterol diet there will 
be an excess of cholesterol available for ab­
sorption. At present, there are two conflicting 
theories to account for tVie iv^ ay in which man 
prevents liypercholesterolaemia of dietary origin 
from occurring. One of these is the negative 
feedback mechanism (Bhattathiry and Siperstein, 
1963)* This would re suit in a decrease in 
cholesterol synthesis and would be accompanied 
by an increase in bile acid fox'mation. Tliese 
two processes would operate in an attempt to 
maintain the amount of choiestero1 being secreted 
from the liver at the basal level. The other
2 6 1 .
mechanism is that the human intestine has a 
limited capacity to absorb cholesterol (Karvinen 
et al. 1957» Kaplan e_t aT. 1963» Taylor ejk al.
1965 and Taylor and Ho, I967). If this were 
the mechanism, then a marked increase in faecal 
neutral steroid excretion with no change in 
faecal bile acid excretion would be observed.
The slight increase in daily faecal 
neutral steroid excretion and the marked in­
crease in faecal bile excretion in the subject 
described here suggests that it is the negative 
feedback mechanism which operates during diets 
rich in cholesterol. This is further supported 
by the finding that during the high cholesterol 
diet less steroid was excreted than ingested 
whereas on the low cholesterol diet the converse 
took place.
It would appear therefore that dietary 
cholesterol has a controlling effect on cholesterol 
metabolism. It must be re-emphasised, however, 
that no firm conclusions can be drawn because of
2 6 2 .
the paucity of data available from the present 
study.
General discussion
From the results of these investigations 
it would appear that the most effective means 
of lowering serum cholesterol levels is by 
inhibiting the synthesis of cholesterol prior 
to the cyclisation step.
Decreasing the dietary intake of cholesterol 
had no appreciable effect on the serum cholesterol 
level although this increased when the dietary 
intake of cholesterol was increased. The in­
vestigation did show however, that the negative 
feedback mechanism may be a controlling factor 
in regulating hypercholesterolaemia of dietary 
origin. The marked increase in faecal bile 
acid excretion during calcium administration 
appeared to influence the faecal excretion of 
neutral steroids without having a significant 
effect on the serum cholesterol level. An 
effect similar to that produced by cholesty­
ramine - increased faecal bile acid excretion
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accompanied by a decrease in serum cliolesterol 
level - was anticipated but it may bave been 
that the dose of calcium given was insufficient 
to promote an increase in faecal bile acid 
excretion sufficient to overcome the effect 
of the resulting increase in cholesterol syn­
thesis, From these two investigations it 
appears that alteration of cholesterol intake 
or output is not a very effective means of 
lowering serum cholesterol levels.
Another major route of cholesterol loss 
from the body is the conversion of cholesterol 
to bile acids in the liver. Alteration of the 
glycine/taurine ratio of the conjugated bile 
acids appeared to be a mechanism whereby serum 
cholesterol levels could be lowered. However, 
the alteration of the glycine/taurine ratio by 
feeding taurine was ineffective and suggests 
that the increased taurine conjugation of bile 
acids which accompanies the lowering of serum 
cholesterol in hypothyroid subjects after
Z6k.
treatment with thyroid hormones is probably 
an epiphenonienon• This is furtlier supported 
by the finding that the bile acid conjugation 
ratio was unaltered by administration of 
clofibrate even although serum cholesterol 
levels decreased.
The mechanism of action of clofibrate lias 
not been completely elucidated. It has been 
suggested that cholesterol synthesis is in­
hibited by clofibrate and the study of the 
faecal excretion of neutral steroids and bile 
acids (part IV, p, 1^4) appears to support 
this theory, Clofibrate was originally 
thought to act by causing an increase of thyx'oxine 
in the liver (see Part IB, p, 59 ) which resulted
in diminished synthesis of cholesterol and tri­
glyceride, From the three investigations in­
volving clofibrate and from the suggested 
mechanism of action of thyroid hormones on 
cholesterol metabolism (see Part IB, p. 56 )
it seems doubtful whether the availability of
265.
thyroid hormone is necessary for the serum 
cholesterol lowering effect of clofibrate.
From a technical standpoint these in­
vestigations also show the effoctiveness of thin- 
layer chromâtography in lipid analysis. The 
quantitative densitometry technique is a 
particularly useful analytical tool and could 
be well employed in investigations of various 
diseases, such as diabetes mellitus, in which 
there is a disorder of lipid metabolism.
2 6 6 .
APPENDIX
67.
INDEX TO TABLES
Tables XL - XLXX give the results of the effect 
of clofibrate administration (l.O g, daily for 
9 - 15 days) on the serum and faecal lipids in 
11 subjects,
Tables L - LJX give the results of the effect 
of clofibrate administration (2.0 g. daily for
9 - 15 days) on the serum and faecal lipids in
10 subjects.
Tables - LXVI give the results of the effect
of clofibrate administration (2.0 g. daily or 
1.0 g. daily for 9 - 15 days) in the group of 
21 subjects.
Tables LXVXI — LXXVT give the results of pro­
longed administration of clofibrate (1.5 g. 
daily or 2.0 g. daily for 1 - 9  months) on the 
serum and faecal lipids in 10 subjects.
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Table XLVX. The effect of clofibrate I'g.
daily for 9 - 1 5  days.
TOTAL BILE ACIDS
mg./lOO g. dry faeces mg,/24 hr.
Subject InitlBl level Change Initial level Change
j.p. 334.4 -38.4 54.4 +12.7
W.B. 148.6 -20.3 74.8 -19.3
J.E. 0 +82.6 0 +25.2
J.G. 735.5 -175.1 137.3 +11.3
M.M. 303.1 -223.0 94.9 -81.7
J. MeA. 1039.0 -530.2 128.8 -57.1
F.R. 434.1 +35-0 74.7 -50.1
A.IC. 476.4 -175.6 54.0 -18.2
M. McD. 274.7 -194.3 41.9 -13.9
M.w. 504.4 -242.1 107.1 -56.8
J.M. 384.3 -70.4 77.5 -29. f.
Mean 421.3 -l4l.l^^ 76.9 -25.2
S.D. +283.6 p < 0.05 +39.7 p < 0.05
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293.
0 q A
p o • • * • O •
0 • X q q ■ q q • q
ÎH 0 <! • » « • O *
q 0 HP X X X X X
•H P O V
q 0
o B q
H 0
ü q
q 73
p 53
'H 0
0
73 0
0 P m A VÛ o -d-
P 0 q ♦ • « • •
0 E q h* vo M3 oo t- co
0 00 CM CM P A c\i
U S s A + P 1 1 1
p 0 •H q I I
X q
0 0 0 0
a q P ko
0 0 b
o A b 0
u r4 q q
tiq •H o
1 q
o o b
CA P 0
P ü o
ÎH X
0 O q
q q 0 q vo q* CM A P CA
p q • • * • •
X "P q CM A M3 O CO A
q p ü g VO MO A A P CM
0 'H 0 s + C'j 1 + I 1
0 q +
0 73 q
p 0
H • 0
0 tz 0 P 73
0 q 0 0 O •ri
0 01 q 73 73 b b
b P X •H X 0 0u O b O b p Ü
73 o b 73 b 73 0 X
0 $ 0 0 0 . P  •
0 . H P « P  • 0 * 0 • P  P kz p
•H hZ î> Q 0 bjD (D b 73 bû 70 b o Ë •H E
q X X q •H •ri q q b
S P q 5 P O 0 iH ü O 0 ü ü o P O
o o 0 O 0 0 q* < O 0 0 ^ o O
Ü 0 q b P ü b CM p ü CM E H S p
p % P \  0 P 0 0 0 \
q o 0 • 0 0 • P • 0 P  . b • b .
0 o 0 boq 0 •H tioq •ri bÛ 0 bO 0 EO
q X E X  E m s q s (0 E q  B
294.
N0
73
bù
04
u
O
X0
7 3
A
P
0
P
0
q
o
q
q
q
q
o
X
o
0
bû
§
q
o
A  CO IPVO A  M3 ^  O
P
P
I
CJ\
+
0\
p
p
i
q-
p
1
A
MO
I
o\
CM
I
ï>
M O
I
>!<
A
O
A î p G\ «
# . • O
q - q A
P p A \ /
+ i 1
A
» -
b pq 0
>
q 0
CM P
q A q q CM ! S h - CA A q CM CO
• P • • • « • • « # • • o «
LO 0 p CM M 3 A CM A A P O CM o A
B • r !
P
•H
C
H
A
A
C-
P
A A CO A C A CO A P
P %
b 0 0 co p 0\ q A p vo A q t'- co
q 0 bo o • • , • • • • • « • •
• H Ü b A î v q CM q o C A co P A co
q 0 0 ï > q* P O O G\ A O A M O M O •
o 0 q P P CM q P V O I q CM 1 P Xp « H ü + 1 1 I l .1 I + 1
ü
q b
0 7 3
H
p « 0
ü bû >
0 0
q O P
q O
0 P P
0 A P q q q V O t- q CM 3>- q vo
73 # *H • # • • « • • « * « *
0 bZ P 0 0 A - A CM A vo q A- A OV P vo
to B •H A 00 V O O O p O A h- A O o
b b vo A A 00 A co A A A CM A CM
0 * H +
p H
0 H
b î>
h %
q P •
0 0 Q
bq 0 0 • « • ü • • ü * • • »
p •O m O X % q X 0 Q
q q • • • • • • • » 0 •
0 b > H ;s: • q q • *7> h ) s co
q co
295.
>•
0
73
W
CM
bO
73
k:
A
0
P
0
b
q•ri
O
p
ü
«H
O
p
ü
ü
<t-l
q
o
o
g*
o
u
b
q
0
0
ü
0
0
<P
73
bO
O
0 o P O A vo VO O A 00 00 O •
bû • • • « 9 • • • • m
b A A q P CM CM h- CO A P A •
0 q VO P + A O A N P A CM X
q CM CM P 1 P P CM l + I
o 1 + + + l t
0
0
p
CM q O 0 0 A O A VO O CM A A
p • • • • • • # • ‘ • • • •
0 P o A p A q h- q O O VO A
bo •H h- h- VO vo A q A A q q 03 CO
E P
•H
b
h- CM q CM q P A A CM A A P
4*1
H
0 o O p 00 O A O P A •
bJ3 • » • # • • • • • • • CO
b o A A CM P A 00 A VO A •
0 h - p
8
A VO O vo D- vo A X
q t-H p CM A A VO c o A CM 1
o t + f 1 I + 1 P
1
+ 4-
P0
>0
P
Vi o A O P q A (M vo p A A A A
0 p p • • • • • • • • » « * •
0 CM o q CM q O C\î A O VO CM A
73 •ri A A 00 p O P A CM A co h- A
0 bô P A q q P A P CO q r-i vo 00 t -
bjD B •ri P P P CM CM P P A P p p 4-1
b • b
G H H
P H
0 H
b >
p.
5 P * ,
0 ü < P
q 0 0 • • • ü • Ü • * b #
q P *n ÇQ ü X X h-H X X q 5: X' 0 P
q q « • • • * * • 0 •
0 b H X • < • h) X H X m
q co h) X
29^.
0 A q A CM P P A A
bO # « • • • * * « • •
b X- A VO A P O A CM O vo h- CO
0 0 CM A p + + A + A p P •
73 q P I p + + + 1 i X
bo
CM
UO
X CM P O q A CO MO A A P CO A o
0 • • « • • • • • • #
73 # P A P vo X - vo O A CM CO A q A
bo 0 VO q P P CM VO A CO CM VO O A
• ' X S •H q P P P P
bjD
A
H
0
P
0
O
hi
0
p
Ü
0
P
Ch
0
73
0
tp,
bo
p
o
u
ft
0
q
q
XH
0
r4
0
q
o
§
o
X
ft
o
Ü
uq
o I
r4
0
>0
p
•H
b
H
b
73
bo
o
O
P
bO
B
r4
0
>
0
p
p
0
•H
P
•rl
b
H
4-1
b 0 0 OV P A A A P CM X- A CO •
q 0 bO » • • # • # • * • • • CO
•H Ü b vo X- A CO vo P A vo MO X- A ■
ft 0 0 A p X- q 1 CM q q CM MO A X
0 0 q 1 A A + I + + A I I
P ft o I 1 +
o A P O vo q CO O A A O vo» » • • • * • # » » »
A A A q A P A P CM VO q O
04 A X- q A q CM A q P X-
A X* A P P A CM A p A q 04
+ I
•P
Ü 4 ft
0 • » « o » Ü » « • b •*D
q
pq X X ft X X ft X X 00
ft
b
CO
5= X
h)
ft
X
p) X X CO
297.
0 o CM P CO CM A A A q
X ft • • • • , . * » •
0 b CM A CM P A A A A P o
73 0 00 P CM A VO VO CO P vo +
ft
q A
1
CM
+
P
1
1 1 + P
I
A
1
+
CM
bO
X0
TO
bo
A
H
0
+)
0
b
q•H
ft
o
p
Ü
ft
o
p
Ü
0
ft
ft
0
TJ
0
W
b
o
p
o
b
ft
0
g
CM
A
b
q
q
CM
i
0
0
O
0
0
ft
X
b
73
bO
O
O
P
bo
B
iH
<D
>
0
p
p
0
•H
P
■H
bH
P
0
>
0
P
P
0
P
P
*H
b
H
CO
X
A O CO P A CM X* q vo q A A
« • • • * • • • • • « »
CO •b" A A CO O VO A CO CM P P
vo CO A ZX X- A A O q VO O X-
A
P
q X- A A CM q IX A q vo
?l
0 p 00 P A O A A o CM A A
ft 4 * • # • • 0 o • • * •
b IX X A A A A VO p A X VO CO
0 CM A A H. X O CM q A A q o
q 1 A q VO VO q X CM P P CM X
o I P
4-
t I I 1 CM
I
P
+
+ I
vo VO VO CO A C4 p q o A A P• • • # • « • a # « • •
A CM CM CO A CO A A CM C^4 CO o
P A CM A VO VO PT CO q A CO X
P A q O A q q q vo CM X X
A CM CM A A CM CM q P CM CM + 1
q p » •
0 Pi
0 • # • Ü • • o • * • b •p 'D pq ft X ft ft X ft 0 ft
q q • • • • « » • # 0 •
0 b > ft « ft < • ft ft 2 CO
q CO ft %
298.
X0
73
ft
CM
b
o
73
ft
A
P
0
P
0
b
q
•H
ft
O
P
Ü
ft
o
p
o
0
ft
ft
0
73
0
ft
b
o
p
o
b
ft
0
q
ft
HÜ
<
O
H
ftO
X
o
§
ft
0 q M3ft ,
b O A
. 0.._ CM CMq 1 +Ü
b p
q 0
>
q 0
CM P P A
• •
• P A X
ft 0 A VO
E •H
P
•H
b
H
00
CM
I
00 A A A P A •# • » • • CO
A P CM VO CM q •
CM
+
P
1
I A
I
CM
1
p
1
X
A  00 P P
CM
A A A O P
• • « » •
A A A CM q
A X q A CM,
*
A
O
0 A CM CO p CM A O vo CO A o *
0 f t • • • • • 9 • • • • o
0 b O X A A VO CM P p o A X
Ü 0 A X VO A . + VO CM p A O CO
0 q I 1 P CM + 1 1 CM P 1
0 Ü 1 1 ( I ft
ft
X
b
73 rHQ)
• >
ft 0 X X q A VO P q q CM VO CO A
H * # • • • • # • o # •
O X o p X A X P X CO X p A
O p X vo CM A A A A o q P CO A
P 0 A CM X CM P P CM A CM CM H
•H + 1
P
ft
E b
H
P
Ü < ft
0 * * 9 Ü • • Ü « • • b •
•o f t CÎ3 X z f t X Z f t z 0 ft
q • # 9 • • • # • 0 •
b 'X X • f t < • Z h) z COCO
299.
ft
CM
bO
0
73
"X
ft
A
P
0
P
0
b
q•H
ft
O
P
0
ft
o
p
Ü
0
ft
ft
0
73
0
ftt
bo
p
o
b
b
0
q
q
H
s
ft
0r4
q
0
q
ft
H
Ü
<
O
H
ft
O
X
Ü
O
g
3
b
q
q
CM
ft
s
Ü
p
0
>
0
p
p
0
• r i
P
•H
b
H
A  O  
A X
A
CM
O  A  CM 
A A A
P
O
X 0 CM VO VO VO VO p CO O A VO q o
0 ft » « • • • • • • • • •
73 b A CM q CM o p A A O o CM V
0
q .
P + CM
1
P
1
+ CM
1
1 I CM
1
CM
1
P
1 ft
X A CM VO A A
o O A A CM A
p CM A A A P
+ 1
P
o
0 00 X vo 07 A A A X O A A 9
0 f t • • • « • • • * # • a o
0 b q CM A 00 A. A A A CM CO X
Ü 0 A VO X P P P CM A X A CO V /
0 q 1 p I P 1 CM 1 1 1 1 1
0 o 1 1 1 ft
f t
X
b p
73 0
>* 0
f t p A CO X X A A O P CM X A CM# • • • « « » • a a a
O p O q P p q A CM X VO VO VO A
o 0 X X CO -Cj" A X X CM A vo X 07,
p •H A CM P CM P P p p + 1
"X P• •H
ft b
B H
P
Ü ft
0 • * 0 # # Ü * a b a
•o m f t Z Z ft X z ft Z 0 f t
q • » • « • • a 0 a
b ft Z a f t < • f t z ft z CO
0 ) ft z
300.
73
bj]
CM
Uo
73
fci
A
H
<D
P
0
u
q
•rl
ft
OP
Ü
ft
0
p
Ü
0G-
ft
0
73
0
bo
p
o
u
ft
0
qq
H
H
q
0
r - j
-s
CO
Q
5
3
H
ft
ft
ëq
u
q
&
73
to
O
O
P
bO
E
0 vo CM A A ÏX X A CO X X
A
O
bo • • • • • • • • • • O
b A CM q o CM A P vo CM vo
0 A 07 CO q + + P P X *q CM V
q .
Ü
+ 1 I 1 1 I I 1
Qi
P
0
>
0
CM P CO A A CO X o A q P A A P
a • ■ • • » » • • • • •
• p q X q 0 0 q q P q X X q CM
bO 0 X A A CM X A q A o X CO A,
E •H P p p + 1
p
*H
b
H
P
0
>
0
P
P
0
•H
P
•H
b
H
P
Ü < ft0 0 • • Ü . » u ■ • •
q
ft c3 Z z ft X Z ft z
b
ft
> Z ft < z z
h)
P
o
0 0 p A q O X q CM X CO VO A •
0 bo • • • • • * « * • « • o
Ü b A A P 00 A CM VO A c\i p CM
0 0 q A q p i. A q .VO O o X V/0 q 1 CM CM q P I 1 A CM P
ft Ü I 1 I 1 1 I I ft
A P O P q A q A A A
. . • • • . • . . » • •
CO A A A q vo A q q q CO P
q A O A A X CM C ft O CO A CO
P X A O
P
q q CM A A A q CM 
+  1
0
0
ft
ft
301.
X0
73
53
CM
U
o
X
0
7)
X,
Ù)
A
H
0
P
0
b
q
•riCh
O
P
ü
<MO
ft
C:1
O
ft
<
ft
ft
o
ü
s
ft•->
0 o O O O C o C O O O p
0 bû • « . * • • • • . . ft
0 b Cft CO O q VO A q q q c\ A
ü 0 CM A CM I p CM CM P A p 1 X
0 q I + 1 I + 1 1 1 l
0
ft
p
0
q
CM
bû
0
0
ft
X
b
Ü
P
0
>
0
P
0
'ri
P
•ri
b
H
Ü
C O O O O
X  vo q  
OD vo vo
p
CM
q
p  X  A
A  A  03
o C O o CM
. * # . *
A P C O A CO
X A
P
00 CO q
+
0 A A P CO A P X C^ CM CM A •
bû . • * • . . . • . ft
0 b P 1/7 A p P A P VO P P •
0 0 P P P + + + I + I 1 i X
O q 1 4- 1 .
p 73 1— 1
ü 0
0 . >
ft b 0
C-i q p A X A q CM q A A CM CM O CM
0 a a a a a a a a a a a a
q p O CO P CM X A CO V O P O CM P
-0 CM 0 A p A P p P p p CM CM CM P
0 • X, •ri +  f
bû * P -
b • bû •ri
o > H
P p H
o X
b X
ft q P a a0 < ft
b0 0 0 « • « O a a ü a a a a
q p • p ÇQ O' Z z q X Z ft X Z 0 ft
e-i q q • • * a • a a a 0 a
0 0 h > z a ft < a h) Z h) Z ft
ft ft P Z
302.
X|0
7:
b:
oj
U
o
X0
7:
"X
ko
A
P
0
P
0
b
q
•H
ftO
P
ü
ft
0
p
ü
0
ft
ft
0
73
0tû
bo
p
o
u
ft
0 0
q
0
H
ft
q
<
ü
ft
*■*1
ft
0 o 00 *~cf* vo vo o p CM A X p a
bû p p X q O A A A A CM o ft
b # • • * a a a a a a a a0 o p o O O O O P O O O X
ü ' ' -
. l + 1 + 1 I 1 + I I +
a
q
CM
b3
p  
0 
> 
0 
I— !
P
0
•ri
P
•H
b
H
CM A CO X A VO co CO co CM -T O
A P P X CM X A A A A VO X
A P CM O P p P P P P P o
0 A q q - p q CO vo q q p
bû X A A q" O A CM A co vo
0 b a a a a a a a a a a
0 0 P O P CM .H A P CO O O
ü q + + + + 1 I 1 + I 1
0 o
0ft
X
b p
73 0
>
a 0
bû p A co X P X X q p X 00
A A A CM q- q q A A q
O p a a a a a a a a a a
O 0 VO VO VO VO X O CO 00 VO X
P •rl p
P
a •ri
bû b
H
P
Ü -< Q
0 a a a Ü a a ü a a a•1-5 m CÎ3 Z z f t X Z ft X Z
q a a a a a a a
b b: h) z a f t <=3 a h) Z Hft h) Z
+1
A
A  ft
O X 
+
X
q
X
CM
A
P
+ I
0 q 
0 •
z ft
303.
p
0
bo
CM
b
O
X
0,
73
tjO
A
H
0
P
0
b
q
■H
ft
o
Hü
ft
O
Pü
0
ft
ft
0
73
0
be
b
o
p
o
b
P4
0
H
H
>
M
ft
P
H
ft
H
q
i
ft
0 o o O O O O o O O O X ft• bû m • « • • • # • ♦ •p b X o vo CO p A p vo X co A X
s 0 p X 1 CM q A CM O + vo 1
q + 1 1 t : l CM 1o o +o
p
\
bû
E
q p
p 0
a 0 o o o o O o O O o O A P
q p • • ■ • • • • • • « • *o co vo A P A A o A X X A 00
X p GO CM A 00 q CM p X CM 00 A Aq 0 p p P 1—1 p P P p P + 1
o •ri
H •I-»
ft •H
q b
H
0 o o O o O O o O O o P
• bO • • • • • • « • • ♦ • ftp b p q X q A O A CM vo A P ♦
S 0 X A CM P CM p 00 CM A VO A Xq + I P : 1 + + I 1 1 1 I
O ü 1o
p
bû
qo
g
ft*
ft
2O
K
O
P
0
>
0
P
O O O O O O O O O O A P
P • • • • » » • • « » « *
0 00 O O A q A A A O A P A
•H q CM X A X q A O O VO P A
•P CM A A CM CM CM CM A q A A + 1
■H
b
H
q -P a a
ü < Q0 0 • • • 0 a a ü a a a b ap • r -5 m O Z z ft X Z ft > z 0 n
q q • # h a a a 0 a0 b 5: h) Z a ft < a H z H z ftft* ft h) Z
3o4.
BIBLIOGRAPHY
ABELL, L.L., B.B. LEVY, B.B. BRODIE and E.E. 
KENDALL. J. biol. Chem. 1952, 195. 357.
ACHESON, j : -and E.G. HUTCHINSON. J. Atherosclor. 
Res. 1963, 711.
AHRENS, E.H. (jr.), J. HIRSCH, W. INSULL (Jr.), 
T.T. TSALTAS, R. BLOMSTRAND and M.L. PETERSON. 
Lancet 1957, 1 , 9^3 .
AHRENS, E.H. (Jr.), J. HIRSCH, K. CETTE, J.W. 
FARQUHAR and Y. STEIN. Trans. Ass. Amer,
Phycns. 19^1 , , 134.
ALBRINK, M.J., J.W. MEIGS and M.A. GRANOFF.
New Engl, J, Med, I962, 266. 4 84,
ALTSCHUL, R., A. HOFFER and J.D. STEPHEN. Arch. 
Biochem. Biophys. 1955, Zltf 5 58.
ANKER, H.S. and K. BLOCH. J. biol. Chem. 1949,
, 971.
ANTONIS, A, and I. BERSOHN. Lancet I961, 1, 3.
ANTONIS, A. and I. BERSOHN. Amer. J. din.
Nutr, 1962, IT, 142.
ATROMID, LIPIDS and THROMBOSIS. Lancet, 1963,
1, 1360,
AVIGAN, J., DE WITT S. GOODMiVN and D. STEINBERG. 
J, Lipid Res. I963, 4 , 100.
AVIGAN, J., D. STEINBERG, M.J. THOMPSON and 
E. MOSETTIG. Biochem• Biophys• Res* Communs,
1960(a), 2, 63.
305.
AVIGiVN, J., D. STEINBERG, H.E. VROMAN, M.J. 
THOMPSON and E. MOSETTIG. J. biol. Chem.
1960(b) 3123.
AVOY, D., E.A. SWYRYD and R.G. GOULD. J.
Lipid Res. 1965, 6, 369.
AZARNOFF, D.LI and D.R. TUCKER. Fed. Proc. 
1964, (part 1) 552.
AZARNOFF, D.L., D.R. TUCKER and G.A. BARR. 
Metabolism I965, l4 , 959.
BAKER, R.D. and G.W. SEARLE. Proc. Soc.
Exper. Biol. Med. I96O, 105. 521.
BARRETT, C.B., M.S.J. DALLAS and F.B. PADLEY, 
Chem. Ind. I962, IO5O.
BARRETT, C.B., M.S.J. DALLAS and F.B. PADLEY.
J. Amer. Oil Chem. Soc. I963, 4o , 5S0.
BEHER, W.T., W.L. ANTHONY and G.0 . BAKER.
Proc. Soc. Exptl. Biol. Med. 1957, 7 34.
BBIERWALTES, ¥,H, and G.B, RUFF. Arch, intern, 
Med. 1958, 101. 569.
BENNETT, R.D. and E. HEFTMANN. J. Chromatog.
1962, £, 359.
BERGEN, S.S. (Jr.), T.B. van ITALLIE, D.M.
TENNENT and V.H. SEBRELL. Proc. Soc. Exptl. 
Biol. Med. 1959, 102. 676.
BERGSTROM, S* Ciba Foundation Symposium on 
Biosynthesis of Terpenes and Sterols,
J,A. Churchill Ltd., London, 1959*
BERGSTROM, S. and H, DANIELSSON. Acta Physiol. 
Scand. I958, 1 .
306.
BERGSTROM, S., K. PAABO and J.A. RUMPP. Acta 
chem. Scand. 1954, S_, 1109«
BERKOWITZ, D. J. Atheroeoler. Res. 19^3 (a), 
In 538.
BERKOWITZ, ,D.__ Circulation 1963(b), 2 8 , 648.
BERSEUS, 0 . and H. DANIELSSON. Acta. chem. 
Scand. I963, 1%, I293.
BEST, M.M. and C.H. DUNCAN. J.A.M.A. 1964,
187. 3 7.
BEST, M.M. and C.H. DUNCAN. Arch, intern. Med.
1966, 118. 97.
BEVERIDGE, J.M.R. Canad. J. Biochem. Phys.
1957, 22, 257.
BHATTATHIRY, E.P.M. and M.D. SIPERSTEIN. J. 
Clin. Invest. 1963, 4 2 , l6l3 «
BIGGS. M.W., M. FRIEDMAN- and S.O. BYERS. Proc. 
Soc. Exptl. Biol. Med. 1951, %8, 64l.
•f ••
BIORCK, G., H. BOSTROM and A. WIDSTROM. Acta. 
Med. Scand. I965, 178. 239.
BLOCH, K., B.N. BERG and D. RITTENBERG. J. 
biol. Chem. 1943, 149, 511.
BLOCH, K. and D. RITTENBERG. J. Biol. Chem.
1942(a), 1 42, 297.
BLOCH, K. and D. RITTENBERG. J. Biol. Chem.
1942(b), 1 45. 625.
BLOHM, T.R. and R.D. MACKENZIE. Arch. Biochem. 
Biophys. 1959, 82, 245.
307.
BLOOMFIELD, D.K. J. Lab. din. Med. 1964(a),
6 4 . 613.
BLOOMFIELD, D.K. Clin Research 1 9 6 4 (b), 12.
2 6 3 .
BOLLMAN, J.L, and E,V, FLOCK. Amer, J, Physiol
1951, l6'4 ,-48o.
BORGSTROM, B. J. din. Invest. I96O, 2 2 , 8C)9 . 
BOYD, G.S. and M.F. OLIVER. Brit. med. Bull.
1960, 16, 138.
BREMER, J. Biochem. J. 1956, 63,-5 07.
BRIGGS, T. and E. STAPLE. Fed. Proc. I9 6O,
12, 2 3 9 .
BROOKS, C.J.W. The Society for ilnalytical 
Chemistry, 1962, Monograph No. 2 . p. 18.
BROWN, J.L. and J.M. JOHNSTON. J. Lipid Res.
1962, 2, ^80.
BYERS, S.O. and M.W. BIGGS. Arch. Biochem. 
Biophys. 1 9 5 2 , 22, 3 0 1 .
BYERS, S.O., R.H. ROSENMviN, M. FRIEDM/iN and 
M.W. BIGGS. J. exptl. Med. 1952, £6, 513.
CAREY, J.B. (jr.). J. Lab. din. Ned. 196O,
56, 797.
CAREY, J.B. (jr.) and G. MLLIAMS. J.A.M.A.
1961, 126, 432.
Ca r e y , J.B. (Jr.) and G. WILLIAMS. J. Lab. 
din. Med. I962, 865.
CAREY, J.B. X .) and G. WILLIAMS. J. din. 
Invest. 1 9 6 3 , 42, 450.
308.
CARGILL, 1).I. The Analyst. 19^2 , 87_, 865.
CARLSON, L.A., B. HOGSTEDT and L. ORO. J. 
Atheroscler. Res. I963, 2 » 467.
CILIIKOPF, I.L., B. BLOOM, M.D. SIPERSTEIN,
J.Y. KIYASU, W.D. REINILUIDT, W.G. DAUBEN 
and J.F.'-EASTHAM. J. biol. Chem. 1952,
194. 407.
CMVLVARDJIAN, A.M. Biochem. J. 1964, £ 0 , 518.
CHiVLVARDJIAN, A., L.J. MORRIS and R.T. HOLMAN. 
J. Nutr. 1962, %6, 52.
CHEVREUL, M.E. Ann. Chim. I815, ££, 5-5 0 . see 
"Cholesterol" R.P# Cook. Academic Press Inc. 
New York, 1958 p , 2 .
CHEVRBUL, M.E. Mem. Musll. Hist. Nat. Paris 
1824, JT, 239.
CLAUDE, J.R. J. Chromatog. I965, 1%, 596.
CLAYTON, R.B. Quarterly Reviews Chem. Soc. 
London, 1965, 1£, 168,
COLEMAN, D.L. and C.A. BAUMANN. Arch. Biochem. 
Biophys. 1957, 66, 226.
CONNOR, W.E., R.E. HODGES and R. BLEILER. 
Circulation i960, 22, 735«
CONNOR, W.E., R.E. HODGES and R.E. BLEILER.
J. Lab. Clin. Med. 196I, £1 , 3 3 1.
CONNOR, W.E., D.B. STONE and R.E. HODGES.
J. din. Invest. 1964, 4£, 169I.
COOK, R.P., D.C. EDWARDS and C. RIDDELL. 
Biochem. J. 1956, 6 2 , 225.
309.
COOK, R.P. "Cholesterol" Academic Press Inc.,
New York, 1958(a), p. 17 *^
COOK, R.P. "Cholesterol" Academic Press Inc.,
New York, 1958 (b), p.244.
COOK, R.P. "Cholesterol", Academic Press
Inc., New York, 1958(c), p. 289.
COPIUS-PEEREBOOM, J.W. and H.W. BEEKES. J. 
Chromatog. 19^5 1 Ü »  9 9 *
COREY, E.J.^ W.E. RUSSEY, P.R. ORTIZ de MONTELLANO. 
J. Amer. Chem. Soc. I986, 88, 4750.
COUERBE, J.P. Ann. chim. et phys. 1834, 56,
160. See "Cholesterol" R.P. Cook. Academic 
Press Inc. New York, 1958, p. 2 .
COUNIHAN, T.B. and P. KEELAN. J. Atheroscler.
Res. 1963, 2 , 580.
COUNSELL, R. E., P.O. KLIMSTRA, R.E. RANNEY and 
D.L. COOK. J. med. pharm, Chem. 1962(a) 2*
720.
COUNSELL, R. E. , P.D. KLIMSTRA and R.E. RANNEY.
J. med. pharm. Chem, 1962(b) 1224.
CORNFORTH, J.W. J. Lipid Res. 1959» i» 3 .
CRAMER, K. J. Atheroscler. Res. I963, JJ, 50O.
CRAWFORD, T. and M.D, CRAWFORD. Lancet I967,
IjL 229*
CURRAN, G.L. and R.L. COSTELLO. Proc. Soc.
Exptl, Biol. Med. 1956, JgJL, 5 2 .
310.
DANIELSSON, H. Acta. chem. Scand. I96O, 14,
348.
DANIELSSON, H. Arkiv. Kemi. 1961(a), 17, 373.
DANIELSSON,'fl."" Arkiv. Kemi. 1961(b), 1%, 363.
DANIELSSON, H., P. ENEROTH,- K. HELLSTRÜM, S, 
LINDSTEDT, and J. SJOVALL. J. biol. Chem.
1963, 2£8, 2299.
DANIELSSON, H. and B. GUSTAPSSON - Arch. Biochem 
Biophys. 1959» 8£, 4 82.
DANOWSKI, T.S. and R. ALLEY. Lancet I967, 2 »
854.
DAVID, J.S.K., P. MALATHI and J. GANGULY. 
Biochem. J. 1966, 98, 662.
DAVIES, B.H., D. JONES and T.W. GOODWIN.
Biochem. J. 1963, 82_, 326.
DAWBER, T.R., W.B. ICANNEL, N. REVOTSKIE and 
A. ICAGAN. Proc. roy. Soc. Med. 1962, 55,
265.
DE FOURCROY. Ann. chim. 1789, £, 2 42. 
see "Cholesterol" R.P. Cook. Academic 
Press Inc. New York, 1958» p.l.
DENBOROUGH, M.A., R.R.H. LOVELL and G. TREVaKS. 
Mod. J. Aust. 1963» 1 » 498.
DE VRIES, B. Chem. Ind. I962, 1049.
DIETSCHY, J.M. and M.D. SIPERSTEIN. J. clin. 
Invest. 1965» 4 4 , 1311.
311.
ENEROTH, P. J. Lipid Res. I963, 4 , 1 1 .
ENEROTH, P., B. GORDON, R. RYHAGE and J. 
SJOVALL. J. Lipid Res. 1966(a)2 , 5II.
ENEROTH, P., B. GORDON and J. SJOVALL. J. 
Lipid Res. 1966(b),2 , 524.
ENEROTH, P., K. HELLSTROM and R. RYHAGE.
J. Lipid Res. 1964, £, 245 «
ERICKS ON, B .A ., R.H. C OOTS, E.H. MATTS ON 
and A.M. KLIGMAN. J. clin. Invest. 1964,
42, 2017.
ERIKSSON, S. Proc. Soc. Exptl. Biol. Med. 
1957, £4 , 582.
EYSSEN, H., E. EVRARD and H. VANDSRHAEGHE.
J. Lab. clin. Med. I966, 68, 753.
FAILEY, R.B., (Jr.) E. BROWN and M.E. HODSS.
Circulation 1959, 2 0 , 984.
FAILEY, R.B., (jr.) R.Hi CHILDRESS and T.P.
McCONAHAY. Amer. J. clin. Nutr. 1962,
10. 158.
FASOLI, A, and A. CESANA. J, Atheroscler, 
Res. 1963, 2, 4.75.
FELDM/H, E.B. and A.C. CARTER. Metabolism
1963, 12, 1132.
FLEISCHMiVN, A.I., H. YACOWITZ, T. HAYTON and 
M.L. BISRENBAUM. J. Nutrition 1967, 9 1 .
151.
FOWEATHER, P.S. Brit. J. exptl. Path. I926,
Z, 15.
FRANTZ, I.D. (Jr.J, M.L. MOBBERLEY and G.J. 
SCHROEPFER (jr.). Progr. in cardiovasc. 
Disease i960, 2 , 511.
312.
FRANTZ, I,D, (Jr.), H.S. SCHNEIDER and B . T . H .  
HINKELMAN. J. biol. Chem. 195^» 206, 465.
FREDRICKSON, D.S. and K. ONO. Biochim.
Biophys. Acta. 195^, 22, I83.
FRIEDMAN, M . , S.O. BYERS and R.H. ROSENMAN. 
Circulation‘^d.952, 657.
OANSHIRT, H. , F.¥. KOSS and K. HORIANZ.
Arzneimittel-Forsch. I960, 10, 9^3*
G E R S O N ,  T., F . B .  S H O R L A N D  and G. G .  D H N C K L E Y . 
Nature, I963, 200, 579*
GERSON, T., F.B. SHORLAND and G.G. DUNCKLEY. 
Biochem. J. I965, £ 6, 399-
GILDEA, E.F., E.B. M/LN and J.P. PETERS. J.
Clin Invest. 1939» M »  739.
G L O V E R ,  J. and 0. G R E E N ,  "Biochemical Problems 
of Lipids". Popjak and Le Breton, 1935 »
p. 359.
G L O V E R ,  J. and C. G R E E N .  Biochem. J. 1957,
il, 308.
GOBLEY, M. J. pharm. chem. 1846, 2.9 8l . see 
"Cholesterol" R.P. Cook. Academic Press Inc.
New York, 1958, p. 2.
G O L D S M I T H ,  G.A, Fed. Proc. (Suppl. ll) I962,
21, 81.
GOLDSMITH, G.A., J.G, HAMILTON and O.N. MILLER. 
Arch, intern. Med, I960, 105, 512.
G O O D M A N ,  L.3. and A. GILMiVN. "The Pharmacological 
Basis of Therapeutics", Collier-Macmillan Ltd., 
London, 1965» 3^ ci Edition, p. 759*
313
GOOLDEN, A.\J.G. L a n c e t  I956, 1 , 890.
GOULD, R.G. Amer. J. Med. 1951, Ü ,  209.
/•
GOULD, R.G. and G. POPJAK. Biochem,. J. 1957, 
66. 5IP.
GREEN, K.G.-,-~W.H.W. INMjVN and J.M. THORP,
J. Atheroscler. Res. 1963, 2.» 5 93*
GREEN, K. and B. SAMUELSSON. J. Lipid Res. 
1964, 117.
GROSS, J., R. PITT-RIVERS and W.R. TROTTER. 
Lancet I952, 1 , 1044.
GRUNDY, S.M., E.H. AHRENS (jr.) a n d  T.A. 
MIETTINEN. J. L i p i d  Res. I965, 6, 397.
HilAHTI, E. and T. NIKKARI. Acta Chem. Scand.
1963, 17, 536.
HAAHTI, E., T. NIKKARI and K. JUVA. Acta.
C h e m .  Scand. I963, 1%, 538.
HAMILTON, J.G. Arch. Biochem. Biophys. I963,
101. 7.
HAMILTON, J.G. and J.E. MULDREY. J. Amer,
oil. chem. Soc. I961, 5 82.
HANSEN, P.P. J. Atheroscler. Res. I963, 3 ,
584.
H A R R X S O N ,  G . A ,  i n  C h e m i c a l  M e t h o d s  i n  C l i n i c a l  
M e d i c i n e .  G # A .  H a r r i s o n ,  Ed. L o n d o n ,  J, a n d  
A. C h u r c h i l l  Ltd., 19^9 » P # 49^.
H A R R I S O N ,  M . T ,  a n d  R. M c G .  H A R D E N .  S c o t . med.
J. 1966, 11, 213.
314.
HAUST, H.L. and J.M.R. BEVERIDGE. J. Nuti’ition
1963, 81, 13.
HAUST, H.L. and J.M.R. BEVERIDGE. Canad. J. 
Biochem. 1964, 4 2 , 251 »
HEFTMANN, E. Annual Review of Plant Physiology
1965, 1 4 ;~ 225.
HELLM/IN, L. , E.L. FRAZELL .and R.S. ROSENFELD.
J. din. Invest. I96O, 3 9 , 1288.
HELLMAN, L., R.S. ROSENFELD, W. INSULL (jr.) 
and E.H. AHRENS (Jr.). J. din. Invest. 1957,
36. 898.
HELLMAN, L. , B. ZU>10FF, G. KESSLER, E. lOULV, 
I.L. RUBIN and R.S. ROSENFELD. iVnn. intern. 
Med. 1963, 477.
HELLSTROM, K. and S. LINDSTEDT. J. lab. din. 
Med. 1964, 6^, 666.
HELLSTROM, K. and S. LINDSTEDT. Amer. J. din. 
Nutr. 1966, 18, 4 6 .
HELLSTROM, K. and J. SJOVALL. J. Atheroscler. 
Res. 1961, _1 , 205.
HELLSTROM, K. and J. SJOVALL. J. Lipid Res.
1962, 2 > 397.
HENDRY, E.B. Brit. med. J. I96O, 2 , 975.
HERRMANN, R.G. Circulation Res. 1959, %, 2 24.
HERNANDEZ, H.H., D.W. PETERSON, I.L. CHAIKOFF 
and W.G. DAUB EN. Proc, Soc. Exptl. Bid.
Med. 1953, 83, 498.
315.
HOFMANN, A.F. J. Lipid Res. I962, 2 f 127.
HOFMANN, A.F* in "Biochemical Problems of 
Lipids" A.C. Frazer ed., Elsevier, 
Amsterdam, I963, p .1.
HOFMANN, A.F. and B. BERGSTROM. Fed. Proc.
1962, 21V ^3-
HOLMES, W.L. and N.W.Di TULLIO. Amer. J. 
din. Nutr. 19^2, 10, 310.
HORNING, E.G., H.J.A. VANDENHEOTEL and B.G. 
CREECH, Methods in Biochemical Analysis.
1 9 6 3 , 1 1 , 6 9 .
HOTTA, S. and I.L. CHAIKOFF. Arch. Biochem, 
Biophys. 1953» 3^> 28.
HOVE, E.E., D.K. B O S S H a R D T  and J.W. HUFF. J. 
Nutrition I96O, %2, 379.
HUTTON, H.R.B. and G.S. BOYD. Communication at 
the Annual Meeting on .the Chemistry of Lipids, 
Stockholm, 1983* see "Cholesterol, Bile Acids 
and Atherosclerosis" H. Van Belle, North™ 
Holland Publishing Company, Amsterdam, I963,
p. 75.
lACONO, J.M., J.F. MUELLER and C.B. AMMERMAN. 
Fed. Proc. I960, 1^, I5 .
IVY, A.C., E. lOVRVINEN, T.M. LIN and E.K. IVT.
J. appl. Physiol. 1957» 11 » 1 #
JACOBSEN, E.D., R.B. GHODOS and V.V. FALCON. 
Amer. J. Med. 19^0, 3^, 524.
JANÎOIU, L. Arch, exptl, Pathol. Pharmakol.
1892, 29, 237.
3 1 6
JOLLIFFE, N. Metabolism I96I, 10, 497.
KAPLAN, J.A., G.E. COX and C.B. TAYLOR. Arcb. 
Pathol. 1963, %6, 359.
KARP, A. and D. STETTEN(jr.) J. biol. Chem.
1949, 112» 819.
ICilRVINEN, E. , T.M. LIN and A.C. IVY. J. appl. 
Physiol. 1957, LI, l43. ,
KAUFMANN, H.P. and Z. MAKUS. Fette, Seifen, 
Anstriohmittel, I96O, 62, 10l4.
ICAUNITZ, H. , D.C. MiVLINS and D.G. McKAY. J.
Exptl. Med. 1962, 115, 1127.
KAYSER, F. and R. BALAT. Bull. soc. chim. 
biol. 1952, 24, 8O6 .
KEYS, A., J.T. ANDERSON and F. GRANDE. Lancet 
1957(a) 1 , 66.
KEYS, A., J.T. /iNDERSON and F. GRANDE. Lancet 
1957(b), 2, 959.
KEYS, A., J.T. ANDERSON and F. GRANDE. Metabolism
1965, 14, 759.
KEYS, A., H.L. TAYLOR, H. BLACKBURN, J. BROZEK, 
J.T. ANDERSON and E. SIMONSON. Circulation
1963, 28, 381.
KIMM, K.S. and A.C. IVY. Amer. J. Physiol. 1952,
171. 302. '
KINSELL, L .W. "Progress in the Chemistry of Fats 
and other Lipids" ed. R.T. Holman, V.O.
Lundberg and T. Malkin, New York, I963, p. I3S.
317.
KNUCHEL, F. Med. Welt. 1964, 2530.
KOBAYASHI, J. Ber. Ohara. Inst. 1957, Ü ,  1 2 . 
KRELL, K. and S.A. HASHIM. J. Lipid Res. I963,
4 , 407. '■
KRITCHEVSKY 
Sons Inc.
KRITCHEVSKY 
Sons Inc.
KRITCHEVSKY 
Sons Inc.
KRITCHEVSKY
IŒITCHEVSKY
D. "Cholesterol" John Wiley and
New York, 1958(a), p. 75.
D. "Cholesterol" John Wiley and
New York, 1958(b), p. II6.
D. "Cholesterol", John Wiley and 
New York, 1958(c), p. 188.
D. Metabolism I960, £, 9 8 4.
D. Penn. Med. J. I96I, 6 4, 188.
ICURON, G.W. and D.M. TENNENT. Fed. Proc. I96I,
20, 268.
LACK, L. and I.M. WEINER. Amer. J. Physiol.
1961, 200. 313.
LACK, L. and I.M. WEINER. Fed. Proc. I963,
22, 1334.
LANGDON, R.G. and K. BLOCH. J. biol. Chem.
1953, 202, 77.
LAUBINGER, G. Fortschr. Med. 1964, 82 ,^ 783.
LECANU, L.R. Ann. chim. et. phys. I838, 67 « 5 4 , 
see "Cholesterol" R.P. Cook. Academic Press 
Inc. New York, 195Ô» p. 2,
3 1 8 .
LINDSEY, C.A. and J.D. WILSON. J. Lipid Res.
1965, 6, 173.
LINDSTEDT, S. Acta. chem. Scand. 1956, 10.
1051.
LINDSTEDT, S. Acta. chem. Scand. 195?(a).ll. 4l7.
LINDSTEDT, S. Acta, physiol. Scand. 1957(b),4o.
1 .
LINDSTEDT, S., J. AVIGAN, De WITT S. GOODMAN,
J. SJOVALL and D. STEINBERG. J. din. Invest.
1965, 44, 1754.
LITTLE, H.N. and K. BLOCH. J. biol. Chora. 1950,
182, 33.
McKILLICAN, M.E. and R.P.A. SIMS. J. /oiier.
Oil Chem. Soc. 1963, W ,  I08.
MAIBACH, E. Schweiz. Med. Wchnschr. I967, 97, 
4l8.
MALINS, D.C. and J.C. WEKELL. J. chem. Educ.
1963, 4o, 531.
MALMROS, He and B. SWAKN. Acta. med. Scand.
1953, 142, 361.
MALMROS, H. and G. WIGAND. Lancet 1957, 2 ,
1.
MANN, G.V., S.B. ANDRUS, A. McNALLY and F.J. 
STARE. J. exptl. Med. 1953, ^ 8 , 195•
MARTENSSON, E. Acta Chem. Scand. I963, 17.
1174.
MAYER, G.A., W.F. CONNELL, M.S. de WOLFE and 
J.M.R. BEVERIDGE. Amer. J. din. Nutr. 1954,
2 , 316.
319.
MES SINGER, V.J., Y. P0R0S0WSK.4 and J.M. STEELE. 
Arch, intern. Med. 1950» 86, I89.
MICHALEC, C. J. Lipid Res. I963, k, 110.
MICILALEC, C. , M. SULC and J . MESTAN. Nature
1962, 193. 63.
MIETTINEN, T.A., E.H. AHRENS (Jr.) and S.H. 
GRUNDY. J. Lipid Res. I965, 6 , 4ll.
MILLER, O.N., J.G. HAMILTON and G .A . GOLDSMITH. 
Amer. J . din. Nutr. I96O, 480.
MILLER, O.N., J.G. HAMILTGN and G .A . GOLDSMITH. 
Amer. J . clin. Nutr. 1962, ^0, 285.
MOORE, R.B., J.T. ANDERSON, A. KEYS and I.Û. 
FRANTZ. J. Lab. din. Med. I962, £0, 1000.
MORRIS, J.N., M.D. CRAWFORD and J.A. HEADY. 
Lancet I96I, 1, 860.
MORRIS, J.N., M.D. CRAWFORD and J.A. HEADY. 
Lancet I962, 2» 506.
MORRIS, J.N.,'A. KAGAN, D.C. PATTISON, M.J. 
GARDNER and P.A.B. RAFFLE. Lancet, 1966,
2 , 553.
MORRIS, L.J. Chem. Ind. I962, 1238.
MORRIS, L.J. J. Lipid Res. I963, 4, 357.
MOSBACH, E.H., J. BLUM, E. ARROYO and S. MILCH. 
Anal. Biochem. 1963» 2» 158.
MUELLER, J.H. J. biol. Chem. 1915, 22, 1.
MURTHY, S.K ., J.S.K. DAVID and J . GANGULY. 
Biochem. Biophys. Acta. I963, 70, 490.
3 2 0 .
NESTED, P.J., S.Z. niRSCH and E.A. COUZSNS.
J, d i n  Invest. I965, 44.» 89I.
NICHOLS, G.W. (Jr.), M.D. SIPEUSTEIN and I.L. 
CHAIKOFF. Proc. Soc. Exptl. Biol. Med.
1953, 756.
NORDIN, B.E.'Cl-and D.A. SMITH. "Diagnostic 
Procedures in Calcium Metabolism" (London)
J.A. Churchill Ltd. 1963-, p. 166.
NORMIN, A. Acta physiol. Scand. 1955, 22> 99«
NORMAN, A. and J. SJOVALL. J. biol. Chem.
1958, 231, 8 7 2.
NUNN, S.L., W.N. TAUXS and J.L. JUERGENS. 
Circulation I961, 24, 1099«
NUTRITION REVIEWS 1964, 22, 326-328.
OLIVER, M.F. Lancet I962, _1, 1321.
OLIVER, M.F. J. Atheroscler. Res. I963, 1, 427.
OLIVER, M.F. and G.S. BOYD. Lancet 1956, 2, 1273.
PANTON and MARRICK "Clinical Pathology", (London), 
J.A. Churchill Ltd. 1934.
PARSONS, R.S., T.C. BUTLER and E.P. SELLARS.
Lancet 1961, 2, 213.
PARSONS, W.B. (Jr.). Circulation I961, 24,
1099.
P E T S R S O N ,  P . W .  P r o c .  Soc. E x p e r .  B i o l . M e d .
1951, 18, 143.
PETERS, J.P. and E.B. MAN. J. din. Invest.
1950, 29, 1.
3 2 1 .
PIHL, A. Acta physiol. Scand. 1955(b),34, I83.
PIHL, A. Acta physiol. Scand. 1955(a).34, 206.
PITT-RIVERS, R. and J.R. TATA in "The Thyroid 
Hormones". London, Pergamon Press, 1959,
PS- 79.
POLLAK, O.J. Circulation 1953, 7, 696.
POLONOVSKI, M. and R. BOURRILLON. Bull. soc. 
chim. biol. 1952, 24, 703.
POPJAK, G. and J.W. CORNPORTH. Biochem. J.
1966, 101, 553.
PORTMAN, O.W. Arch. Biochem. Biophys. 1958, 78,
125.
PORTMAN, O.W. and G.V. MANN. J. biol. Chem. 
1955, 212, 733.
PORTMAN, O.W. and F.J. STARE. Physiol. Rev.
1959, 22. 407.
POWELL, R.C., W.T. NUNES, R.S. HARDING and 
J.B. VACCA. Amer. J. d i n  Nutrition I962,
11, 156.
PREZIOSI, P. "Lipid Pharmacology" ed. R.
Paoletti, New York/Basel, 1964, vol. 2. p.442.
PRIOR, I.A.M. and D.G. CAMPBELL. N.Z. Med. J.
1963, 62, 538.
RANNEY, R.E. and R.E. COUNSELL. Fed. Proc.
1962, 21, 96.
REID, J. in "Drugs Affecting Lipid Metabolism"
S. Garattini and R, Paoletti eds*, Elsevier, 
Amsterdam, I96O , p. 4-23.
3 2 2 .
RODBARD, S., C. BOLENE, R. PICK and L.N. KATZ. 
Circulation 1950, 2, 4?9.
ROSENFELD, R.S., D.K. FUKUSKIMA, L. HELLMAN 
and T.F. GALLAGHER. J. biol. Chem. 1954,
211, 301.
ROSENFELD, ■RTS', and L. HELLMAN. Arch. Biochem. 
Biophys. I962, 2Z» 406.
ROSENHEIM, O. and H. KING. Chem. and Industry
1932, 2 1 , 954.
ROSENHEIM, 0. and T.A. WEBSTER. Biochem. J.
1943(a),2 1 , 513.
ROSENHEIM, O. and T.A. WEBSTER. Biochem. J.
I 943( b i21> 5 8 0 .
ROSENMAN, R.H., M. FRIEDMxiN and S.O. BYERS. 
Circulation 1952, 2> 5^9 •
RYAN, W.G. and T.B. SCHWARTZ. J. Lab. din.
Med. 1964, 6^, 1001. .
SACHS, B.A. and L. WÜLFMAN. Circulation I962,
2 6 , 6 6 9 .
SACHSJ B.A. and L. WOLFMAN. Arch, intern. Med,
1 9 6 5 ,  1 1 6 , 3 6 6 .
SAKAKIDA, H., C.C. SHEDIAC and M.D. SIPERSTEIN. 
J. din. Invest. I963, 42, I521 «
SAMUEL, P. and A. STEINER. Proc. Soc. Exptl. 
Biol. Med. 1959, 100, 193.
SAMUEL, P. and M.S. WAITHE. Circulation I961,
24. 578.
SCHOENHEIMEH, R. , H. BEHRING, R. HU>ÎMEL and
L. SCHINDEL. Z. physiol. Chem. 1930, 192, 73.
o23.
SCHOENHEIMEU, R. and E. BREUSCH. J. biol.
Chem. 1933, 103. 439.
SCHROEDER, H.A. J. Amer. med. Ass. I960, 172.
1902.
SEIDEL, J.cy, If. NATH and A.E. HARPER. J.
Lipid Res. I960, X, 4?4.
SEMENUK. G. and W.T. BEHER. J. Chromatog.
1966, 21, 27.
SETTY, C.S.N. and A.C. IVY. Amer. J. Physiol.
i960, 199. 1003.
SIPERSTEIN, M.D., I.L. CHAIKOFF and W.O.
REINHARDT. J. biol. Chem. 1952, I98. 111.
SIPERSTEIN, M.D. and I.L. CHAIKOFF. J. biol. 
Chem. 1952, 198. 93.
SIPERSTEIN, M.D. and V.M. FAGAN. J. biol.
Chem. 1966, 241, 602. •
SIPERSTEIN, M.D.', V.M. FAGAN and J.M. DIETSCHY. 
J. biol. Chem. I966, 241. 597.
SIPERSTEIN, M.D. and M.J. GUEST. J. din. 
Invest, i960, 39 » 642.
SIPERSTEIN, M.D., F.M. HAROLD, I.L. CHAIKOFF 
and W.G. DAUBEN. J. biol. Chem. 1954, 210. 
181.
SIPERSTEIN, M.D., C.W. NICHOLS (jr.) and I.L. 
CHAIKOFF. Circulation 1953(a), %, 37.
SIPERSTEIN, M.D., C.W. NICHOLS (jr.) and I.L. 
CHAIKOFF. Science 1953(b), 117. 386.
SJOVALL, J. Proc. Soc. Exptl. Biol. Med. 1959,
100. 676.
324
SJOVALL, J. C l i n .  chim. Acta, i960, 2, 33«
SPiîITZ, N. Circulation I965, 11_ ( Suppl. 31-32; ,
201 .
S P R I T E , N. , C.H. AHjIENS ( Jr. ) a n d  S. G R U N D Y .
J . d i n .  I n v e s t .  I965, 44, 1482.
SRERS, P.A., I.L. CHAIKOFF, S.S. TRSITMHT and 
L.S. BURSTEIN. J. bid,. Chem, I93O, 182. 629.
STAHL, E. P h a r m a z i e  I956, IjL, 633.
STEIN, Y. and 0. STEIN. J. Atlieroscler. Res.
1962, 2 , 400.
S T E I N B E R G ,  D. a n d  J. A V I G A N  in  B r a g s  A f f e c t i n g  
Lipid Metabolism. 3 . Go.rattine and R. Paoletti 
eds,, Elsevier, Amsterdam, 1^6 0(a) p . 132.
S T E I N B E R G ,  D. a n d  J. A V I G A N .  J. b i d .  C h e m .  1960(b)
32» 3127.o a
STEINBERG, D., J. AVIGAN and E.B. FEXGSLSON.
Progr. in cardiovasc. Disease I96O, 2,, -586.
STEINER, A. and B. DOMVKSllI. Amer. J. med. Sci.
1941, 201, 820.
STEINER, A., E. HOWARD and S. AKGUN. Circulation
1961, 24, 729.
STEINER, A. and F.E. KENDALL. A.M.A. Arch. Pathol. 
1946, 42, 433.
STOKES, W.M., W.A. FISH and F.C. HICKEY. J. 
biol. Chem. 1955, 213, 325.
STRISOWER, B., J.W. GOFMAK, G.F. GALIONI, A.A. 
AL^LIDA and A. S I M O N .  Metabolism^ Clin, and 
Exptl. 1954, 2> 218.
325
STRISOWER, E.H. and 3. STRISOWER. J. din.
Endoc. Metab. 1964, 139.
STRISOivER, E.H. , A.V. NICHOLS, F.T. LINDGREN and 
L. SMITH. J. Lab. din. Med. I965, 62, 748.
SVOSODA, J.A. and M.J. THOMPSON. J. Lipid Res.
1967, 8 ,--1-52.
SWARTWOUT, J.R., J.W. DIECKERT, O.N. MILLER and 
J.G. HiU'IILTON. J. Lipid Res. I96O, 2» 281.
SWEELEY, C.C. and B. KLIONSKY. J. biol. Cliem. 
1963, 238 PC. 3148.
SWELL, L ., T.A. BOITER, H . FIELD (jr.) and C.R. 
TREADWELL. Proc. Soc. Exptl. Biol. Med.
1954, 86, 295.
SWELL, L . , D.F. FLICK, H. FIELD (Jr.) and C.R.
TREADWELL. Proc. Soc. Exptl. Biol. Med.
1953, 84, 428.
SWELL, L ., E.C. TROUT (Jr.), H . FIELD (Jr.) and
C.R. TREADTfELL. J. biol. Chem. 1959, 234,
2286.
SWELL, L., E.C, TROUT (Jr.), J.R. HOPPER, H.
• FIELD (Jr.) and C.R. TREADWELL. J. b i d .
Chem. 1958, 222, 49.
TAYLOR, C.B. and K-J. HO. Arch. Pathol. 1967, 84
3 .
TAYLOR, C.B., B. MIKEELSON, J.A. ANDERSON, D.T.
F O H M I N  a n d  S.S. C H O I .  E x p e r .  a n d  M o l .  P a t h .  
1965, 4 , 480.
TECHNIC ON AOTOiVNALYSER MANUAL, Method N.' 24P.
TENNENT, D.M. , G.W. ICURON, M.E. ZANETTI and 
W.H. OTT. Proc. Soc. Exptl. Biol. Med.
1961, 108, 214.
3 2 6
TENNENT, D.M., H. SIEGEL, M.E. ZANETTI, G.W.
KURON, W.H. OTT and F.J. WOLF. J. Lipid 
Res. i960, 1, 469.
THORP, J.M. Lancet I962, 1, 1323.
THORP, J.M. J. Atheroscler. Res. 19^3, 2» 351*
THORP, J.M. and W.S. WARING. Nature I962, 194,
948.
TOMKINS, G.M., H. SHEPPARD and- I .L . CHAIKOFF.
J. biol. Chem. 1953W 201. 137.
TOMKINS, G.M., H. SHEPPARD and I.L. CHAIKOFF.
J. biol. Chem. 1953(b),202» 781.
TREADWELL, C.R., L. SWELL and G.V. VAHOUKY.
Fed. Proc. I962, 2_1, 903.
TREADWELL, K., L. SWELL, G.V. VAHOHNY and H.
FIELD (Jr.). J. Amer. Oil Chem. Soc. 1959,
2 6 , 107._
TYGSTRUP, N., K. mNKLEP' and K, JORGENSEN in
"Drugs Affecting Lipid Metabolism", S. Garattini 
and R. Paoletti eds•, Elsevier, Amsterdam,
i960, p. 493.
TYGSTRUP, N ., K . WINKLER and E . WARBURG.
Lancet 1959, 1, 503.
VAHOUNY, G.V. and C.R. TREADWELL. Amer. J.
Physiol. 1958, 195. 516.
VAN BELLE, H. - "Cholesterol, Bile Acids and 
Atherosclerosis". North-Holland publishing 
Company, Amsterdam 1963? P* 77*
VAN DEN BOSCH, J. and P. CLAES. Progress in 
Biochemical Pharmacology" D. Kritchevsky, R. 
Paoletti and D . Steinberg eds, Basel, S.
ICarger, A.G. I967, vol. 2, p. 97*
327.
VAN HANDEL, E. and D,G. ZILVERSMIT. J. lab. 
Clin. Med. 1957, 22> ^52.
VAN TAMELEN, E.E., J.D. WILLETT, R.B. GLAYTON 
and K.E. LORD. J, Araer. Chem. Soc. Igoé,
88. 4752.
WAINFAN, E., G. HENKIN, L.I. RICE and W. MARX. 
Arch. Biochem. Biophys. 1952, 2S.» L87.
WALTON, K.W., P.J. SCOTT, J.V. JONES, R.F. 
FLETCHER and T. WHITEHEAD. J. Atheroscler. 
Res. 1963, 2» 396.
WANG, C.I., L.E. SCHAEFER, S.R. DRACHMAN and
D. ADLERSBERG. J. Mt. Sinai Hosp. N.Y.
1954, 21, 19.
WEISS, S.B. and W. MARX. J. biol. Chem. 1955,
213. 349.
WELLS, V.M. and B. BRONTE-STEWART. Brit. med.
J. 1963, 1, 577.
WELLS, W.W. Arch. Biochem. Biophys. 1957, 66.
217.
WELLS, W.W. and S.B. COOPER. Arch. Biochem, 
Biophys. 1958, 273.
WELLS, W.W. and P.A. MORES. Nature 1961, 189. 
483.
WIGGINS, H.S. and I.D.P. WOOTTON. Biochem.
J. 1958, %o, 349.
WILSON. J.D. J. Lipid Res. I961, 2, 350.
WINDAUS, A. Nachr, kgl. Ges. Win. Gottingen, 
Math-physik, K1. 1919? P# 237»
WINDAUS. A. Z. physiol. Chem. 1932, 213. l47.
328.
W O O D ,  P . D . S . ,  R. S H I 0 D A  a n d  L . W ,  K I N S E L L .  
L a n c e t ,  I 9 6 6 , 2» 6o4.
W O O T T O N ,  I . D . P .  a n d  H . S .  W I G G I N S .  H i o c h e m .
J. 1 9 5 3 , 1 2 ,  292.
YAG 0WITZ , H . , A.I. FLEISCHM-VN a n d  M . L .
BIERBNBATO'K—  B r i t .  m e d .  J. I 9 6 5 , 1, 1 3 5 2 .
ZAK, B . , R . C .  D I C K E N M i N , E . G .  W H I T E ,  H. B U R N E T T  
a n d  P.J. C H E R N E Y .  A m e r .  J. d i n .  P a t h o l .
1 9 5 4 , 24, 1 3 0 7 .
